Articles of Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences | Volume , Issue suppl.1 / 2014

Search by Journal

HOME
> Search by Journal
> Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2014

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	The clinical pharmacy frontier which opens up new age 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2014.

	It is ... from a viewpoint of recollection of 1 clinical pharmacy and fine-view - healthcare setting and academia 乾賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2014.

	2 Leading the Pharmacy Enterprise to Ensure Continuity of Patient Care Scott J.Knoer Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2014.

	New flow of 3 cancer immune therapy 珠玖洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2014.

	About 1 new pharmacy education model core curriculum 太田茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2014.

	1 revision pharmacy education model core curriculum <F pharmacy clinical practice and business training> which turn big 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2014.

	As for 2 hospital pharmacist regular Tolly science 平山佳伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2014.

	Prescription adequacy by the pharmacokinetic analysis of the side effect case 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2014.

	Improvement of the quality of pharmacist duties in the cancer medical therapy and study on clinical evaluations 中島誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2014.

	Mechanism elucidation of the side effect expression that assumed PK-PD theory a base and search of the risk factor 永田将司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2014.

	Pharmaceutical intervention about antimicrobial medicine proper use, Clinical application of pharmacokinetics-pharmacodynamics 浜田幸宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2014.

	Role of large intestine aquaporin 3 in the catharsis effect of osmotic laxative magnesium sulfate and large intestine irritant cathartic bisacodyl 五十嵐信智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2014.

	Study about decomposing it of the pharmaceutical products waste fluid using the electrolysis 小林豊英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2014.

	Pharmacokinetic and pharmacodynamic clinical studies of prochlorperazine in patients with opioid analgesic administration cancer 田代将貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2014.

	Study on role of the mTOR course in exacerbation and the restoration of the renal tubule lesion 中川俊作 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2014.

	Learning from CDTM of the 27-A-S1-1 United States 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2014.

	Introduction ... of the formula Lee introduction case in our practice ... House of the medical treatment by local formula Lee in the 27-A-S1-2 U.K. 上田彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 22-22, 2014.

	Of the CDTM education in the 27-A-S1-3 University, actually 山下美妃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2014.

	The fact and problem of the duties in the 27-A-S1-4 drugstore 飯島康典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 23-23, 2014.

	Point on taking the good communication with the 27-A-S2-1 patients 藤崎和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2014.

	To face sense of values of the each 27-A-S2-2 patients; the educational inflection of the talk of health and the illness 後藤惠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2014.

	Introduction of communication skill training (CST) which utilized the way of 27-A-S2-3 simulated patient who put the principal objective to return 半谷眞七子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2014.

	Development and the inflection of the communication skill measure in the 27-A-S2-4 pharmacist 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2014.

	27-A-S3-1 International contribution of Japan's pharmaceutical administration 日本の薬事行政の国際貢献 Yasuhiro Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2014.

	27-A-S3-2 Establishment and Application for the Rational Drug Use Management Platform Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 28-28, 2014.

	27-A-S3-3 Survey for the experience of Hospital Pharmacy hands-on training in Korea Hyewon Han Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2014.

	27-A-S3-4 The role of therapeutic drug monitoring (TDM) in pharmaceutical service of China Zhao Li Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2014.

	27-A-S3-5 Clinical trial implementation system at Okayama university hospital Nagai Miki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2014.

	27-B-S4-1 perioperative medical care and pharmacist, the next move 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2014.

	We think about the figure which should have the remedy medicine pharmaceutical management in preoperation in 27-B-S4-2 perioperative care 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2014.

	How long can 27-B-S4-3 pharmacist be concerned with the management in the operation? 小西寿子, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2014.

	27-B-S4-4 postoperative patients follow-up technique 柴田ゆうか, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2014.

	We join pharmaceutical management together until discharge adjustment before 27-B-S4-5 hospitalization 奥貞智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2014.

	A physician demand it from a pharmacist in 27-B-S5-1 ambulatory practice 岸田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2014.

	27-B-S5-2 cancer survivor expect it from a pharmacist 溝口綾子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2014.

	Action to the treatment at home by the 27-B-S5-3 opening of an office pharmacist 中野正治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2014.

	Pharmacist outpatient department for patients with 27-B-S5-4 diabetes 大西順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2014.

	Action - of pharmacist interview - joint management in the 27-B-S5-5 respiratory organs / sleep outpatient department 伊藤光 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2014.

	The present conditions and directionality of the pharmacist duties in the 27-B-S6-1 outpatient department chemotherapy room 松尾宏一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2014.

	Evidence by a pharmacist being associated with 27-B-S6-2 outpatient department chemotherapy 林稔展 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2014.

	Role (1) of the pharmacist in the 27-B-S6-3 outpatient department chemotherapy - Duties - that a pharmacist should be carried out 組橋由記 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2014.

	Role (2) of the pharmacist in the 27-B-S6-4 outpatient department chemotherapy - Duties - necessary for team approach in medical care 黒田純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2014.

	Role (3) of the pharmacist in the 27-B-S6-5 outpatient department chemotherapy - Duties - that we went step further 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2014.

	In hope of the extermination of specialty, the harmful effect to expect of a pharmacist from the situation of the 27-C-S7-1 patients and 金田和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2014.

	Expectation to a pharmacist in the 27-C-S7-2 acute phase medical care team 足立裕史1, 沼口敦1,2, 宮川泰宏3, 阪井祐介3, 松田直之4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2014.

	Specialty to expect of a pharmacist from the situation of the 27-C-S7-3 nurse 荒井有美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2014.

	Specialty of the pharmacist judging from the viewpoint of the specialized pharmacist according to 27-C-S7-4 domain, the disease 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2014.

	Specialty of the pharmacist judging from the viewpoint of the pharmacist specialized in 27-C-S7-5 medical therapy 三浦篤史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2014.

	Evaluation of CDTM to practice in pharmacist outpatients (support outpatient department) specialized in 27-C-S8-1 cancer 今村牧夫1,2, 松井裕典1, 上原孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2014.

	27-C-S8-2 joint medical treatment management: Dispatch of competency and the evidence of the clinical pharmacist necessary for practice 土手賢史, 澤井麻記, 野崎歩, 小林由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 48-48, 2014.

	Outcome evaluation of the pharmacist duties in the 27-C-S8-3 ward 鈴木昭夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2014.

	Outcome evaluation of the pharmacist outpatient department for the 27-C-S8-4 oral anticancer agent 松井礼子, 川澄賢司, 森田智子, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2014.

	The pharmaceutical management and the outcome evaluation aiming at risk aversion of the 27-C-S8-5 perioperative period 北田徳昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2014.

	Value ... of the pharmacist outpatient department support that we saw from outcome evaluation - physician of the joint medical treatment management (Japanese type CDTM) in the 27-C-S8-6 OAB treatment 永江浩史1, 前堀直美1, 安田公夫2, 岩崎智奈美1,2, 重山昌人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2014.

	Matters that require attention at the drug administration for patients with 27-D-S9-1 renal failure: It is the role to be assumed by the pharmacist in chronic kidney disease (CKD) practice 安田宜成, 柴田佳菜子, 松尾清一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2014.

	The medical therapy for patients with 27-D-S9-2 diabetic nephropathy: Prevention of extension of the diabetic nephropathy 秋吉明子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 52-52, 2014.

	Prevention of the decreased renal function with the appropriate immunosuppressive therapy for 27-D-S9-3 autoimmunity-related renal disease, renal-transplant recipients 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2014.

	For the prevention of the decreased renal function due to the 27-D-S9-4 drug-related renal failure 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2014.

	Summary of 27-D-S10-1 kidney disease medical therapy specialty, the authorized pharmacist 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2014.

	Pharmaceutical management for the decreased renal function patients early for 27-D-S10-2 CKD stage G1, stage 2 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2014.

	27-D-S10-3 CKD stage stage G3: Pharmaceutical management for the moderate decreased renal function patients 大野能之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2014.

	27-D-S10-4 CKD stage G4, stage G5: Pharmaceutical management for the extensive decreased renal function patients 古久保拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 56-56, 2014.

	27-D-S10-5 CKD stage stage G5D: Pharmaceutical management - group management for patients on dialysis and individual medication counseling ... 浦田元樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2014.

	The present conditions and importance of the antimicrobial surveillance in the 27-D-S11-1 inside and outside the country 笠原敬1, 重田純一2, 岡西康治2, 三笠桂一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2014.

	The results of the antimicrobial consumption surveillance of the nosocomial infection measures meeting attached to the 27-D-S11-2 country public university and future problem 西村信弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2014.

	Method of the antimicrobial surveillance to work on in 27-D-S11-3 area and how to use results 室高広, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2014.

	Inflection of a summary and data of the 27-D-S11-4 Ministry of Health, Labour and Welfare hospital infection measures surveillance (JANIS) business 鈴木里和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2014.

	The practice management at the 27-E-S12-1 immune function drop 今村顕史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2014.

	27-E-S12-2 immunodeficiency and HIV infection 横幕能行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2014.

	27-E-S12-3 malignant tumor and immunodeficiency 石原正志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2014.

	27-E-S12-4 elderly people complications and HIV infection 関根祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2014.

	Positioning of the medical treatment in 27-E-S13-1 pressure sore treatment 磯貝善蔵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2014.

	Because seamless medical treatment is provided for 27-E-S13-2 pressure sore 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 65-65, 2014.

	Relation of the pharmacist to pressure sore treatment in the 27-E-S13-3 care mix type hospital 飯塚雄次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2014.

The pressure sore team approach in medical care that 27-E-S13-4 pharmacist has begun to be associated with
坪井憲江1, 浅野康彦2,4, 棚橋康子3, 大草さとこ3,4, 佐藤由紀4, 福岡愛実4, 池内祐子3,4, 村山紋子3,4, 竹山浩子3,4, 鈴木麻里3,4, 宮里志穂美3,4, 春田博美3,4, 神戸智子3,4, 足利久代3,4, 有馬豪5, 古田勝経6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2014.

	About the result by the relation of many types of job cooperation in the pressure sore medical care of our 27-E-S13-5 House and the authorized pressure sore pharmacist 岡戸京子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2014.

	Pit fall of the 27-E-S14-1 intravenous alimentation therapy 林勝次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2014.

	Point of the 27-E-S14-2 infusion formulation study 丘龍祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 69-69, 2014.

	The present conditions of the pharmacy education about the 27-E-S14-3 intravenous alimentation therapy 井上岳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2014.

	We work on the practice in the hospital for 27-E-S14-4 acute phase 中村直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2014.

	We work on the practice in 27-E-S14-5 small and medium size, the medical treatment sickbed 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2014.

	27-E-S14-6 generalization 林宏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2014.

	About importance of the 27-F-S15-1 many types of job cooperation education 亀井浩行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2014.

	Employment cooperation educational program - using action - Interprofessional PBL of the employment cooperation education in 27-F-S15-2 Tsukuba University 前野貴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 73-73, 2014.

	Systematic, graded team approach in medical care education curriculum utilized the characteristic of the university of specialist in 27-F-S15-3 line 木内祐二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2014.

	For construction of the team approach in medical care education utilized the 27-F-S15-4 medicine cooperation: Practice (Inter Professional Education & Practice: IPEP) of the many jobs cooperation education 野田幸裕1, 半谷眞七子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2014.

	Home care patient, family participation type many types of job cooperation education in the 27-F-S15-5 area 阿部恵子1, 半谷眞七子2, 野田幸裕2, 亀井浩行2, 會田信子3, 内山靖4, 末松三奈1, 安井浩樹1, 植村和正5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2014.

	The thing which 27-F-S16-1 new model core curriculum aims at 寺門成真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2014.

	For 27-F-S16-2 new core curriculum: A problem and correspondence of the Japanese Society of Hospital Pharmacists 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2014.

	About the business training of the drugstore corresponding to the 27-F-S16-3 new core curriculum 生出泉太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2014.

	Training evaluation of the existing model core curriculum for the 27-F-S16-4 new core curriculum 望月正隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2014.

	A pharmacist image and the systematic clinic expectation and problem that 27-F-S16-5 new core curriculum aims at 木内祐二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2014.

	It is an action to becoming it hospital preparation marketing by the 27-G-S17-1 hospital pharmacist 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2014.

	Research necessary for the marketing to join the drug which 27-G-S17-2 society demands together to becoming it 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2014.

	Information of the healthcare setting necessary for the pharmaceutical products development that 27-G-S17-3 drug industry demands 中川祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2014.

	Correspondence to an unlicensed drug, medicine having high need in the 27-G-S17-4 medical care out of the adaptation 益山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2014.

	TPN therapy to think about from 27-G-S18-1 medical care security 東海林徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2014.

	Risk of the 27-G-S18-2 parenteral injection mixture and parenteral injection material 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 84-84, 2014.

	Risk about the 27-G-S18-3 parenteral injection titer drop 内田享弘1, 高子優子1, 吉田都1, 志野訓之2, 野村泰生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2014.

	Risk management in the 27-G-S18-4 antibiotic exposure 石坂敏彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2014.

	The total management of the chemotherapy in 27-G-S18-5 ward drug duties 室井延之1, 高瀬尚武1, 樋本繭子1, 米澤圭祐1, 田中智也1, 原美紀2, 井上祐子2, 末次弘実3, 小野成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2014.

	Risk aversion by the reporting about the parenteral injection mixed preparation of the 27-G-S18-6 anticancer agent 松原肇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2014.

	Risk aversion about the 27-G-S18-7 anticancer medicine pollution and exposure 濱宏仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 87-87, 2014.

	The thing which 27-G-S19-1 Japanese clinical tumor Pharmaceutical Society aims at 本田泰斗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2014.

	Basic knowledge of the 27-G-S19-2 regional alliances system 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2014.

	About the medical cooperation that 27-G-S19-3 Kure medical center regional alliances network used "a wave and a wind net" 小川喜通1, 小川弘太1, 平本敦大2,5, 大塚茂雄3,5, 大塚幸三4,5, 市場泰全1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2014.

	Significance of grasping the name of disease, the test value using the cooperation system in the 27-G-S19-4 drugstore 山村万里子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2014.

	Electronic prescription, pharmaceutical cooperation proof business in 27-G-S19-5 Kagawa District and the problem 飯原なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2014.

	27-G-S19-6 Approach of the Sado community medical care cooperation network "Sado sunflower net" 佐藤賢治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2014.

	From the viewpoint of role - physician of the pharmacist in the 27-H-S20-1 children medical therapy - 中村秀文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2014.

	Relation one - present conditions and problem ... of 27-H-S20-2 children medical therapy and the pharmacist 冨家俊弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2014.

	Intervention to the childhood medical therapy of the pharmacist in the 27-H-S20-3 university hospital 鳥本真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2014.

	Intervention to the childhood medical therapy of the pharmacist in the 27-H-S20-4 General Hospital 藤村尚子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2014.

	Optimum doses of 27-H-S21-1 UGT1A1 genetic polymorphism and irinotecan 安藤雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2014.

	Pharmacogenetics-like action to be possible as 27-H-S21-2 pharmacy school clinical system teacher 中村克徳, 鈴木匡, 松永民秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2014.

	Pharmacogenetics-like action in the 27-H-S21-3 Hospital 渡邉淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2014.

	An effect and CYP2D6 genetic polymorphism of tamoxifen in patients with 27-H-S21-4 breast cancer 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2014.

	The effect that the CYP genetic polymorphism of the 27-H-S21-5 hematopoietic stem cell transplantation patients gives to tacrolimus levels out of the whole blood 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2014.

	Application to the innovative drug development of 27-H-S21-6 genetic results 鎌谷直之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 98-98, 2014.

	Directionality of the clinical studies as the 27-H-S22-1 pharmacist 今村知世 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2014.

	The introduction of the use of identification antimicrobial report system which linked an order ring system 27-H-S22-2 example introduction 1 and the usefulness 山田武宏1, 石黒信久2, 井関健1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2014.

It is interaction with terra pre-building and cyclosporine in the hepatitis C youngest case after a liver transplant 27-H-S22-3 example introduction 2
増田智先1,4, 奥田有紀1, 西岡由貴1, 菊池実緒1,5, 上杉美和1, 端幸代1, 中川俊作1, 松原和夫1, 上田佳秀2, 千葉勉2, 海道利実3, 上本伸二3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2014.

	It is the retrospective study about the risk factor of the hypersensitivity symptom with the oxaliplatin administration 27-H-S22-4 example introduction 3 関恭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2014.

	A design and data analysis of 27-H-S22-5 clinical studies 森田智視 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 102-102, 2014.

	About the publication of 28-A-S23-1 JPHCS 桂敏也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2014.

	Mental attitude to 28-A-S23-2 English article making 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2014.

	The making of the 28-A-S23-3 English article: From experience in the municipal hospital 辻泰弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2014.

	The making of the 28-A-S23-4 English article: From the situation of the university 高野幹久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 105-105, 2014.

	Expectation to a summary and the pharmacist of the 28-A-S24-1 risk management plan 磯崎正季子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2014.

	Offer of the pharmaceutical products safety information in the 28-A-S24-2 pharmaceutical products medical equipment reporting homepage 中村悟 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2014.

	Of 28-A-S24-3 pharmaceutical products risk management plan (RMP), actually 新井寿久2, 小林幹英1, 山本郁男1, 滝田諭1, 宇田恒信2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2014.

	Of the risk management plan in the cottage-hospital out of 28-A-S24-4, actually 荒木隆一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2014.

	Role of the hospital pharmacist in 28-A-S24-5 RMP 伊藤忠明, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 109-109, 2014.

	Outcome of team approach in medical care and the community medical care that 28-B-S25-1 pharmacist takes 吉山友二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2014.

	The demanded function of the drugstore on the basis of the social conditions of 28-B-S25-2 late years and the figure which there should be 田宮憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2014.

	For the drugstore which the 28-B-S25-3 nation expects, expect it from a drugstore pharmacist 山口育子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2014.

	The economic effect that promotion of the community medical care with 28-B-S25-4 family drugstore function results in 櫻井秀彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2014.

	About a drugstore function on the basis of the social conditions of 28-B-S25-5 late years 山本信夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2014.

	About the basic system and enforcement of the medical therapy that 28-B-S25-6 drugstore should include 安部好弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 113-113, 2014.

	Role of the pharmacist in the 28-B-S25-7 community medical care 藤秀人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2014.

	The pharmacoepidemiology that we applied a 28-B-S26-1 medical care system database in, a clinical epidemiology study and development to medical care 川上浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2014.

	28-B-S26-2 pharmacoepidemiology study and National receipt data 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2014.

	Application of 28-B-S26-3 size scale side effect spontaneous report database case (JADER example) 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2014.

	Application of 28-B-S26-4 size scale side effect spontaneous report database case (FAERS example) 中村光浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 117-117, 2014.

	Inflection (MIHARI project) to safety measures of the 28-B-S26-5 electron practice information 山本弘史1, 竹内由則2, 宇山佳明2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2014.

	- to think about a psychiatric element necessary for treatment preferences, drug control instruction in the mental health for management - perinatal period of the 28-D-S27-1 mental disorder merger pregnant woman 鈴木利人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2014.

	Medication counseling to 28-D-S27-2 schizophrenia merger pregnant woman 刈込博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 120-120, 2014.

	Medication counseling to 28-D-S27-3 depression merger pregnant woman 山田総 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2014.

	Medication counseling to 28-D-S27-4 epilepsy merger pregnant woman 八鍬奈穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2014.

	When, at 28-D-S28-1 new anticancer medicine introduction, we evaluate information on adverse drug reactions 清水久範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2014.

	Significance ... of clinical studies that ... pharmacist predominates when evidence to become the 28-D-S28-2 background is poor and performs 辻大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 123-123, 2014.

	When we make use of 28-D-S28-3 basics-like pharmaceutical knowledge in the latest cancer medical therapy 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2014.

	When we grasp 28-D-S28-4 going to hospital treatment average and a side effect symptom at being at home 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2014.

	Do olanzapine which was placed in the antiemesis therapy guidelines of ... foreign countries when new evidence was sent from the 28-D-S28-5 foreign countries for a case; and ... 矢内貴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2014.

	Imaging in the tissue of the antitumor agents using the 28-E-S29-1 mass microscope 新間秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2014.

	Cancer diagnosis development to review from the 28-E-S29-2 protein measurement 大槻純男, 平山未央, 伊藤慎悟 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 127-127, 2014.

	The present conditions and problem of anticancer medicine preparation duties in the 28-E-S29-3 healthcare setting 森川琢也, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2014.

	It is ... mainly on development trend - kinase of the 28-E-S29-4 molecules target medicine 吉野公一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2014.

	The present conditions of the DDS preparation contributing to 28-E-S29-5 cancer treatment 菊池寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2014.

	The prospects to result and the clinical application of the genetic analysis of the 28-E-S30-1 multiple factor disease 田原康玄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2014.

	Utilization to the health care using an examination for 28-E-S30-2 telomere, the examination for microRNA 田原栄俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 131-131, 2014.

	Making of rule - FDA guidelines for 28-E-S30-3 personalized medicine and international standardization - 中江裕樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2014.

	Human resources utilization and pharmacist duties in 28-F-S31-1 British clinical settings 渥美景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2014.

	Utilization of the intern resident in 28-F-S31-2 American clinical settings 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2014.

	Medical safe promotion by defense strategy - pharmacist of the 28-F-S31-3 United States healthcare setting 岩澤真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2014.

	Action of the journal club in the 28-F-S31-4 Tohoku University Hospital 中川直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 135-135, 2014.

	Human resources utilization and duties efficiency for the future prospects and measures - ward duties promotion of 28-F-S31-5 Japan 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2014.

	About importance of the team approach in medical care in the 28-F-S32-1 basic tone lecture intensive care 松田直之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2014.

	About the relation of the pharmacist in the intensive care domain in the 28-F-S32-2 Ogura memory hospital 福島将友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 138-138, 2014.

	Intervention of the pharmacist to the nourishment management of patients with 28-F-S32-3 serious case 野崎歩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2014.

	Viewpoint ... of sedative management - pharmacist in the 28-F-S32-4 intensive care 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2014.

	The role that a drugstore, the pharmacist in the 28-G-S33-1 area inclusion care system should take 中井清人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2014.

	The difference between 28-G-S33-2 Japan and at-home duties of the United States and the future prospects 恩田光子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2014.

	Role of importance and the pharmacist of the many types of job cooperation in the 28-G-S33-3 treatment at home 高瀬義昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2014.

	Action of 28-G-S33-4 Hospital and the other types of job cooperation 岩崎清隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 142-142, 2014.

	It is ... about other types of job cooperation model business using present conditions and need - information sharing system of the opening of an office drugstore for 28-G-S33-5 24 hours 松浦惠子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2014.

	Testing request based on the protocol in the 28-G-S34-1 psychiatry 馬場寛子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2014.

	The appropriate medical therapy of the habit-forming drug in the 28-G-S34-2 psychotropic drug and the management: Method to reduce the use of benzodiazepine drugs 高橋結花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2014.

	It is ... for the infection measures that gangs are different from infection measures - regular hospital in the 28-G-S34-3 psychiatry domain in 別所千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2014.

	The prescription intervention case study of the 28-G-S34-4 psychiatry pharmacist: For a reduced risk and a benefit rise of the medical therapy 永田健一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 146-146, 2014.

	Role of the pharmacist carrying it out for medical therapy management in the 28-G-S34-5 psychiatry community medical care 桑原秀徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2014.

	The master management that 28-H-S35-1 does not fail in 谷口美悠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2014.

	Invention of the 28-H-S35-2 formulations support system 佐藤弘康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2014.

	Bar code utilization example using the mobile terminal in the 28-H-S35-3 formulations system 荒義昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2014.

	Electronic management of the drug, specific organism origin preparation of the operating room which is not performed 28-H-S35-4 order ring use of 冨岡謙二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 150-150, 2014.

	Invention of the 28-H-S35-5 bringing medicine management 高橋正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2014.

	The system which supports 28-H-S35-6 clinical studies 青柳吉博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2014.

	28-H-S35-7 usable information system architectural invention 木下元一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2014.

	28-H-S36-1 We will regard remedy characteristics as dosage form of the oral medicine once again - Concrete suggestion, overseas mini-tablet introduction of the taste bitter inhibition - 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2014.

	It is ... from the situation of invention - hospital pharmacist for medication ad here Lance improvement and maintenance of 28-H-S36-2 children 中井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2014.

	It is ... from the situation of invention - drugstore pharmacist for medication ad here Lance improvement and maintenance of 28-H-S36-3 elderly people 政田啓子, 永井佳代子, 平田ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2014.

	28-H-S36-4 medication ad here Lance and medication adjuvant jelly 福居篤子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2014.

	Remedy characteristics and taste bitter masking evaluation of the 28-H-S36-5 dry syrup 吉田都, 原口珠実, 櫨川舞, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2014.

	Remedy-related evaluation of the collapse film preparation in the 28-H-S36-6 oral cavity 竹内淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2014.

	Clinical functionality of the orally disintegrating tablet promoting 28-H-S36-7 medication ad here Lance improvement 並木徳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2014.

	Point of a trend and the system official regulations revision of the pharmacist authorization specialized in 28-C-ES-1 cancer 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2014.

	A fact and case summary (stomach cancer) of the 28-C-ES-2 pharmaceutical intervention 末次王卓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2014.

	A fact and case summary (non-small cell lung cancer) of the 28-C-ES-3 pharmaceutical intervention 浅野裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2014.

	A fact and case summary (breast cancer) of the 28-C-ES-4 pharmaceutical intervention 縄田修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2014.

	A fact and case summary (biliary cancer) of the 28-C-ES-5 pharmaceutical intervention 高瀬美咲枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2014.

	The art of the 28-C-ES-6 case summary form: Inappropriate example 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-1 medical therapy (psychiatry domain) 千崎康司1, 亀井浩行2,3, 山田清文1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-2 medical therapy (digestive organ domain) 山崎美保1, 前田頼伸1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-3 medical therapy (heart, vascular disease domain) 錦織淳美1, 千堂年昭1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-4 medical therapy (internal secretion, metabolism domain) 岡田守弘1,2, 河原昌美3,4, 西上潤1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-5 medical therapy (blood and blood-forming organ disease domain) 安武夫1, 黒川陽介1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-6 medical therapy (infection domain) 吉田優子1, 矢野育子1,2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2014.

	How to write case summary for authorized application of the pharmacists specialized in 28-WS-7 medical therapy (circulatory organ domain) 登佳寿子, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2014.

	Examination of the racial differences between 27-O1PM-01 warfarin and hemorrhagic side effect in the dabigatran 小川喜寛, 伊東真紀, 河合加奈, 西川良平, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2014.

	Examination of the onset of dermatopathy factor with the cytarabine administration in patients with 27-O1PM-02 blood-forming organ tumor 森尾佳代子1,2, 水木満佐央3, 寒水孝司4, 上島悦子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2014.

	Fact-finding of the hepatoscopy level abnormality with the 27-O1PM-03 sulbactam / cefoperazone preparation 下田賢一郎1, 星野輝彦1,2, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2014.

	Effect of the fact-finding of the side effect of 27-O1PM-04 clozapine and the intervention by the pharmacist 八田眞菜美1, 重面雄紀1, 山本将太1, 萱野勇一郎1, 大村友博1, 矢野育子1, 諏訪太朗2, 村井俊哉2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2014.

	An action to safe breaking news about the serious hypocalcemia by the 27-O1PM-05 orchid mark (denosumab) and the result 小田泰弘, 伊藤忠明, 福司佳穂里, 熊木雄一, 箕曲真由美, 藤井博之, 内田ゆみ子, 田村宏美, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2014.

The trial that we compile the outside Parliament prescriptions which a 27-O1PM-06 University outbuilding, internal secretion internal medicine metabolism department published into a database, and the actual situation analyzes diabetes medical therapy
富田基郎1, 竹之内敏孝2, 中野泰子1, 谷山松雄3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2014.

	Study on detection of the agranulocytosis as the side effect that we applied 27-O1PM-07 medical care information database in 山田健人1, 渡邊崇1, 木村通男2, 堀雄史3, 川上純一3, 頭金正博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2014.

Examination of the measures by all case registration systems and many types of job teams of Serious Adverse Event (SAE) which needed hospitalization after 27-O1PM-08 outpatient department chemotherapy
浅子恵利1,2, 石原優1,2, 近藤芳弘1,2, 熊谷匡也2,3, 味八木寿子2,4, 山田みつぎ1,5, 鎌形幸子1,5, 中澤裕子1,5, 辻村秀樹2,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2014.

	The drug residual actual situation and the risk factor to have an influence on the 27-O1PM-09 endoscopy upper gastrointestinal tract 伊勢文孝1, 安藤貴志2, 今本栄子2, 北澤文章1, 東克彌1, 上田久美1, 杉井彦文3, 長井克人4, 小西廣己4, 国府孝敏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2014.

	Modified simple suspension method 2 that used 27-O1PM-10 supersonic wave vibration together 松村久男, 飯田美奈子, 松田佳和, 木村正幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2014.

	The effect that wall Invasion depth of the primary tumor in the 27-O2PM-01 cancer of the esophagus chemotherapy gives to retching, vomiting with the chemotherapy 早坂州生1, 佐藤佑一朗1, 竹内公美1, 高橋宏明3, 細川正夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2014.

	Examination of the risk factor due to the candidiasis infection onset after the chemotherapy for patients with 27-O2PM-02 malignant lymphoma 小室雅人, 松井礼子, 高橋邦雄, 市田泰彦, 齋藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2014.

	One case that suggested an index to predict hyperammonemia attributable to the 27-O2PM-03 5-FU hypermetabolism and the expression 池村健治1, 永春圭規2, 山下芳樹2, 石橋美紀1, 水野聡朗2, 村木優一1, 岩本卓也1, 片山直之2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2014.

	Identification of the risk factor of vincristine-induced early peripheral neuropathy in 27-O2PM-04 R-CHOP therapy and the R-CHOP-like therapy 岡田直人1, 花房剛志2, 寺岡和彦1, 中村敏己1, 川添和義1, 水口和生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2014.

	Examination of the total bilirubin levels that can become the dose setting standard of irinotecan in patients with 27-O2PM-05 gastrointestinal carcinoma 東さやか, 槙原克也, 川戸順之, 上野裕之, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2014.

	Examination about the risk factor of the hypocalcemia onset in 27-O2PM-06 denosumab treated patients 計良貴之, 持田理菜, 塚田泰隆, 山岡結, 荒木良介, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2014.

Association with dermatopathy frequency, the disease severity of 27-O2PM-07 STAT3 genetic polymorphism and the molecular target drug
山本和宏1, 平田佐智1, 山口徹郎1, 須野学2, 三宅秀明3, 藤澤正人3, 尾藤利憲4, 錦織千佳子4, 西岡達也1, 久米学1, 槇本博雄1, 中川勉1, 平野剛1, 平井みどり1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2014.

	Factor analysis of the hands and feet skin test with sorafenib using the 27-O2PM-08 order logistic-regression analysis 神林祐子1,2, 細川豊史2, 安居幸一郎3, 本郷文弥4, 山口寛二3, 森口理久3, 四方敬介1, 三木恒治4, 伊藤義人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2014.

We see a clinical factor and the rear of the glomerular filtration rate calculation method affecting the serious blood toxicity expression of the 27-O2PM-09 gynecology cancer carboplatin combination chemotherapy and analyze a mark
岡田浩司, 大村雅之, 高橋紗英子, 菊池亮大, 増田晃, 松川幸市
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2014.

	The dihydropyrimidinase genetic polymorphism of the patients who developed a serious side effect by 27-O2PM-10 capecitabine administration and the family and urinary pyrimidine analysis 平塚真弘1,2,3, 山下洋2, 赤井文香1, 細野寛貴1, 平澤典保1, 森隆弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2014.

	Construction of medical treatment management (PBPM) based on a physician, a pharmacist collaboration protocol in the 27-O3PM-01 HIV outpatient department and the evaluation 石橋美紀1, 浦野公彦1,2, 松本剛史3, 大石晃嗣3, 村木優一1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2014.

	It is examination about the usefulness of the pharmacist outpatient department by the adjuvant chemotherapy after 27-O3PM-02 stomach cancer technique 洞澤智至, 松井礼子, 川澄賢司, 市田泰彦, 高橋邦雄, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2014.

It is ... through 569 times of number of role - medical examinations of the pharmacist examining with a physician in the outpatient department of the 27-O3PM-03 lenalidomide remedy patients, 27 case
高柳信子1, 久保嘉靖1, 奥野昌宏1, 中田学1, 浅野仁2, 田中康博2, 新里偉咲2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2014.

Development of the lifesaving practical skill practice for pharmacy students which intended pharmaceutical intervention to the Primary care in the 27-O3PM-04 emergency visit
座間味義人1, 相良英憲2, 今井徹3, 原直己4, 小山敏広5, 武本あかね6, 北村佳久6, 千堂年昭6, 名倉弘哲1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2014.

	Construction of the doubt inquiry protocol by the cooperation with the physician in the 27-O3PM-05 outside Parliament prescription 吉田宗広, 船戸元子, 奥村雅美, 階戸美和, 井藤俊, 森正昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2014.

27-O3PM-06 Disclosure of the regimen name to outside Parliament prescription aiming at reporting of the better cancer chemotherapy ･･Thing to see from a meeting a demand drugstore questionnaire･･
徳永晃1,2,3,4, 末松耕輔1, 中山貴夫1, 松永尚1, 佐保澄子2, 嬉野紀夫3,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2014.

	We examine illness using 27-O3PM-07 tracing report (medication reporting book) and are promoted the medicine cooperation 礒本唯, 萱野勇一郎, 池見泰明, 杉本充弘, 大村友博, 米澤淳, 深津祥央, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2014.

An inhalational instruction foreign action and the evaluation to be carried out by 27-O3PM-08 health insurance pharmacy and collaboration
寺尾真琴1,2, 杉本充弘1, 萱野勇一郎1, 蓼原昌美1, 木村嘉彦1, 小形瑛1, 都築徹教1, 山際岳朗1, 吉田優子1, 今井哲司1, 矢野育子1, 佐藤晋2, 松本久子2, 室繁郎2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2014.

Trial of the medical support by the pharmacist dispatch to depopulated area Hospital of the 27-O3PM-09 pharmacist absence
石橋直哉1, 津田真弘1, 佐藤裕紀1, 池見泰明1, 松田裕也1, 八田眞菜美1, 小枝正吉3, 高橋和也4, 大原雄希4, 志賀弘康5, 中川俊作1, 深津祥央1, 米澤淳1, 田崎嘉一3, 宮本篤4, 井関健5, 白井正信2, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2014.

	Cost effectiveness analysis of the long time effect type bronchodilator in patients with COPD of the 27-O3PM-10 climax 長谷川彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2014.

	Examination of the clinical features of the in-hospital onset bloodstream infections in patients with 27-O4PM-01 solid carcinoma and the prognostic factor 塚本仁1,2, 新谷智則1, 飛田征男2,3, 室井洋子2, 池ヶ谷論史2, 岩崎博道2, 中村敏明1, 政田幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2014.

	Risk factor of the preoperation MRSA intranasal carrying germ in the 27-O4PM-02 inflammatory bowel disease (IBD) patients 高橋佳子1, 竹末芳生2, 辰己純代1, 田久保慎吾1, 木村健1, 植田貴史2, 内野基3, 池内浩基3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2014.

	Enforcement situation investigation of the 27-O4PM-03 HBV reactivation initial screening test 清水倫子1, 津田真弘1, 池見泰明1, 深津祥央1, 石塚良子1, 米澤淳1, 松村由美2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2014.

	Improvement ... of the risk management awareness by HBV reactivation measures - HBView introduction in the 27-O4PM-04 cancer chemotherapy 真川明将1,2, 竹本将士1, 伊豆田美晴1, 黒田純子1, 江崎哲夫1, 木村和哲1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2014.

Examination about the association with the herpesvirus infection onset after the R-CHOP therapy start in patients with 27-O4PM-05 diffuse large-cell B-cell lymphoma and the index of immunity
伊藤佳織1,2, 岡本昌隆2, 安藤舞子1, 辻井奈保1, 屋良枝利1, 岡本晃直2, 稲熊容子2, 徳田倍将2, 加藤さや香1, 牧原俊康1, 赤塚美樹2, 恵美宣彦2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2014.

	Analysis of the new onset mechanism of the 27-O4PM-06 morphine-induced constipation 今理紗子, 五十嵐信智, 早川晃央, 羽賀裕介, 笛木愛華, 北岡諭, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2014.

	Analysis of the onset mechanism of 27-O4PM-07 oxaliplatin-induced acute peripheral neuropathy: Participation of redox-sensitive TRPA1 中川貴之1,2, 趙萌2, 中村彩希2, 三宅崇仁2, 宗可奈子2, 白川久志2, 金子周司2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2014.

	Expression of skin change of aquaporin 3 at the 27-O4PM-08 diabetes-related xeroderma 五十嵐信智, 今理紗子, 豊田絵理, 中村麻里奈, 高橋悠太, 内藤春香, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2014.

Search of the new treatment target molecule of the chronic renal failure that assumed 27-O4PM-09 molecular clock mechanism a base
松永直哉1, 池田恵理子1, 濱村賢吾1, 近藤英明2, 一町和史1, 池山久子1, 徳重和孝1, 古市葉子1, 吉田優哉1, 小柳悟1, 大戸茂弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2014.

	Examination about the effect of the apolipoprotein E genetic polymorphism which gives it to the effectiveness of the thiazolidine dione system medicine in patients with 27-O4PM-10 Alzheimer type dementia 池谷怜, 大野恵子, 松本邦洋, 岸野吏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2014.

	The actual situation and intervention effect of the non-proper use that blood level measurement enforcement based on the protocol for the new inpatient during 27-O5PM-01 digitalis remedy shows 岸田充弘1, 森優子1, 金子真弓1, 村木優一2, 奥田真弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2014.

	Prescription suggestion associated with the collaboration with the physician about the medication instructions by the 27-O5PM-02 ward pharmacist 唐澤暁代, 箕曲真由美, 熊木雄一, 内田ゆみ子, 藤井博之, 田村宏美, 伊藤忠明, 林昌洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2014.

	Effect of the ward drug duties enforcement addition calculation for the hospitalization of the 27-O5PM-03 inpatient 濃沼政美1,4, 礒野淳一2,3, 稲葉健二郎4,5, 菅野浩-1,2,6, 佐藤透2,7, 清水淳一2,8, 加賀谷肇2,9, 赤瀬朋秀2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2014.

	Medical economic effect ... by the action of the ward drug duties in the 27-O5PM-04 otolaryngology ward and the prevention of evaluation - adverse event and the effect of treatment 小林亮, 鈴木昭夫, 飯原大稔, 岡安伸二, 伊藤善規 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2014.

	Support systems construction and action as the team approach in medical care aiming at adequacy of the 27-O5PM-05 posttransfusion hyperferremia practice 冨田敦和1, 惠谷里奈1, 吉本一恵2, 河野彰夫3, 森下剛久3, 野村賢一1, 野田直樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2014.

Examination ... about analysis - effectiveness of the clinical response about the VCM initial loading dose design in the 27-O5PM-06 serious case infection concerned
實川東洋1,2, 片山皓希1, 渡邉暁洋1, 福田恵子1, 若松孝嘉3, 齋藤伸行2,4, 八木貴典4, 原義明4, 松本尚4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2014.

	Population pharmacokinetics analysis of the linezolid in patients with 27-O5PM-07 impaired renal function (adults) and clinical inspection 辻泰弘1, 湯川栄二2, 平木洋一3, 太田幸雄1, 山本善裕4, 藤秀人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2014.

	The establishment of the separation assay of erlotinib out of the 27-O5PM-08 human plasma and metabolite OSI-413 and OSI-420 and clinical applicable evaluation 石田卓矢1, 内藤隆文1, 須田隆文2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2014.

	AUC estimate-style development of mycophenolic acid which considered the 27-O5PM-09 renal transplantation future 榎屋友幸1, 西川晃平2, 村木優一1, 岩本卓也1, 杉村芳樹2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2014.

	An antiemesis effect of prochlorperazine in patients with 27-O5PM-10 cancer and evaluation of the factor to give it to adverse effect 田代将貴1, 内藤隆文1, 賀川義之2, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2014.

	The analysis of pre-Abo id collected through 27-O1AM-01 ward drug duties and the prescription suggestion example and the joint ownership 林淳雄1, 木下里紗1, 松村友和1, 西崎恵利3, 籠本基成1, 杉山正敏2, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

	Usefulness of the cooperation of ward drug duties and dispensary duties based on the 27-O1AM-02 pharmaceutical products safety information 山田直香, 平野公美, 青野浩直, 堀雄史, 八木達也, 丸山修治, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

	Examination of the liver function test time at the 27-O1AM-03 pharmaceutical products prescription 佐藤雄己, 遠山泰崇, 西村文宏, 唐川聖司, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

	Problems in the role of MR and the drug industry in the 27-O1AM-04 drug information transmission 生島五郎, 亀田圭輔, 長澤梢, 一色靖洋, 渡来和宏, 高橋憲二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

	We consider 27-O1AM-05 with the confirmation investigation about "the drug with mentions such as prohibition such as the driving" and examination for alerting it 長谷部啓子, 一ノ瀬直樹, 芝崎健志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2014.

	Action for 27-O1AM-06 generic medicine adoption promotion and the evaluation of the generic medicine 真鍋健一, 井上大奨, 高田正温, 大窪典子, 田代早紀, 橋本崇広, 永野真久, 平木洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

	Effect on human liver gene expression analysis of the valacyclovir preparation using the 27-O1AM-07 humans hepatocytes chimera mouse 中嶋幹郎1, 江頭かの子1, 大脇裕一1, 中嶋弥穂子2, 島田卓3, 長塚伸一郎4, 榎本初音5, 立木秀尚5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

Comparison of the frequency of renal failure, other adverse events with 27-O1AM-08 cisplatin (CDDP) innovator drug and the generic drug
植田有希1, 金銅葉子3, 鈴木秀和2, 平島智徳2, 岡本紀雄2, 森下直子2, 田宮基裕2, 白山敬之2, 口分田章典1, 碓氷尚子1, 福地裕哉1, 山東真寿美1, 志村和子1, 田中恵美子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

Utilization and application of the universal test of the 16th revised Japanese Pharmacopoeia publication for the 27-O1AM-09 commercial pharmaceutical products adoption
冨岡貢1,6, 小林智子1, 齋藤勲2,6, 向後麻里3,6, 坂田穣5, 渡邉徹4,6, 渡部直木9, 杉浦宏美10, 大塚誠11, 中村明弘8, 木内祐二12, 山元俊憲7, 村山純一郎1,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

	Effect of the foreign element derived from the ceftriaxone which gives it to incompatibility of 27-O1AM-10 ceftriaxone sodium and calcium 丹下美緒, 吉田都, 櫨川舞, 原口珠実, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2014.

	Fact-finding in the use of 27-O1PM-11 electronic edition medicine notebook and examination about the usefulness 市橋哲平, 清水俊樹, 長南謙一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

	The inflection situation of activity and the medicine counselor's office as the pharmacist specialized in HIV infection in the 27-O1PM-12 health insurance pharmacy 中村美紀, 佐藤真基子, 城尾秀和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

	Prescription fact-finding of the osteoporotic therapeutic drug after the proton pump inhibitor remedy in the 27-O1PM-13 health insurance pharmacy 濱田光洋, 彼末桃子, 有馬和希, 勝田剛史, 妹尾波枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

	The 27-O1PM-14 patients choose an OD lock; or in the case of - pitavastatin - 星野輝彦, 中尾美希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

	Inspection of the formulations maneuver in a very small amount of preparation with the 27-O1PM-15 powders automatic packeted plane 木下佳苗1,2, 長谷川裕子1,2, 菊地智恵里1,2, 玉井典子1,2, 小池一男3, 佐藤忠章3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2014.

	The workshop which regards a countermeasure as problems aiming at consciousness improvement in the medication assistance for the 27-O1PM-16 care staff 朴恵林1, 三木晶子1, 佐藤宏樹1, 馬来秀行2, 浅井康平2, 小西ゆかり2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

	Attitude survey about the communication of the pharmacist in the 27-O1PM-17 healthcare setting 原伸輔1, 谷向仁2, 松井智子3, 上森美和子4, 岡本禎晃5, 三輪芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

	Examination of consciousness and the job evaluation of the pharmacist of the 27-O1PM-18 chronic phase hospital 岡添進1, 渡邉百合子2, 新井亘3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

	Change - second report ... of a consciousness change and the duties contents of the 27-O1PM-19 pharmacist 新井亘1, 渡邉百合子2, 岡添進3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

	Development and inspection of the 27-O1PM-20 new face pharmacist educational program 笠師久美子, 宮本剛典, 原田幸子, 熊井正貴, 深井敏隆, 山田武宏, 井関健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2014.

Enforcement of the benchmark about antimicrobial consumption and the chemosensitivity between the preventive measures against 27-O2AM-01 infection addition 1.2 cooperation hospital
石田茂伸1,2, 楠本茂雅1, 太田真希1, 笹谷純平1,3, 京和里枝1,2, 竹村陽介1,3, 田中まこと1,3, 川村真代1,3, 大島利夫1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

	Difference in Defined Daily Dose and Prescribed Daily Dose at the 27-O2AM-02 antimicrobial consumption evaluation 宮崎元康, 坂元佑哉, 川田哲史, 田中麻衣子, 山廣胤之, 井上貴文, 島田安希子, 西美樹, 松尾宏一, 神村英利 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

	It is examined the antibiotic for the surgical site infection prevention after the stomach cancer surgery in 27-O2AM-03 elderly people 深見和宏1, 間瀬広樹1, 木ノ下智康1, 溝神文博1, 藤崎浩太郎2, 北川雄二3, 深田伸二3, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

	Importance to think about 27-O2AM-04 antimicrobial proper use from a clinical situation 松永宣史1, 畑中絵里子1, 池田寿昭2, 上野琢哉2, 須田慎吾2, 奥山清1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

	Use fact-finding for the azithromycin infusion for 27-O2AM-05 elderly people pneumonia 昆貴志1, 森雅之1, 橋本貴尚1, 飯島秀弥2, 栃窪克行1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2014.

	Three cases with suspected bradyarrhythmia with the 27-O2AM-06 donepezil hydrochloride 木下真理子, 吉岡大樹, 廣兼誠, 森善洋, 藤田有紀子, 佐道紳一, 吉村敏朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

	Analysis of carbohydrate metabolism, the electrolyte abnormality risk factor of the 27-O2AM-07 steroid (hydrocortisone succinic acid ester sodium) pulse therapy 児玉暁人1, 吉野新太郎1, 岩田智津子1, 高橋文香1, 八尾祥子1, 森信介1, 小竹武2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

	The situation of the prophylactic administration of osteoporotic medicine for the steroidal osteoporosis in our 27-O2AM-08 House 佐藤幸恵, 龍田涼佑, 槇原洋子, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

	Investigation about the onset of sleep loss by the steroid introduction in the 27-O2AM-09 collagenosis internal medicine 藤田強記, 福山雄卯介, 松尾圭祐, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

	Study on improvement effect of the eicosapentaenoic acid which gives it to onset of impaired glucose tolerance mechanism in the cyclosporine administration for 27-O2AM-10 long term 真島崇1, 佐々木一樹2, 大原宏司2, 高橋則男2, 関健二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2014.

	Investigation analysis of the central nervous system side effect of pregabalin in 27-O2PM-11 haemodialysis patients 隅野和美1, 古久保拓1, 吉田拓弥1, 三宅瑞穂1, 田中梨惠1, 小田智子1, 庄司繁市2, 山川智之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

	Safe examination of rivaroxaban in the 27-O2PM-12 decreased renal function case 宮村大佑1,2, 芦川直也2, 鷲見佳子1, 上村裕美1, 岩田晃佳1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

	One patient who succeeded in treatment continuation by hyposensitization for the 27-O2PM-13 rifampicin liver damage suspicion 仲鉢英夫1, 簑島隆仁1, 齋藤佳苗1, 松浦亮2, 守矢英和2, 日高寿美2, 大竹剛靖2, 小林修三2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

	Present conditions report in pseudoaldosteronism with the 27-O2PM-14 Glycyrrhiza preparation and our House 吉澤亜紗美, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

	Usefulness of the pharmacist participation in the early diagnosis of the 27-O2PM-15 drug induced hepatic injury 橋本陽1, 大森茂2, 松田真左子1, 石川久高1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2014.

	Analysis of the infusion reaction onset risk factor with 27-O2PM-16 rituximab 雨宮貴洋, 本間雅, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

Examination about the effectiveness and the safety of 27-O2PM-17 rasburicase
安藤舞子1, 岡本昌隆2, 伊藤佳織1,2, 辻井奈保1, 屋良枝利1, 岡本晃直2, 稲熊容子2, 徳田倍将2, 蟹江匡治2, 加藤さや香1, 牧原俊康1, 赤塚美樹2, 恵美宣彦2, 山田成樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

	It is ... mainly on proper use of intervention - rasburicase of the pharmacist about tumor lysis syndrome measures in the 27-O2PM-18 our hospital 中川隼一, 伊藤あゆみ, 桝茂典, 岡田悠美, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

	Examination of the onset of hypocalcemia predictor with the 27-O2PM-19 denosumab subcutaneous injection 松本浩明, 奥田敏勝, 森谷康志, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

	Examination of the onset of hypocalcemia by the decreased renal function at use of 27-O2PM-20 denosumab 石田耕太, 清水里紗, 植松和子, 遠藤巌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2014.

	27-O3AM-01 The prescription situation in patients with schizophrenia in our hospital - Comparisons from 2011 to 2013 - 加藤剛1, 北川綾子1, 唐澤佳孝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

	Use of clozapine experience for treatment-resistant schizophrenia in our 27-O3AM-02 House and action of the pharmacist 吉村優1, 岡田孝司1, 馬場浩一2, 馬場信二2, 亀井聖史2, 坂本成映2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

	Attitude survey of the medication self-care introduction in the 27-O3AM-03 psychiatry clinical pass 高橋満里, 森亨, 石塚淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

	Retrograded investigation in the medication continuation of the 27-O3AM-04 donepezil hydrochloride 渡邉ゆきの1, 松田公子1, 加瀬浩二1, 秀野武彦2, 浅井邦彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

	About patients with Alzheimer's dementia that led to improvement of the drug compliance by many types of job cooperation in 27-O3AM-05 at-home visit medication counseling 成井繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2014.

	Examination of the sitagliptin in the 27-O3AM-06 obesity type 2 diabetes model mouse and the usability for the diabetes progress by the pitavastatin combination 廣谷芳彦, 奥村香利, 尾崎望, 浦嶋庸子, 名徳倫明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

	Comparison - second report - between the preparation of the 27-O3AM-07 DPP-4 inhibitor 富岡節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

	Effect and examination of the patients background factor that administration gives to lipid metabolism of the 27-O3AM-08 liraglutide 藤田有紀子1, 吉岡大樹1, 佐道紳一1, 木下真理子1, 森善洋1, 川崎英二2, 森内昭江2, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

	Examination about the usefulness of the DPP-4 inhibitor sitagliptin in 27-O3AM-09 type 2 diabetes treatment 出羽祐基, 有本諭司, 坂野千賀, 松浦暢子, 大里恭章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

About the construction of the contraindicated medicine prescription order check system according to the 27-O3AM-10 renal function and the use
野々内裕紀, 眞継賢一, 黒岩勇人, 上田浩貴, 古場建, 岡本朋子, 西田修司, 久保しおり, 塚本泰彦, 大石容司, 濱口良彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2014.

The development of the 27-O3PM-11 ward drug duties support system ("a doubt inquiry traceability system") and utilization report to pre-Abo id
坂上嘉浩, 藤江直輝, 竹田健志, 菅田優子, 的場美香, 石樋康浩, 大津由美子, 高木麻里, 藤田敬子, 室井政子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

	About an action of the pre-Abo id activity visualization in our 27-O3PM-12 House and the effect 宮尾美佐欣, 石倉久美子, 松浦仁志, 有田順子, 北田尚子, 松本チサ子, 楠本臣彌, 小槻典子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

	Reevaluation of the 27-O3PM-13 internal use anticancer agent check system 尾崎正和, 廣實清司, 内田豊, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

	Change of the prescription incident by the continuous drug reporting to 27-O3PM-14 physician 山下敦哉, 仲鉢英夫, 小澤康久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

	About the enforcement of doubt inquiry content analysis and the once quantity input restrictions after the quantity of 27-O3PM-15 one time order start 山下和彦, 吉田幸洋, 山岡慶子, 池田佳那子, 西岡達也, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2014.

Intervention to the sleeping drug proper use by the pharmacist aiming at 27-O3PM-16 fall, fall accident decrease
重面雄紀1, 八田眞菜美1, 山本将太1, 山縣有子2, 萱野勇一郎1, 石塚良子1, 中川貴之1, 矢野育子1, 杉原玄一3, 村井俊哉3, 松原和夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

	Analysis - using - diazepam conversion of a dosage and the fall rate of the 27-O3PM-17 sleep inducer of relationships 小田真司1, 平井覚2, 井上智喜1, 渡邊良平3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

	Usefulness of personal sheet in the biological drug for the 27-O3PM-18 rheumatoid arthritis 三柳直子1, 香川仁美1, 井澤裕子2, 三柳政道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

	Action aiming at improvement of the antithrombotic drug off-period at the 27-O3PM-19 digestive organ endoscope enforcement 三戸田大1, 金森美由紀1, 九門実加1, 河村真徳1, 荒川隆之1, 向田一敏2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

Investigation about the difference with the side effect that the subjective side effect and chief physician of the patients in the outside Parliament prescription of our 27-O3PM-20 in-hospital clothes anticancer agent described
桂英之1, 北出紘規2, 森光世3, 筒井伸幸4, 酒井淳志5, 高田直子1, 城座圭子6, 石田外樹1, 湊明志1, 西田秀樹1, 山本裕実子7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2014.

	It is change ... by discussion third report - customer-oriented breeding about the satisfaction of the patients after consciousness and the instruction of the 27-O4AM-01 pharmacist 渡邉百合子1, 新井亘2, 岡添進3, 矢吹直寛4, 矢嶋美樹5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

	The action for 27-O4AM-02 ward drug duties and the evaluation 中西涼子, 林淳雄, 山瀬大雄, 福島智子, 小松絵美, 畔柳弥生, 平井三保子, 松村友和, 山田邦義, 小平いく子, 籠本基成, 土井孝尚, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

	The example that led to early detection, the becoming severe evasion of the side effect in conference with 27-O4AM-03 ward exclusive duty pharmacist and the drug information supervising pharmacist 井出直仁, 甲賀麻里子, 佐竹啓彰, 平野茂子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

	Examination of the factor influencing the drug self-care in patients with cerebrovascular disorder that is hospitalized at a rehabilitation ward for 27-O4AM-04 convalescence 細野真吾, 堀浩子, 松崎奈津子, 磯野礼果, 山崎崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

	Examination about contents of doubt inquiry and the consultation meeting a demand in 27-O4AM-05 ward drug duties 杉本崇, 中村安孝, 外間まみ, 中川貴弘, 児玉典子, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2014.

	Examination of the pharmaceutical intervention method by the injection situation grasp sheet improvement in 27-O4AM-06 ward drug duties 田口美菜子, 鐵尚美, 篠崎希望, 土居美幸, 大和田有, 濱武久美子, 蛭田千昭, 田村明広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

	Study on simple and easy PT-INR monitoring for the 27-O4AM-07 warfarin remedy patients and pharmaceutical intervention 近藤昭志, 原田和彦, 岩澤真紀子, 和田恭一, 粉川俊則, 中村慶, 桑原健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

	Action of the ward pharmacist for the appropriate antiplatelet therapy for 27-O4AM-08 elective PCI case 寺島純一1, 梅村拓巳1, 勝野晋哉1, 山田哲也1, 鷹見繁宏1, 味岡正純2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

It is ... mainly on action ... pharmaceutical support of the ward drug duties in the 27-O4AM-09 Ogura memory hospital and the use of FileMaker
町田聖治1, 曽我弘道1, 富田敏章1, 福島将友1, 小田原由香1, 前田朱香1, 川井友美子1, 新治嘉一1, 長谷悠紀1, 相部真希1, 山下悟史1, 入江利行1, 津口正勝2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

	The pharmaceutical intervention in 27-O4AM-10 ward drug duties is an effect on effectiveness of the medical therapy and safety improvement 木幡雄至, 永瀬怜司, 今浦将治, 西悠吾, 安藤純子, 山谷武司, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2014.

	Examination of a pharmacist job evaluation and the skill mixture in the 27-O4PM-11 perioperative care team 阿部猛1, 川名賢一郎1, 小川真由美2, 片山正夫3, 宮坂勝之3, 後藤一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

	Evaluation of an action to the perioperative antimicrobial proper use by the 27-O4PM-12 ICT pharmacist and the intervention effect 加藤豊範, 高井希依 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

	The perioperative prophylactic antimicrobial guidelines revision in cooperation with the 27-O4PM-13 physician and examination of the observance rate and the surgical site infection rate 石原義久, 平川尚宏, 柿元郁代, 安藤卓, 田邉徹, 向井俊貴, 福岡龍一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

	Effect on infection frequency by the oral antibiotic deletion of the 27-O4PM-14 cataract surgery clinical pass 寺澤邦子1, 廣戸照龍2, 中島由紀2, 杉浦宗敏2, 大谷道輝1, 山村喜一1, 善本三和子3, 松元俊3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2014.

	Usefulness of the COPD simple test in the 27-O4PM-16 ethical pharmacy 畑中知笑美1, 内田佳久1, 藤田恵美子1, 草川美乃1, 津幡理恵1, 富田郁子1, 末澤千恵1, 須藤早百合1, 村木優一2, 奥田真弘2, 野田明雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

27-O4PM-17 The logistical support system by pharmacy SPD - Trial to showing the professional ability of the pharmacist -
宅和真由美1, 守谷顕人1, 橋本恵梨花1, 寺井易子1, 岸本侑子1, 入山奈央1, 植野聖子1, 村上賢次1, 神農理衣1, 小森正貴1, 三木郁帆1, 井本陽子1, 吉田尚史1, 津田里香1, 西山絵美理2, 深谷覚志2, 吉川政利2, 平田敦宏1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

	Outcome evaluation - long-term medication continuance rate of the joint medical treatment management (Japanese type CDTM) in the 27-O4PM-18 OAB treatment and effect ... which gives it to shortening in the consultation hours 前堀直美1, 永江浩史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

	Extraction ... of the problem in the practice (2) - formulation study of the telephone symptom monitoring for patients with foreign urination disorder by the 27-O4PM-19 pharmacy student 鈴木結衣1, 安田公夫1, 前堀直美2, 永江浩史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

	For fact-finding - prescription representation input introduction of the prescription suggestion in the 27-O4PM-20 going to hospital treatment center - 龍島靖明1, 板垣麻衣1, 後藤功一2, 吉野孝之3, 池田公史4, 齊藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2014.

	Effect on retching, vomiting examination of aprepitant with liver intraarterial injection chemistry embolus treatment using 27-O5AM-01 platinum drugs 岸本真, 長ヶ原琢磨, 田中沙耶香, 砂田和幸, 吉村真, 佐久間弘匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

	The effectiveness of the aprepitant palonosetron combination for the 27-O5AM-02 HEC, MEC regimen 小島一晃1, 美和孝之1, 濱武清範1, 奥村茜子1, 小西史子1, 中西和樹1, 北英夫2, 菅理晴3, 千葉渉4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

	Effect of the sodium azulene sulfonate gargle on stomatitis with the 27-O5AM-03 sunitinib 志田敏宏1, 遠藤裕司1, 加藤智幸2, 冨田善彦2, 豊口禎子1, 白石正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

	Examination of oral mucositis prophylaxis of the chemoradiotherapy in patients with 27-O5AM-04 head and neck cancer and the pain relief effect 坂本卓也, 斎藤和悦, 渡部義和, 小林義美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

	Present conditions recognition investigation of the hypertriglyceridemic expression with 27-O5AM-05 capecitabine 野口裕介, 三谷卓哉, 瓦比呂子, 徳山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2014.

	Examination of the effectiveness and the optimum doses of the steroid as the eruption prevention with 27-O5AM-06 pemetrexed 櫻田巧1, 柿内聡司2, 堀ノ内裕也1, 森剛志1, 西迫寛隆1, 寺岡和彦1, 中村敏己1, 川添和義1,3, 西岡安彦2, 水口和生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

	It is ... through the intervention by dermatopathy management - pharmacist in the 27-O5AM-07 EGFR inhibitor 上ノ段友里1, 吉田まつみ2, 上原英雄3, 藤井及三3, 岸原文明3, 縄田好一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

	Hand-and-foot syndrome measures in the 27-O5AM-08 XELOX therapy 中村久美, 鬼窪利英, 中村将人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

	Operational ... of the relation ... Regorafenib assessment sheet of the pharmacist in the oral 27-O5AM-09 molecular target drug 鈴木直哉, 地主隆文, 吉嶋抄苗, 福井美規子, 渡辺祐子, 徳村麻衣子, 高橋誠, 青田忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

	Effect of the Goshajinkigan on peripheral neuropathy in 27-O5AM-10 paclitaxel 遠藤拓未, 坪井久美, 神谷晴敏, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2014.

	The evaluation of the pain using the sharp pain assessment sheet for the use of medical drug patients in the 27-O5PM-11 on admission and the future prospects 林隼輔, 安藤尚美, 須田奈美, 石井賀津二, 染谷雅弘, 平島徹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

	National survey about the duties contents of the pharmacist assigned to the 27-O5PM-12 palliative care team 伊勢雄也1, 森田達也2, 木澤義之3, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

	Medical therapy support to the delirium patients by the 27-O5PM-13 palliative care team pharmacist 中村博子1,2, 鈴木藍1,2, 長谷綾1,2, 輪湖理絵1,2, 加藤あゆみ1,2, 池田征史2,3, 鈴木規仁2,4, 片山志郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

	Examination of the factor to affect during the medication period of the tramadol oral formulation for the 27-O5PM-14 cancer sharp pain 八木貴彦, 坪井久美, 川口千香, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

Use of the 27-O5PM-15 fentanyl citrate oral mucosa absorption preparation (E fen buccal tablet) and fact-finding of the pharmaceutical care
畠山織江1, 近藤泰礼1, 伊藤麻子1, 矢口まりな1, 永吉ひとみ1, 岡田美香1, 岡崎千絵1, 田嶋美幸1, 佐藤邦義1, 西羅輝雄1, 竹田省2, 高橋和久3, 梶山美明4, 代田浩之1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2014.

	Examination of the improvement effect of the chronic constipation by 27-O5PM-16 Lubiprostone 木寺康裕1,2, 川口明範1, 藤原季美子1, 野村守弘1, 西田升三2, 山添譲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

Research about the use situation of onset of mucositis and the opioid analgesic in the 27-O5PM-17 craniocervical part cancer cisplatin combination chemoradiotherapy
金剛圭佑1, 吉田幹宜1, 和田敦1, 古川美緒1, 小寺克典1, 脇下大樹1, 西村英輝2, 岡田秀明3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

	Evaluation of the management method change of the naloxone hydrochloride note in the 27-O5PM-18 operating room 新井聡子1, 小井土啓一1, 牧野好倫1, 岩瀬治雄1, 佐藤哲文2, 林憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

Examination about the terminally ill cancer patients given the 27-O5PM-19 antinarcotic
上葛義浩1,2, 東口高志2, 二村昭彦1,2, 伊藤彰博2, 大原寛之2, 中川理子2, 阿波宏子2, 三吉彩子2, 最上恵子1, 伊東知美1, 前川ゆか1, 岩佐雅子1, 吉岡京子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

	27-O5PM-20 Analgesic effect part density of opioid immediate release simulation for patients with cancerous sharp pain - Oral morphine deceleration time release formulation - 齋藤明子, 久保直子, 神谷絵梨奈, 壁谷めぐみ, 日比聡, 横井沙緒里, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2014.

	Examination ... in our comparison ... House of the effect of treatment by the difference of the immunoglobulin preparations in the 28-O1AM-01 Kawasaki's disease 木原理恵1, 後藤降1, 尾上泰弘2, 上村宅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

	Symptom improvement of acute pericarditis, the pleurisy in 28-O1AM-02 colchicine alone and prevention of recurrence effect 上村裕美1, 芦川直也2, 岩田晃佳1, 宮村大佑1, 鷲見佳子1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

	Evaluation about the effect of clindamycin phosphate which gives it to taste of the mother's milk using the 28-O1AM-03 taste sensor 吉田都1, 中井由佳2, 原口珠実1, 櫨川舞1, 内田享弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

	A nourishment evaluation and side effect investigation in patients who received 28-O1AM-04 rt-PA IV therapy 大津幸, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

	Study on blood pressure fluctuation of 28-O1AM-05 sitagliptin treated patients 高井靖1, 伊藤涼子1, 梶間勇樹1, 鈴木啓之2, 宮原眞敏2, 西川英郎2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2014.

	Investigation about the drug participation in patients with 28-O1AM-06 bradycardia 小林由香, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

	Medication fact-finding results in the 28-O1AM-07 BP agent remedy patients 佐古有紀1, 桐林東一郎2, 河野弥生3,4, 花輪剛久3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

	One case that developed allergic by agents type change from 28-O1AM-08 tocilizumab infusion preparation to an automatic injector (pen type instillator) (injection site reaction) 臺裕子1, 平林史子1, 佐藤理仁2, 西村幸治2, 青木和利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

	About validity of the prior purchase judging from 28-O1AM-09 Eculizumab dosage interval change factor 中山裕一, 石橋正祥, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

	Optimization of 28-O1AM-10 ward drug duties and the formula Lee management by the cooperation of the pharmaceutical products administrative work 高井伸彦, 佐野慎亮, 石田卓矢, 大江未来広, 丸山修治, 青野浩直, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2014.

	Interaction analysis of lamotrigine for patients with 28-O1AM-11 children epilepsy 山本吉章1,2, 中井正彦1, 高橋昌明1, 今井克美1, 高橋幸利1, 賀川義之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

Case - pharmacokinetic analysis and basic examination ... which caused interaction of 28-O1AM-12 kidney cancer therapeutic drug sunitinib and warfarin
野田哲史1, 佐村和紀2, 大塚凌3, 堀江美弥1, 平大樹1, 藤原遼4, 河内明宏4, 生城真一5, 榊利之5, 森田真也1, 寺田智祐1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

	Interaction of etodolac and mycophenolic acid which paid attention to the competition in the drug-binding site of 28-O1AM-13 albumin 坂元利彰, 森塚暁裕, 松永典子, 林佳奈, 川鍋早紀, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

	Effect of the gastric-acid secretion inhibitor to give to blood MTX concentrations at the 28-O1AM-14 high dose methotrexate (MTX) administration 鳴海克哉1, 樋口一世1, 難波正志1, 山田順子1, 笠師久美子1, 山田武宏1, 豊嶋崇徳2, 井関健1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

	Analysis of the factor influencing 28-O1AM-15 blood lithium concentrations 赤羽理也1, 上西幸治1, 野田哲史1, 平大樹1, 星野伸夫1, 森田真也1, 稲垣貴彦2, 高橋正洋2, 森田幸代2,3, 山田尚登2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2014.

	Than an attitude survey for treatment at home, the many types of job cooperation of the importance recognition - Kyoto Medical Association position physician of the physician for pharmacist duties in the 28-O1PM-01 treatment at home ... 小村富美子, 荒井秀典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

	Medical therapy management by the pharmacist physical assessment in the 28-O1PM-02 nursing facility 須田潤1, 市川隆之2, 杉山憲司2, 杉浦伸哉2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

	It is an action toward becoming it improvement of 28-O1PM-03 treatment at home 西園憲郎1,2, 大庭信行3, 大庭隆弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

	Development of the high-speed simple suspension, infusion bag for the 28-O1PM-04 transluminal administration 盛本修司, 松永祐士, 野崎雅男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

	Thing ... which we saw from the questionary survey to role - cooperation physician of the hospital pharmacist in the 28-O1PM-05 PCI regional alliances pass 西野真代, 米田勝晃, 生川賀代, 増田晶子, 西尾佳奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2014.

	Effect of the water transport protein aquaporin which gives it to the gastrointestinal absorption of the 28-O1PM-06 drug 北岡諭, 名古屋智香, 五十嵐信智, 梶原小百合, 齊藤雅代, 川端あかね, 今理紗子, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

Possibility as the TDM estimation of the monetary value of housework of the vancomycin densitometry out of the cells intercellular fluid with the 28-O1PM-07 solubility micro needle
稲垣勇斗1, 宇野智哉1, 谷口真優1, 林明日香1, 河渕真治1, 伊藤由佳子1, 高田寛治2, 栄田敏之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

	Examination about the correlation of measuring equipment TDxFLx analyzer and blood methotrexate levels between TBA-25FR using the 28-O1PM-08 immunoassay method 金子哲也, 藤岡孝志, 鈴木陽介, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

	Examination of the simple and easy liver metabolic capacity rating system by the HPLC method which assumed 28-O1PM-09 4β-hydroxycholesterol an index 佐野芽衣, 笠原美那子, 浅見麻由佳, 須賀梓, 望月伸夫, 松本邦洋, 大野恵子, 岸野吏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

	Effect of the transporter genetic polymorphism which gives it to the blood level of the 28-O1PM-10 mycophenolic acid glucuronic acid metabolite 加賀谷英彰1, 新岡丈典1, 齋藤満2, 沼倉一幸2, 羽渕友則2, 佐藤滋2,3, 三浦昌朋1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2014.

	The establishment of the simultaneous assay of free form piperacillin out of the 28-O2AM-01 human plasma and tazobactam levels and evaluation of the clinical applicability 八木達也1, 内藤隆文1, 山田尚広1, 土井松幸2,3, 佐藤重仁3, 川上純一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

	1 case - that we made transitional - synovectomy to a knee joint of 28-O2AM-02 gentamicin 大石博史1, 山形真一1, 佐藤陽昨2, 大神降行1, 井原和彦2, 冨澤達1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

Development ... of construction and the simulation tool of individualization medication - PGx-PK-PD population model of voriconazole based on the 28-O2AM-03 clinical Pharmacometrics
猪川和朗1, 松元一明2, 茂見茜里2, 金澤直子2, 渡辺英里香2, 右川博明1, 横山雄太1,2, 森川則文1, 武田泰生2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

	Search of the factor influencing a blood early tacrolimus levels change after 28-O2AM-04 liver transplant 後藤綾1,2, 亀井秀弥3, 千崎康司1, 小原美和1, 毛利彰宏2, 大西康晴3, 野田幸裕2, 小倉靖弘3, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

Analysis with blood level and the choler quantity at oral preparation and the IV preparation administration of cyclosporine in 28-O2AM-05 liver-transplant recipients concerned
早川智久1, 池谷修1, 笠井雄佑1, 篠田昌宏2, 日比泰造2, 石川春樹1, 山吉康子1, 板野理2, 尾原秀明2, 北郷実2, 阿部雄太2, 八木洋2, 松原健太郎2, 戸枝美奈子1, 山口雅也1, 星野健2, 黒田達夫2, 北川雄光2, 岡本真一郎1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2014.

	Compatibility evaluation of analysis software and TDM guidelines in the initial administration plan on 28-O2AM-06 vancomycin 中島誠1,2, 中木原由佳1, 野間口寛1, 林秀樹2, 寺師守彦1, 杉山正2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

	Evaluation of the usefulness of the high-dose Teiko plastic Nin loading dose in the 28-O2AM-07 blood internal medicine domain 山口諒, 山本武人, 折山豊仁, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

	Examination of the Teiko plastic Nin administration regimen for the 28-O2AM-08 sustained hemofiltration dialysis embodiment 植田貴史1, 竹末芳生1, 中嶋一彦1, 一木薫1, 和田恭直1, 今本千絵1, 土井田明弘1, 高橋佳子2, 石原美佳2, 木村健2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

One case that a multifaceted viewpoint was required in the Vayko streptomycin administration plan for patients with 28-O2AM-09 children bacterial meningitis
竹田真理子, 山崎伸吾, 鈴木達也, 高塚博一, 鈴木貴明, 岸本路子, 中村貴子, 有吉範高, 石井伊都子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

Construction of the initial administration of vancomycin nomogram for the febrile neutropenia complicated with 28-O2AM-10 blood malignant disorder
鈴木陽介1,2, 時松一成2, 森永裕子1, 佐藤雄己1,2, 橋永一彦2, 高野久仁子3, 幸野和洋3, 緒方正男3, 平松和史2, 伊東弘樹1, 門田淳一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2014.

	The effectiveness of PIPC / TAZ in pneumonia and the UTIs due to 28-O2AM-11 ESBL production bacteria 柴田祐希1, 眞中章弘1, 後藤智彦2, 小林亮治2, 百武宏志1, 小林明信1, 高木章次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

	The ESBL-producing bacteria investigation that was detected than 28-O2AM-12 medical treatment ward long-term inpatient 継田雅美1, 石井美帆1, 細川泰香1, 山口利男2, 尾崎京子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

	Treatment and the effect on adult ESBL-producing bacteria detection patients in our 28-O2AM-13 House 山本圭城1,2, 安井友佳子1,2, 塚本あゆみ1,3, 大谷典子1, 和泉多映子2, 石坂敏彦1, 八野芳巳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

	Conversion ... from change - meeting room by the interventional method change to 28-O2AM-14 wide area antimicrobial proper use to the settings 長谷川浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

	An effect and problem of the action to the antimicrobial proper use that 28-O2AM-15 small and medium size hospital pharmacist is concerned with 齋田正和1,2, 東陽一郎2, 松井健一1, 廣瀬浩一1, 金本秀之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2014.

	The onset of adverse effect situation of the FOLFIRINOX therapy for patients with pancreatic cancer in our 28-O2PM-01 House 高橋新次, 前田章光, 松崎雅英, 水谷旭良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

	Fact-finding of the onset of hyponatremia with cisplatin in the 28-O2PM-02 solid cancer and examination about the risk factor 北国憲剛, 北出紘規, 森光恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

	Examination about the need of the nedaplatin doses adjustment depending on 28-O2PM-03 renal function 岩水秀敬1, 荒木理沙1, 片岡智美1, 熊倉康郎1, 宮崎雅之1, 安藤雄一2, 永井拓1, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

	Analysis of the factor to have an influence on the gemcitabine doses to 28-O2PM-04 elderly people 宮崎俊明1, 田中洋輔2, 筒井由佳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

	Examination of the effectiveness of the primary prophylaxis of the G-CSF for the febrile neutropenia with the 28-O2PM-05 TPF therapy 山本圭祐1,3, 石塚友一1, 川村和美1,2, 辻大樹3, 中道秀徳1, 梅原毅4, 袴田桂4, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2014.

	Examination of the liver damage aggravation expectation possibility by the 28-O2PM-06 regorafenib 久保杏奈, 米澤美和, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

	Various GFR estimate-style comparisons on the 28-O2PM-07 electronic chart and examination of the factor affecting the difference 袰岩靖子1, 田口伸1, 鈴木翔子1, 佐藤優弥1, 吹谷和子1, 齋藤裕之2, 佐藤宏和3, 七海泰彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

	Cytoreductive effect on intracranial abscess (meningioma) of the 28-O2PM-08 antimammary gland tumor agent (mepitiostane) 洞口拓也1, 竹中勝信2, 加藤雅康2, 野中裕康2, 吉岡史郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

	It is examined the tolerability in the S-1 therapy as the adjuvant chemotherapy after 28-O2PM-09 pancreatic cancer technique 魚住真哉1, 篠原旭1, 小林美沙樹1, 宇田川涼子1, 大野泉2, 市田泰彦1,2, 高橋邦雄1, 池田公史2, 齋藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

	Example that 28-O2PM-10 uterine leiomyosarcoma was given docetaxel / gemcitabine combination therapy 眞継賢一1, 倉橋基尚1, 濱口良彦1, 芦原由香2, 勝矢聡子2, 谷和光2, 竹森和正2, 松本里佳3, 柳原一広4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2014.

	From a setup of the action - outpatient department chemotherapy center of the cancer authorization pharmacist of the 28-O3AM-01 Chiba west general hospital to regimen management and side effect measures - 香取哲哉, 河本怜史, 白幡拓也, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

	Practice of the pharmacist outpatient department based on Collaborative Drug Therapy Management in the 28-O3AM-02 outpatient department chemotherapy 奥田泰考, 荒川昌史, 深谷裕之, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

	Role of the pharmacist in the foreign chemotherapy room judging from 28-O3AM-03 intervention content 上田綾佳, 倉橋基尚, 林万紀子, 野々内裕紀, 黒岩勇人, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

	The intervention results of the pharmacist in the 28-O3AM-04 outpatient department chemotherapy room and questionary survey of the patients 草野淳一, 佐伯佳奈, 吉田理, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

	Evaluation after the by physician consultation front start in the 28-O3AM-05 outpatient department chemotherapy 野村充俊, 上岡彩佳, 齋藤結, 日浦寿美子, 木村麗砂, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2014.

	Construction and the expression situation of the serious adverse event report system associated with the cancer chemotherapy in our 28-O3AM-06 House 内田充恵1, 川田祐一2, 椎木淳2, 飯塚香2, 萩原謙3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

	Effect of treatment of early peginterferon alone of the hepatitis C virus infection patients by the 28-O3AM-07 needle pad accident 齋藤真慈1, 大橋憲嗣2, 加藤典華1, 小木曽真由美1, 三輪耕次1, 森昭裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

	Relations with the number of hand hygiene per number of patients and patients with positive Clostridium difficile Toxin A in the 28-O3AM-08 Nagaoka Red Cross hospital with hospitalization 100 小林謙一1,5, 塩入久美子2,5, 永井久美子3,5, 西堀武明4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

	Construction of a side effect, interaction intelligence, analysis, the evaluation system in the 28-O3AM-09 community pharmacy, construction of the evaluation algorithm of a side effect, the interaction by the drugstore pharmacist 中嶋瞳1, 佐藤宏樹1, 笹島勝2, 澤田康文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

	Fact-finding of the voluntary recall of the generalist medicine in 28-O3AM-10 Japan 山本千琴, 石田卓矢, 大澤隆志, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2014.

	Use fact-finding of the nonsteroidal antiinflammatory drug drug for external use during the 28-O3AM-11 pregnancy 西順也1, 持永早希子1, 田崎正信1, 橋口真理子2, 横山正俊2, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

	Evaluation of the exposure prevention effect using a closed ring system "neo-shield" for the product made in 28-O3AM-12 JMS Co., Ltd. anticancer agent 賀川裕貴1, 渡部匡史1, 藤室雅弘1, 竹内正彦2, 沖山忠2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

	The worker exposure to 28-O3AM-13 anticancer agent preparation room and indoor environment pollution investigation 飯田純一1, 藤野晴互2, 安岡晋吾1, 山口文子1, 生田和之1, 加賀谷肇3, 内藤信忠2, 佐藤透1, 西沢正人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

	28-O3AM-14 Development for prevention of anti-cancer agent contamination "もれま栓キャップ" 石渡俊二1, 多賀淳1, 藤田秀樹2, 井上知美1, 小竹武1, 長谷川満3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

	Possibility of the exposure through the push child to syringe at the 28-O3AM-15 cyclophosphamide preparation 前田章光1, 高畑知帆子2, 小原真紀子2, 高橋新次1, 松崎雅英1, 梶田正樹1, 水谷旭良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2014.

Examination of rate of application and the infection onset risk of the lipid microsphere in the 28-O3PM-01 low weight patients
堀田栄治1, 高崎紗世1, 中根論士1, 山岸利隆1, 好川隆志1, 伊藤幸男1, 伊藤妃佐子1, 宗本義則2, 津田豪太3, 高嶋孝次郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

	The examination that is safe the use actual situation of metronidazole and an effect on 28-O3PM-02 intraperitoneal infections disease 佐藤和人, 猪瀬裕亮, 稲田寛之, 小川和奈, 海老根香里, 秋山裕史, 関利一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

	Safety assessment of azithromycin for the 28-O3PM-03 infusion 田中広紀1,2, 林誠3, 林宗貴4, 向後麻里1,2, 村山純一郎2,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

	A ratio and the course of the pancytopenia by linezolid (LZD) in 28-O3PM-04 patients on dialysis 加藤秀雄1,2, 浜田幸宏1,2, 萩原真生1,2, 川澄紀代1,2, 平井潤2,3, 山岸由佳2,3, 三鴨廣繁2,3,4, 松浦克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

	Examination of the risk factor of thrombocytopenia with the 28-O3PM-05 linezolid administration 泉澤友宏1, 金子知由1, 水之江亜美1, 勝俣はるみ1, 吉田正樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2014.

	Evaluation of a blood culture-positive patients round by 28-O3PM-06 Antimicrobial stewardship team and the outcome 前田真之1, 詫間隆博2, 峯村純子3, 宇賀神和久4, 内藤結花3, 土屋亜由美5, 大戸祐治6, 小司久志2, 石野敬子1, 二木芳人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

	Effect of Antimicrobial Stewardship Program (ASP) in the pediatric hospital which assumed 28-O3PM-07 Days of therapy (DOTs) an index 諏訪淳一1, 佐々木晴香1, 樋口浩2, 伊藤健太3, 堀越裕歩3, 内川清次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

	An action and effect of symptom minute description making adjuvant four years by the 28-O3PM-08 pharmacist 原弘士, 永井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

	Evaluation of a dose and the effectiveness of micafungin for the 28-O3PM-09 Candida bloodstream infection 菅原隆文1, 岡本良一2, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

	Is the delactation of the nursing mother at the 28-O3PM-10 levofloxacin administration really necessary? 大久保正1,2, 田中真理子2, 大久保七枝3, 大久保節子4, 大久保美穂5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2014.

Introduction of the joint medical treatment management by a physician, a medical technologist, the pharmacist about the HBV reactivation prevention with the 28-O4AM-01 cancer chemotherapy
内畠久美子1, 尾崎誠一1, 高橋恭平1, 村上輝明1, 谷口仁司1, 田阪武司1, 森近俊之1, 小澤秀弘1, 吉田昭昌5, 二五田基文6, 花本公津枝2, 石田克成2, 宮下真奈備3, 久山彰一4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

	Action of our House to the HBV reactivation for the 28-O4AM-02 S-1 new remedy start patients 菅原さやか, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

	We work on a change of the examination for HBV situation for patients who received chemotherapy in our 28-O4AM-03 House and the enlightenment by the pharmacist 磯田祥1, 後藤隆1, 下村真代2, 阪元孝志1, 上村宅司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

	Use and usefulness of the temozolomide bevacizumab combination therapy worksheet in the 28-O4AM-04 team approach in medical care 階戸美和1, 笹山潔1, 藤本直也1, 光田幸彦2, 谷口香3, 山鍬清美3, 森正昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

	Examination about the effectiveness of the regimen observance by the pharmacist intervention in the 28-O4AM-05 cancer chemotherapy 林誠1,2, 長岡宏一1, 舟木弘1, 崔吉道2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2014.

	Duties in the 28-O4AM-06 initial treatment room 佐野邦明1, 高木雄一1, 松本富夫1, 太内田房子2, 浅香えみ子2, 池上敬一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

	Examination ... in study on pneumonia (aspiration pneumonia in particular) onset risk factor - ICU inpatients of 28-O4AM-07 elderly people 松島彩音1, 黒川央2, 辻琢己1, 河野武幸1, 河合実2, 玉田太志2, 上野裕之3, 志馬伸朗4, 北村良雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

	Inspection about the medical treatment intervention by the 28-O4AM-08 altitude critical care center charge pharmacist 藤江直輝1, 佐藤了1, 竹田健志1, 高木麻里1, 藤田敬子1, 坂上嘉浩1, 藤見聡2, 室井政子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

	1 case that we managed pharmaceutical for terminal phase in the 28-O4AM-09 emergency care 九鬼大作, 藤田征志, 山中祐治, 山川卓哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

	The enforcement of the ward drug duties in the 28-O4AM-10 neonatal intensive care unit and drug control instruction duties and evaluation of the usefulness 大原早織, 等浩太郎, 八木達也, 原内智慧, 久保野尚子, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2014.

	Construction of the 28-O4AM-11 disaster support pharmaceutical products supply system of administration 加藤寛1, 北小路学1, 石渡俊二1, 安藤和佳子2, 安達秀樹2, 鵜山泰詳3, 櫻田ゆかり4, 井上知美1, 松山賢治1, 小竹武1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

	Relation of the pharmacist to domestic disaster medical care support to learn from support activity to 28-O4AM-12 Philippines typhoon damage 加藤あゆみ1,6, 浅川淳2,6, 森田貴子3,6, 惠谷誠司4,6, 涌嶋伴之助5,6, 片山志郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

Participate in the large-scale disaster medical care support activity caused by the typhoon in Philippines in 28-O4AM-13 2013; and of the pharmacist in the large-scale disaster medical care support activity in ... foreign countries is associated; ...
佐藤晴彦1,2, 高力俊策2, 池原康一1,2, 村上楽2,3, 伊禮武1, 上原克代1, 知花幸仙1, 伊波潔1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

Medical correspondence of our House in 28-O4AM-14 "Fukuchiyama-shi fireworks display stall explosion accident"
立道直美, 藤本華衣, 芦田理沙, 足立圭司, 村上由樹, 真下智行, 川見里奈, 堀雅博, 足垣亮介, 山本真世, 宮谷正哉, 勝井靖, 近藤あい
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

	Simulation at new stock index and inland earthquake of the antimicrobial for the 28-O4AM-15 injection 安田千賀, 寺岡知寿, 岸川有紀, 鈴木博也, 松浦正樹, 佐藤真由美, 久道周彦, 眞野成康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2014.

	Introduction of the joint medical treatment management (PBPM: Protocol-Based Pharmacotherapy Management) in the 28-O4PM-01 MRSA treatment and the effect 中居肇1, 工藤香澄1, 松田俊之2, 中村一成1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

	About usefulness of safety and the blood level monitoring of the 28-O4PM-02 antiMRSA medicine daptomycin 安藤基純1, 小曳恵里子2, 中浴伸二2, 柏木裕子2, 北田徳昭2, 亀井博紀3, 園諭美3, 西岡弘晶3, 福田剛史4, 橋田亨2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

Examination ... about analysis - renal failure of the clinical response about the initial loading dose design of VCM in the 28-O4PM-03 serious case infection of relationships
片山皓希1, 實川東洋1,2, 渡邉暁洋1, 福田恵子1, 若松孝嘉3, 齋藤伸行2,4, 八木貴典4, 原義明4, 松本尚4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

	Improvement of the treatment result of the use of antiMRSA medicine case with all 28-O4PM-04 injectable antimicrobial surveillance systems 鈴木景子1, 丹羽隆1,2, 外海友規1, 渡邉珠代2, 太田浩敏2, 土屋麻由美2, 安田浩二1, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

It is an investigation about the onset of renal failure of the glycopeptide-based antimicrobial in the patients after hematopoietic stem cell transplantation during 28-O4PM-05 tacrolimus administration
中川裕司1, 榎屋友幸1, 石橋美紀1, 村木優一1, 門間文彦2, 藤枝敦史2, 片山直之2, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2014.

	Search of the patients side factor which gives it to the hoarse onset with the 28-O4PM-06 inhalant and the pharmaceutic factor 平大樹1, 腰山節子2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

	Indirect comparison of the effect of treatment of the long-term effect type bronchodilator for the 28-O4PM-07 chronic obstructive pulmonary disease (COPD) patients 茂木まどか, 長谷川彩, 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

	Action of the pharmacist to 28-O4PM-08 inhalant ad here Lance improvement 鶴居勝也1, 波多晶子1, 三谷和恵1, 中尾大介1, 窪田真弓1, 斎田真紀2, 松川珠絵2, 瀧本文恵2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

	Long-term evaluation of the asthmatic inhalational instruction by the 28-O4PM-09 pharmacist 内山直樹1, 井上正朝1, 長嶋恵1, 桜庭好祐1, 川崎裕世1, 寒藤雅俊1, 大井希美1, 小川聡1, 粟屋敏雄1, 福土将秀1, 松原和夫2, 田崎嘉一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

	Comparison between use actual situation - internal medicine and otolaryngology ... of the antiallergic agent used for 28-O4PM-10 allergic property cough treatment 石坂悠1, 武隈洋2, 吉村恵理3, 吉田憲史3, 小嶋希望3, 上野英文3, 菅原満2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2014.

	About an action and the effect of the medicine medicine cooperation on oral 28-O5AM-01 anticancer agent single agent 遠藤征裕, 齋藤雅隆, 森川和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

Action about the cooperation with the local health insurance drugstore by our 28-O5AM-02 House outpatient department chemotherapy room pharmacist
外石昇1,3, 大友雅子4, 村岡周一4, 村上明男1,3, 吾妻美香1, 堀部聖1, 山賀亮祐1, 長久保久仁子5, 山口健太郎2,3, 渡邉一則1, 吉松和彦2,3, 成高義彦2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

	The information communalization by regimen mention of the 28-O5AM-03 anticancer agent prescription and action by the medicine medicine cooperation 小林篤史1, 池上摩弥1, 武田智子2, 長谷川晃司2, 乙黒万喜子3, 小曽部毅4, 箕輪圭一郎5, 和田淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

	Attitude survey of the health insurance pharmacy pharmacist for the prescription including the 28-O5AM-04 internal use anticancer agent 渡部一宏1, 千島己幸2, 縣和宏2, 平子庸志3, 芳川圭治3, 大石美也3, 濃沼政美4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

	Action of the community pharmacy that we went to support 28-O5AM-05 CKD seal 氏内圭一, 木下美香, 栃本真理子, 安田亜衣, 山本真司, 杉山憲司, 杉浦伸哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2014.

	Consciousness change for the psychiatry of the student by the short-term business training at the 28-O5AM-06 psychiatry single department hospital 黒住由依, 谷口律子, 馬場大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

	Trial of the business training that classified 28-O5AM-07 pharmacy education model core curriculum revision into the field 岡崎彰仁, 西川かおり, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

	Suggestion (the second report) about business training instruction curriculum improvement that we thought about based on the training result of the 28-O5AM-08 past 久保みさき1, 林高弘1,2, 福井愛子2, 早川伸樹2, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

	The insulin self injection practice that utilized 28-O5AM-09 elderly people simulated experience set 小野浩重, 毎熊隆誉, 松山祐, 吉川雄貴, 秋山咲絵, 藤江郁, 加地弘明, 柴田隆司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

	Does it induce the interest for the gene to have shown the handmade animation which extracts DNA from a broccoli in 28-O5AM-10 first grader basic biology lecture? 佐藤亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2014.

	Analysis of the pre-Abo id example by the 28-O5AM-11 outpatient department chemotherapy center permanent residence pharmacist 畝佳子1, 北宅良祐1, 田邨保之1, 物部加容子1, 馬場雅子1, 上野裕之2, 河合実1, 北村良雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

	Action of the pharmacist for the perioperative patients in the 28-O5AM-12 admitting department 矢川結香, 居塚しのぶ, 桑村恒夫, 末松文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

	Action of the pharmacist outpatient department for patients with diabetes in our 28-O5AM-13 House 宮原留美1, 江坂美保2, 田中理恵1, 天野博之1, 近藤洋一3, 服部麻美3, 足立守3, 大川内幸代4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

	It is the role of the pharmacist in the follow-up outpatient department to the patients after 28-O5AM-14 hematopoietic stem cell transplantation 平井三保子1, 藤井理絵2, 松浦典子2, 籠本基成1, 通堂満3, 小林政彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

	The administration results of Regorafenib in our 28-O5AM-15 House and action of the pharmacist preliminary examination 畑裕基1, 南野優子1, 宮部貴識1, 堀内哲也2, 山崎邦夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2014.

	Fact-finding of the INR management of patients with non-valvular atrial fibrillation in the warfarin therapy using 28-O5PM-01 TTR 芳賀洋祐1, 井本剛史2, 吉田丘1, 紺野恵3, 佐藤雅之4, 山口修5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

	About the evaluation of the platelet function using the 28-O5PM-02 simple platelet function measuring instrument 本間三絵1, 江川修1, 原口渉2, 北川直毅2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

	28-O5PM-03 It is one patient receiving cilostazol for bradycardia patients on dialysis 園田利広1, 山合耕一2, 諸隈太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

Point of the pharmaceutical management to consider from the case that developed cerebral infarction during use of 28-O5PM-04 new oral anticoagulant drug (NOAC)
徳永晃己1, 柴田啓智1, 甲斐光1, 市川洋一1, 田中忠宏1, 永沼雅基2, 米原敏郎2, 中尾浩一3, 田上治美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

	Examination of the tolerability of the rivaroxaban in the 28-O5PM-05 dabigatran intolerance case 岩田晃佳1, 上村裕美1, 芦川直也2, 宮村大佑1, 鷲見佳子1, 石黒英行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2014.

	The choice of the 28-O5PM-06 new oral intestinal tract cleaner and examination about the usefulness 高山直樹1, 野田恵加2, 中村文保2, 西村大2, 冨樫弘一2, 野一色真弓3, 野洌孝二1, 大岡千寿子1, 多賀俊明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

	Examination of the diuresis effect by the administration time of the 28-O5PM-07 tolvaptan 廣瀬正幸1, 田中伸享2, 高木翔1, 石原弘貴2, 川上徹2, 大野泰良2, 三輪耕次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

	28-O5PM-08 For usage as well as the side effects occurrence of Tolvaptan in Saiseikai Yamaguchi General Hospital 後藤志典1, 赤川英三2, 赤崎淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

	An example of patients with chronic pain that the thinking disturbances with the 28-O5PM-09 high dose fentanyl patch were found in 大東敏和, 佐伯康之, 畝井浩子, 木村康浩, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

	One case of patients with impaired renal function that resulted in myasthenia due to the overdose of 28-O5PM-10 cibenzoline succinate tablets 中川義浩1,2, 山部美千子1, 竹内小百合1, 上山秀嗣2, 石崎雅俊2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2014.

	Relations with crystallinity and the dissolution of the drug out of the 27-P1AM-001 preparation: About itraconazole 安藝初美1, 向井千晶1, 山田楊太1, 溝部健2, 川原光喜1, 湯川美穂1, 湯川栄二3, 池田浩人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Comparison between innovator drug and side effect in the acute phase with the generic drug of 27-P1AM-002 cisplatin 渡嘉敷俊介, 鳴川貴司, 川合麻未, 長浦宏之, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Comparison of preparation properties of the 27-P1AM-003 lidocaine tape 三上充宏1, 杉野雅浩1, 細谷治1, 太田昌一郎1, 安野伸浩2, 從二和彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Study on quality of the generic medicine of the 27-P1AM-004 isosorbide dinitrate tape 大野貴之, 下村斉, 青山隆夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Comparison between starting pharmaceutical products and quantity of skin transmission of the generic medicine of the clobetasol using the 27-P1AM-005 hairless rat keratin injury skin 木下聡美1, 中島由紀1, 杉浦宗敏1, 松元美香2, 大谷道輝2, 山村喜一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Change by the innovator drug in the 27-P1AM-006 dexamethasone propionate ester ointment, the difference in rheology properties of the generic drug and the preservation 山下優太, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2014.

	Mixed difference with the innovator drug of the 27-P1AM-007 difluprednate ointment, the rheology properties of the generic drug and the cream 小谷隆一, 内田梓, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	Report ... first than the consultation drugstore settings of the 27-P1AM-008 eye drops attitude survey - town 佐藤友恵1, 河津みとり1, 佐藤孔治1, 小出美穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	It is ... generic medicine index 72% ... for proper use reliable with 27-P1AM-009 generic drug 甲斐章裕, 石川広大, 谷口公章, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	Investigation about the prescription situation of the 27-P1AM-010 generic medicine 今泉瑛那, 平野裕美, 小幡貴子, 神野堅司, 浦崎圭太, 菱田栄子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	Research about the action of the health insurance pharmacy in the 27-P1AM-011 generic medicine recommendation 金丸朗1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	Action to generic medicine adoption promotion using the 27-P1AM-012 lectotype 赤木圭太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2014.

	Action to the incident inhibition at 27-P1AM-013 generic medicine formulations 川野雅1, 山崎さやか1, 宮本晃圭1, 窪内雅也1, 三浦鉄平1, 宅間大祐1, 竹村和泰1, 濱田篤秀1, 平松久嗣1, 京谷庄二郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	Invention ... of the prescription data screen in examination - electronic chart for smooth changes to 27-P1AM-014 generic medicine 押賀充則1, 赤木圭太1, 佐藤仁宣1, 本郷知世1, 平野光枝1, 関口昌利2, 山口正和3, 伊藤博1, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	Action to in-hospital generic name prescription with the 27-P1AM-015 generic medicine adoption 福田泰代1, 中筋美保1, 中島弘毅1, 小野順子1, 田中毅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	Application of the T-LEX(R) method to the pharmacologic action evaluation in the human liver at the 27-P1AM-016 generic drug administration 榎本初音1, 立木秀尚1, 島田卓2, 長塚伸一郎3, 中嶋弥穂子4, 中嶋幹郎5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	Problems in the information on adverse drug reactions of the 27-P1AM-017 generic medicine anticancer agent 篠原義剛, 井手飛香, 蒲池英博, 斎藤暢人, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	It is compared Japan with Sweden about 27-P1AM-018 generic medicine policy 今井志乃ぶ1, Andersson Sundell Karolina2, 伏見清秀3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2014.

	Is "the Orange Book" not necessary for 27-P1AM-019 infusion preparation? (the first report) 武井佐和子, 影山美穂, 別生伸太郎, 濱田真向, 戸張裕子, 井上みち子, 三溝和男, 倉本敬二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

It is an 8 case using filgrastim BS note "Mochida" at the chemotherapy enforcement for the 27-P1AM-020 malignant lymphoma
大坪達弥1, 中川ゆかり1, 堀西祐太1, 藤田将輝1, 大塚充1, 鹿浦香織1, 神田英一郎1, 岡橋孝侍1, 藤田敦夫1, 西川靖之1, 川本晃男1, 野田能成1, 友金幹視1, 小林裕2, 三上正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

	It is investigated the consumption by the change to by Osh mirror in the 27-P1AM-021 G-CSF preparation 仁田美保子, 中林真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

	About systems construction and the effectiveness to share 27-P2AM-001 drug information in many institutions 山内拓1, 川村和美1, 榊原里依子1, 藤田俊之3, 松下紘輔2, 塩川満1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

	Construction of the simple suspension system for for 24 hours suitable for a hospital for 27-P2AM-002 acute phase 岩尾恭寛, 植山寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

	About the inventive idea that utilized the section system in the electronic chart system for 27-P2AM-003 package 池井健, 堀部正記, 村上功一, 遊見裕子, 安田喜美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2014.

	Use of the medication explanation support application for the tablet type terminal in the 27-P2AM-004 children drug control instruction and investigation about the effectiveness 永井絵里子1, 初田泰敏3, 後藤真千子2, 小川雅史3, 室井政子4, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

	Construction of the 27-P2AM-005 ward drug log book system 池田敦1, 加藤隆2, 谷口聡1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

	Contribution to ward drug duties by the 27-P2AM-006 checking prescription system introduction 増田信一, 植草秀介, 綿貫陽一, 斎藤結, 木村麗砂, 小林秀樹, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

	Construction and evaluation of the antimicrobial proper use check system at the 27-P2AM-007 impaired renal function 佐藤篤郎1,2, 鈴木厚志1, 加藤直紀1, 黒田信行1, 片山広美1, 天野哲史1, 松本薫1, 榊原ゆかり1, 坂田洋2, 板倉由縁1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

The construction of the inside the hospital website for the purpose of securing of constant quality in the 27-P2AM-008 drug information offer and the efficiency of duties and evaluation of the usefulness
石澤佑樹1, 萬谷みゆき1, 坂田拓也2, 佐藤陽1, 奥ヶ谷教1, 久米央子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

	Analysis of the reading situation by the medical staff of 27-P2AM-009 online pharmaceutical products information retrieval system (MD-view) and the factor analysis 上林里絵, 川瀬亮介, 村木優一, 本多立, 杉本浩子, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2014.

	Development of the general-purpose model of the 27-P2AM-010 English version medicine reporting book publication system 井上幹雄1, 西尾優作2, 宮本菜摘1, 瀧裕子1, 吉野翠1, 福田喜彦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	Setup of the 27-P2AM-011 in-hospital product drug information magazine "to have you read" 落合愛子1, 島津英昌2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	System maintenance about the registration of the allergic cover suspicion medicine to 27-P2AM-012 electronic chart and examination of problems 佐々木寿子1, 椎崇1, 関めぐみ1, 鈴木智子1, 八木宏之1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	Efficiency of the information on adverse drug reactions collection by the management tool making in the 27-P2AM-013 University of Tokushima hospital pharmacy 石田俊介1, 前田和樹1,2, 伏谷秀治1, 渡邉美穂1, 寺岡和彦1, 川添和義1,3, 水口和生1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	The database making of pharmaceutical products considered to require attention for 27-P2AM-014 driving and analysis 寺内恭平, 宮村信輝, 柴田里枝子, 大野逸子, 杉平直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	Construction of a drug information sharing and the database using 27-P2AM-015 electronic chart 白府敏弘, 山本笑子, 武藤芳和, 駒澤愛, 畑中愛美, 田村研太郎, 井上陽介, 近藤智幸, 下道一史, 糸川貴之, 後藤吉延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2014.

	Construction of the 27-P2AM-016 ward drug duties assistance database tool 板東達也, 多和田敏朗, 水野善晴, 佐藤嘉孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

Analysis about the association of interstitial pneumonia and the pharmaceutical products in the 27-P2AM-017 American large scale database
松井利亘1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 羽根由基1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

	Analysis of the nephrogenic diabetes using the 27-P2AM-018 FDA-AERS database 中山蓉子1, 梅津亮冴1, 鈴木俊之1, 加藤大和1, 上田夏実1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

	Analysis of the hyperglycemia onset of the antipsychotics using the 27-P2AM-019 adverse event spontaneous report database 加藤大和1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 中山蓉子1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

	The effect that information to alert of the 27-P2AM-020 dabigatran gives to an adverse event database 阿部純子1,2, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

	Evaluation of the adverse event expression of new anticoagulant time using the adverse event spontaneous report database of 27-P2AM-021 Japan and the United States 今野彩1, 五十嵐敏明1, 中村敏明1, 日野村靖2, 上原恵子2, 政田幹夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2014.

	Investigation of the adverse event report in 27-P2AM-022 hepatitis C treatment 上田夏実1, 梅津亮冴1, 鈴木俊之1, 中山蓉子1, 加藤大和1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Analysis of the angioedema in ACE inhibitor using 27-P2AM-023 FDA-AERS and ARB 羽根由基1, 梅津亮冴1, 鈴木俊之1, 上田夏実1, 加藤大和1, 中山蓉子1, 松井利亘1, 阿部純子1,2, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Angiotensin receptor blocker using 27-P2AM-024 JADER, analysis of the adverse event in the thiazide system diuretics combination therapy 野口義紘, 江崎宏樹, 浅野祥子, 横井貴文, 臼井一将, 加藤未紗, 齊藤康介, 舘知也, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Investigation of the tendency to adverse event development of the nonprescription drug using 27-P2AM-025 JADER 梅津亮冴1, 鈴木俊之1, 阿部純子1,2, 中山蓉子1, 上田夏実1, 加藤大和1, 紀ノ定保臣3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Example of the excellent action in acquisition, transmission, the inflection of the 27-P2AM-026 pharmaceutical products safety information 平松彩佳1, 中常恵美1, 飯村康夫1, 渡邊伸一1, 山本弘史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Medication guide - for patients whom utilization is expected of as - reporting tool how you tell information of the 27-P2AM-027 safety breaking news (blue letter) to the patients 岩崎裕佳里, 五十嵐崇子, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2014.

	Attitude survey - of the healthcare worker for the 27-P2AM-028 study on attached document - attachment document model (plan) of the new ethical drug 阿部智美1, 鳥山五月2, 服部洋子2, 浅田和広2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	Effect, overdose, clinical results, examination - of the mention point of other attention to give it to study on attached document - laboratory study results of the ethical drug that 27-P2AM-029 is new 川上明三1, 岩瀬万里子2, 安原一3, 佐藤信範4, 村山純一郎1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	Study on attached document - "attention in the application" of the ethical drug that 27-P2AM-030 is new examination - about the mention point of "the attention in the handling" 工藤賢三1,2, 櫻田大也3, 平舩寛彦1,2, 小林江梨子3, 佐藤信範3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	Discussion about the references of the 27-P2AM-031 ethical drug attachment document 阿部和史1, 平島由香2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	Analysis of the questions and answers in the 27-P2AM-032 drug information room 原田大, 中島清江, 北村正樹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	Follow-up report about the information provided by a 27-P2AM-033 drug information room 橘淳, 原竜太郎, 長谷川豊, 塗木勇介, 戸鹿野美織, 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2014.

	The analysis of questions and answers, the doubt inquiry accumulation example in the 27-P2AM-034 cancer special hospital and future problem 坂本由希子, 宮本聖子, 佐々木由香, 林稔展, 小早川高徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

Evaluation of the usefulness for the information dispatch by the 27-P2AM-035 institution crossing-like DI activity
吉川飛鳥1,2, 相良克海1,3, 関根由香理1,4, 駒井信一郎1,5, 高塚亮1,6, 叶内至1,7, 河野薫里1,8, 上野拓1,9, 森下奈緒1,10, 須藤貴博1,11, 大平優1,5, 小田慎1,3, 三上二郎1,8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

	Evaluation of the drug information offer for 27-P2AM-036 outpatients 栗原千絵子1, 安間浩子1, 厚見恵1, 尾崎真由子1, 妹尾裕美子2, 勝俣はるみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

	How will the patients become able to describe an interview sheet enough 27-P2AM-037? - 2 for solution 藤森美代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

Investigation about the medication method of the antimicrobial for patients with childhood otitis media in the 27-P2AM-038 pharmacy service under health insurance drugstore and the allergic therapeutic drug
加藤芳徳1, 小野村直紀1, 石井浩二2, 阿部倫明1, 柿沼直利1, 船山将栄1, 真野泰成1, 大内かおり1, 前澤佳代子1, 百瀬泰行1, 旭満里子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

	Change second report of the number of the combination drugs with the antihypertensive medications combination drug judging from the prescription fact-finding of 27-P2AM-039 antihypertensive medications 若林進1, 篠原高雄1, 永井茂1, 林潤一2, 山本実2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2014.

	For the improvement of examination - PMDA reporting homepage of the publication page of the 27-P2AM-040 "guide to a vaccinated person" - 樋口昇大1, 五十嵐崇子1, 佐藤大介1, 八田真美子1, 中村悟2, 高松昭二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

	To have a person and the family receiving 27-P2AM-041 "guide - vaccination to a vaccinated person" understand a vaccine formulation; - 三浦百合香, 五十嵐崇子, 樋口昇大, 佐藤大介, 八田真美子, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

	Role of the pharmacist in the 27-P2AM-042 legal declare of brain death 友田明子1, 椎崇1, 近藤留美子1, 厚田幸一朗1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

	About the introduction of the simple suspension method in our 27-P2AM-043 House 増尾直亮, 品田奈津美, 工藤吏恵, 須藤頌, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

Analysis and evaluation of the ward duties results before and after the "ward drug duties enforcement addition" calculation in the southern part of 27-P2AM-044 Saiseikai Yokohama-shi Hospital
北岡晃, 金子美玲, 安岡晋吾, 平間盛吾, 山口文子, 生田和之, 三角真由, 鈴木奈津子, 佐藤透
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

Drug epidemiological investigation by the changes from the antihypertensive medications which assume 27-P2AM-045 valsartan an active ingredient to other antihypertensive medications
田中正臣1, 田中彰一1, 濱克徳1, 杉村ゆかり1, 高橋秀聡1, 前田健太1, 後藤圭介1, 星貴薫1, 武田瑛司1, 水戸麻未1, 宮越貴之1, 佐藤秀紀2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2014.

	Investigation of the prescription actual situation of the NSAIDs drug for external use during pregnancy using 27-P2AM-046 receipt data 塩原千尋, 岡田裕子, 前田恵里, 増田寛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

	Evaluation of the tablet division by 27-P2AM-047 various kinds of fractionation 横山郁子, 竹下治範, 河内正二, 猪野彩, 辰見明俊, 波多江崇, 田内義彦, 沼田千賀子, 杉山正敏, 濱口常男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

	Analysis of the adverse event of the antiallergic agent which became switch OTC using 27-P2AM-048 JADER 江崎宏樹, 野口義紘, 浅野祥子, 横井貴文, 臼井一将, 加藤未紗, 齊藤康介, 舘知也, 寺町ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

	27-P2AM-049 The effect that the number of the preparation standards of the injectable anticancer agent gives to the waste ratio of the left liquid 菱沼隆一, 山村翔, 荒木良介, 小島正照, 三田恭平, 山田英紀, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

Report ... of the reduction effect that we gave to drug costs by the intervention from intervention - early days to the medical therapy of the pharmacist in the rehabilitation ward for 27-P2AM-050 convalescence
妻鹿宏美, 安藤崇仁, 奥野靖隆, 志村吉徳, 永田文恵, 近藤幸男
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

	The effect that a medication investigation before hospitalization in the rehabilitation ward gives to drug costs after the hospitalization for 27-P2AM-051 convalescence 金井紀仁, 大野智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2014.

Economic evaluation for the prevention of fall by the correction of the high-dose prescription of the 27-P2AM-052 sedative hypnotic
横井貴文1, 舘知也1, 梅田道2, 浅野祥子1, 臼井一将1, 加藤美紗1, 野口義紘1, 安田昌宏2, 水井貴詞2, 南谷美朱3, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	A disease severity classification and costs estimation of the COPD using 27-P2AM-053 receipt data 町井徹1, 岩崎宏介2, 赤沢学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	Evaluation of the pharmaceutical intervention for the 27-P2AM-054 cancer chemotherapy 松岡加恵, 中西敏博, 荒川裕貴, 桂川健司, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	27-P3AM-001 [case report] Action of the methotrexate (MTX) side effect evasion in the rheumatoid arthritis (RA) treatment 宮崎徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	Participation and evaluation to cancellation medicine before surgery in the 27-P3AM-002 preoperation patients support center 楠本梨賀, 満田正樹, 佐向美帆子, 中谷亮介, 野際俊希, 野口恵子, 尾崎加織, 三宅美有紀, 瀧浪靖子, 浅井茂夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	Of the 27-P3AM-003 surgery, testing purpose is going to be hospitalized; an action of the common use medicine confirmation in the outpatient department to the patients 木村智美, 寺沢匡史, 片山智章, 北山尚子, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2014.

	About the evaluation of the remedy medicine investigation before surgery in the 27-P3AM-004 outpatient department 石本彩乃, 神谷真悟, 岡村智文, 黒潟貴子, 梅野尚生, 小川丈彦, 柴田文規, 水橋直人, 竹田克明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

	Action of the pharmacist in the 27-P3AM-005 reservation hospitalization support center 鈴山直人, 永江一徳, 潟永安亘, 植村隆, 田中誠, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

The intervention of the circulatory organ physician and the effect on antithrombotic drug discontinuation instruction in the 27-P3AM-006 pharmacist outpatient department
藤吉正哉1, 戸村幸貴1, 伊藤菜美1, 里田栄美1, 三浦遼子1, 森智之1, 野澤美香1, 高橋伸夫1, 生山野々子1, 石川温子1, 岩田杏子1, 中村裕義1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

	27-P3AM-007 "pharmacist outpatient department" introduction - outpatient edition ... 大河万顕, 田井浩子, 下村一徳, 辻陽子, 辻川円, 田代美佳, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

	27-P3AM-008 "pharmacist outpatient department" introduction - ward: Effect ... to ward drug duties 畑暁子, 田井浩子, 下村一徳, 瀬名波宏昌, 大河万顕, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

	Inflection of the LINQ questionnaire to the inhalational instruction for patients with 27-P3AM-009 COPD 中西大介1, 出口綾子1, 伊藤健太郎2, 内藤雅大2, 畑地治2, 柳川泰裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2014.

	Inhalational instruction by our 27-P3AM-010 House pharmacy and the effect measurement investigation 能登啓介, 鈴木有紀, 中尾治香, 松本優香子, 島谷悠里, 新屋悠, 山岸三紗, 平田敦士, 西浦早織, 松岡寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

27-P3AM-011 Establishment of the pharmacist instruction outpatient department in Nagoya Ekisaikai Hospital - In the inhalational introduction patients and diabetes medical treatment patients of asthma, the COPD -
中村敏史1, 後藤康洋3, 池上信昭1, 吉田昌則2, 山本雅史3, 堀田美知成1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

	Relation ... DOTS use ... of the pharmacist for patients with foreign tuberculosis in our 27-P3AM-012 House 佐藤可奈, 福島さやか, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

	Analysis of doubt inquiry and the prescription suggestion by the pharmacist intervention to 27-P3AM-013 outpatient department chemotherapy 田島博樹, 高野洋平, 石田華奈子, 川口照雄, 長谷川恵一, 山田裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

Change ... of the needs of the patients by the questionary survey (2) - duration of treatment about the reporting for the patients with whole 27-P3AM-014 outpatient department chemotherapy enforcement
檀和貴1, 依藤健之介2,4, 木田圭祐2, 堀端真次2, 大上寛子2, 浜本麗子2, 長谷川豊2, 波多江崇3, 江本憲昭4, 平野泰健2, 濱口常男3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

	Questionary survey about the reporting for the patients during the 27-P3AM-015 outpatient department chemotherapy enforcement 依藤健之介1,4, 檀和貴2, 木田圭祐1, 堀端真次1, 大上寛子1, 浜本麗子1, 長谷川豊1, 波多江崇3, 江本憲昭4, 平野泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2014.

	Parenteral injection preparation duties in 27-P3AM-016 outpatient department rheumatoid arthritis treatment 森山傑, 山崎勇輝, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

	About "the pharmacist outpatient department" in our 27-P3AM-017 House 島谷桜子1, 坪谷綾子1, 白土阿貴恵1, 浅見妥江1, 松本浩1, 小宮詠子1, 赤津真衣子1, 東しずか1, 金井知子1, 坂下裕子1, 増原慶壮1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

	27-P4AM-001 Examination of the output usefulness of the test value to a prescription, injection prescription 新関みどり, 長澤欣弘, 嶋崎千絵, 羽生智宏, 森山亜矢子, 尾形美絵, 田村和彦, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

	Practice of the appropriate medical treatment by the test value indication to 27-P4AM-002 prescription 高橋義弥, 石川由香理, 高橋豊, 丸山俊夫, 飯坂美香, 七尾亮子, 谷田拓也, 櫻井正之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

	Action of the 27-P4AM-003 renal function evaluation seal introduction 西尾剛1, 川路明人1, 酒井貞子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

	Action to raise the examination of the pharmaceutical products rate of use needing the testing that it is like 27-P4AM-004 regularly 長水正也, 岡本有紀子, 工藤正治, 竹内敏明, 中村康夫, 鈴村宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2014.

Proper use of the drug for patients with hepatic dysfunction based on 27-P4AM-005 Child-Pugh classification
福元裕介, 野間口寛, 桐野玲子, 柿本智広, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 中島誠, 池ノ上知世, 坂元優太, 平田りか, 寺師守彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

	We conduct the doubt inquiry for the renal excretion type drug after renal function mention in 27-P4AM-006 prescription and investigate it 内田守次, 草野充裕, 石田佳織, 金子華子, 藤本真由美, 進健司, 梅田勇一, 中嶋弘之, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

	Tendency of the doubt inquiry in the analysis third report overtime practice of 27-P4AM-007 doubt inquiry contents 平野裕美1,2, 今泉瑛那1, 辻真由子1, 小幡貴子1, 神野堅司1, 浦崎圭太1, 菱田栄子1, 河井和子1, 伊藤和幸1, 磯谷聡1, 露木幹人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

	Usefulness and problems of the checking prescription system in the 27-P4AM-008 doubt inquiry 平明日美, 上田賢太郎, 合澤啓二, 宮崎美香, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

	Action to a prescription correction for the doubt inquiry prescription by the 27-P4AM-009 pharmacist 尾崎俊幸, 金子奈緒美, 島田杏子, 湯山千明, 安食健一, 寺西正充, 平野榮作, 横手克樹, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

	Examination of the quality of the injection compounding of medicines duties that assumed 27-P4AM-010 doubt inquiry contents an index 佐々弥栄子, 木下元一, 青山智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2014.

Qualitative quantity-like change of the doubt inquiry that an action for the purpose of the efficiency of inpatient dispensing duties in the 27-P4AM-011 Mie University Hospital for the past 5 years resulted in
堀内桂子, 榎屋友幸, 村木優一, 本庄絵美, 水口恵理, 岩本卓也, 奥田真弘
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	Analysis of the doubt inquiry contents in 27-P4AM-012 prescription formulations 永野烈, 小島庸子, 能登英子, 山口美穂, 高岡龍蔵, 安藤彰冶, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	Action for the quality improvement of the doubt inquiry duties in 27-P4AM-013 prescription formulations 能登英子, 永野烈, 小島庸子, 山口美穂, 高岡龍蔵, 安藤彰治, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	Change of the doubt inquiry associated with the renal function by displaying 27-P4AM-014 test value in a prescription 赤崎淳子, 中西裕美, 山崎博子, 林幹也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	Difference between pharmacist and misfrequency of the nurse in the 27-P4AM-015 name of medicine similarity 田川慎二, 辻敏和, 入佐俊弘, 國分千代, 金谷朗子, 末安正典, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	As a result, it is reported with measures for the incident at the formulations in our 27-P4AM-016 House, the accident decrease 佐藤達也, 林誠一, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2014.

	Decrease in formulations incident by the 27-P4AM-017 formulations inspection system introduction 力武隆浩, 甲斐章裕, 石川広大, 谷口公章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

System rebuilding for the quality improvement of injection drug compounding of medicines duties with the new ward move of 27-P4AM-018 pharmacy and the evaluation
野田晋司, 日置三紀, 村木優一, 榎屋友幸, 岩本真拡, 三輪倫加, 須藤宏文, 岩本卓也, 奥田真弘
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

	Construction of the product system of administration derived from the specific organism using the 27-P4AM-019 electronic chart 陸丸幹男1, 柴田七奈1, 重松明美1, 御幡省三2, 清水達紀3, 黒木俊輔3, 宮本誠二4, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

	Evaluation of compounding of medicines duties using the 27-P4AM-020 bar code authentication system 森本重輝, 園部俊輔, 関口麻未, 青山剛, 樋口秀太郎, 中野泰寛, 鈴木賢一, 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

	Development and effect of the automatic RP division function that we accepted in a remedy start timing with the 27-P4AM-021 hospitalization oral medicine order 高橋翠, 五十嵐敏明, 今野彩, 宇野美雪, 松嶋あづさ, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

	27-P4AM-022 Evaluation of the outside Parliament prescription inspection system which utilized clinical test value 鶴田洋平, 幸村瑤子, 上田武司, 西川かおり, 岡崎彰仁, 石坂忠博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2014.

	Construction and evaluation of 27-P4AM-023 ointment, the solution label printing system 梅田道, 大澤友裕, 水井貴詞, 甲田明英, 大野佑城, 市橋厚司, 安田昌宏, 小林健司, 佐橋誠, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	Availability of all automatic tablet withdrawal machine (Tiara) in the 27-P4AM-024 Tokyo Women's Medical College Hospital 前浩史, 深谷寛, 坂丹波礼子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	Action to the 27-P4AM-025 efficiency-like simple suspension method 三砂義敬, 大久保嘉則, 植村ちひろ, 中尾瑞穂, 床島英雄, 鈴田浩孝, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	Elution behavior of levofloxacin in the 27-P4AM-026 simple suspension method and examination about the antimicrobial activity 松浦誠1, 川又歩1, 西谷直之2, 佐塚泰之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	Incompatibility of the dantrolene sodium in 27-P4AM-027 bulk powder 矢島愛理1, 小松敏彰2, 田中博之3, 石田有香1, 尾鳥勝也1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	Incompatibility of the 27-P4AM-028 ceftriaxone sodium preparation and examination about the insoluble particulate matter 太田品子, 渡邉温子, 杉山恵理花, 齊藤清美, 佐藤均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2014.

	27-P4AM-029 Blending change and adequacy of the simple suspension method enforcement of Amitiza capsule 石田志朗1, 岡本育子1, 山川和宣1, 渡辺智康2, 安藤哲信2, 鈴江朋子3, 岡野善郎4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	Examination about the acidifier in consideration of suspension stability and taking 27-P4AM-030 van cancer synchronized swimming building hydrochloride tablets 齊藤順平1, 栗原陽介2, 中島英規3, 寺門浩之1, 石川洋一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	How do show a division position examination ... of the 27-P4AM-031 bougie division method; ...? 玉岡翔弥, 岡野愛子, 田山剛崇, 三宅勝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	Examination of the need of the preservative addition to the solution after 27-P4AM-032 addition water formulations 長浦宏之, 江藤公美, 奥村知香, 柴山芳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	Analysis of the present conditions and problems of the mixture of the skin drug for external use by the 27-P4AM-033 questionary survey 野々山真衣, 大谷道輝, 眞部遥香, 松元美香, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	Investigation about the asymmetry of the information between pharmacist - patients about the merit of the 27-P4AM-034 medicine notebook 入江佑紀1, 庄司雅紀1, 岩出賢太郎2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2014.

	About an association between inflection and blood pressure control of the patients of the 27-P4AM-035 medicine notebook 隅田侑希1, 手塚璃里子1, 榎本真美1, 庄司雅紀1, 岩出賢太郎2, 恩田光子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	Basic study on measurement method of the valganciclovir in the 27-P4AM-036 children domain 正岡康幸1, 菊岡亮2, 河崎陽一1, 江角悟1, 北村佳久1, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	Proper use investigation of quetiapine in the 27-P4AM-037 Kumamoto Red Cross hospital 江島智彦1, 岩田一史1, 上田賢太郎1, 合澤啓二1, モーエン智子3, 采田志麻2, 武井宣之2, 吉田稔2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	The drug loss at the pediatric dose formulations of 50% of 27-P4AM-038 E Keppra dry syrup and packeted error 浜田茂明1, 石田志朗2, 森本真仁1, 山川和宣2, 岡野善郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	About mention of the medication date and time of the 27-P4AM-039 methotrexate capsule 2 mg packing sheet action - for - duties burden reduction 佐藤裕資, 棚谷貢, 鈴木千波, 田畑裕和, 越田晋太郎, 手塚悠希, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	Making of the quantity of minimum disposal for the quantity of prescription, cheapest medicine charge combination list of anticancer agent, biological drugs using 27-P4AM-040 Microsoft Excel 渡来和宏, 亀田圭輔, 齋藤友彦, 干川克巳, 生島五郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2014.

	Effect of the foscarnet which gives it to an internal change of lithium in the 27-P4AM-041 rat 上井優一, 有馬亮輔, 高津千裕, 古田涼, 川嵜達也, 鍋倉智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	The effect that a change of the quantity of essential micro element in the 27-P4AM-042 living body gives to a CYP3A4 function 北山陽菜, 辻本雅之, 寺尾彩, 福田智哉, 川端美穂, 廣川愛, 山田有里子, 峯垣哲也, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	Effect of xanthine oxidase and the aldehyde oxidase activity on allopurinol metabolism in 27-P4AM-043 rat in vivo 田山剛崇1, 杉原数美1, 三宅勝志1, 北村繁幸2, 太田茂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	Examination - using effect - rat of the eating time to give it to the hypoglycemia effect of the 27-P4AM-044 sulfonyl urea system diabetes therapeutic drug 堂本泰大, 宮崎誠, 森幸代, 宮宗悠嗣, 岩永一範, 永井純也, 掛見正郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	Basic study on adsorption saturation to ultrafilter of 27-P4AM-045 Teiko plastic Nin 入江利行1,3, 福島将友1, 富田敏章1, 町田聖治1, 道越淳一2,3, 萩原聡3, 日高正剛3, 後藤孝治3, 畑中美博4, 井上覚4, 野口隆之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	Examination about the proper use of the 27-P4AM-046 rivaroxaban 河内山佳英, 下石和樹, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2014.

	The use situation and patients background in our House of the 27-P4AM-047 new oral anticoagulant drug (NOAC) rivaroxaban 木村順平1, 原田瑞記1, 小林夕紀子1, 藤井亮1, 板木元1, 本間和加子1, 中村博彦2, 山澤裕司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	Use situation investigation of the patients who reduced Apixaban in the 27-P4AM-048 Saga University Hospital 竹内耕治, 持永早希子, 藤戸博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	Present conditions analysis of the warfarin control using 27-P4AM-049 Time in Therapeutic Range (TTR) 吉原郁夫1, 山崎伯都1, 渡部善博1, 村里嘉信1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	The use situation of the 27-P4AM-050 heparin protocol 藤岡貴光1,2, 左右田和枝1, 伊藤千裕1,2, 阿部真也1, 齋藤雅俊1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	Use fact-finding (for the making of the proper use guideline) of the 27-P4AM-051 new oral anticoagulant drug 小嶋俊輝, 柴田大地, 近藤洋一, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	Use situation investigation of the 27-P4AM-052 new oral anticoagulant drug 藤井洋介, 神宮寺秀幸, 長谷川佳孝, 月岡良太, 森澤あずさ, 大石美也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2014.

	Analysis of the use situation and the patients background of the 27-P4AM-053 oral anticoagulant drug 平田尚人1, 臼井達也2, 東裕子1, 大竹真莉絵1, 牛山利昭1, 矢嶋明1, 和田秀一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

Examination about the remedy situation and the background factor of the antithrombotic drug in patients with 27-P4AM-054 cerebral hemorrhage
白石貴寿, 古田悦郎, 宇都宮奈々, 長谷川将, 植中英恵, 上林麻恵, 坂本晃世, 田口みどり, 森田佳博, 中村宏, 面田恵
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

	Examination about the use situation and the adverse event expression of edoxaban in patients with 27-P4AM-055 femoral neck fracture 佐々木貴之1, 日沖雅人1, 森尚義1, 北尾淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

	Attitude survey of the patients whom 27-P4AM-056 direct thrombin repressor, oral Xa factor repressor were prescribed for 武田啓尊1,3, 齋藤誠2, 樋口彰2, 大元宏子2, 柏原通孝2, 竹原伸2, 中山圭一2, 青野章3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

	Examination of the drug choice that we regarded as the use situation investigation of the anticoagulant in the 27-P4AM-057 Tsurumakionsen Hospital from a characteristic of the preparation 仲里梨紗, 福田詩織, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

	Examination about use fact-finding of the 27-P4AM-058 azithromycin IV infusion medicine and the dilution dissolution apothecaries measure reducing effect 春木祐人1, 萩谷英大2, 春木麻衣1, 杉山哲大1, 川上恭弘3, 近藤祥代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2014.

	Relation of the pharmacist to 27-P4AM-059 Helicobacter pylori sanitization treatment 笠原典子, 平井文, 藤岡瑞恵, 眞柴英子, 原野晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

	Use of antimicrobial situation investigation in the community-acquired pneumonia inpatient using 27-P4AM-060 DPC data 梅村拓巳1, 坂田洋2, 山田哲也1, 勝野晋哉1, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

	Consumption change of catecholamine in our House with the change of 27-P4AM-061 guidelines 結城沙英子, 大谷美奈子, 垣尾尚美, 岸本靜佳, 松本敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

It is ... from the questionnaire results of action situation investigation - Toyama throughout the prefecture 31 institution of the pharmacist for 27-P4AM-062 antimicrobial proper use
河井良智1, 舘美幸1, 加藤貴子1, 窪田佳代子1, 岩本智子1, 江尻真理子1, 棚田真紀1, 柳原由香子1, 丸岡ひとみ1, 高田加壽代1, 山本善裕2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

	Fact-finding of the treatment for Clostridium difficile infection in our 27-P4AM-063 House 大塚真理子, 飯嶋友美, 酒井理菜, 山下春香, 田澤匡, 宮崎真紀, 川崎昌子, 福田光司, 原信田努, 冨島修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

	The short-term and long-term use situation of the tolvaptan to patients with heart failure in our 27-P4AM-064 House 九鬼亜衣子, 西浦佳代子, 松本芳信, 川原裕, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2014.

	Safe evaluation in the tolvaptan lock internal use for 27-P4AM-065 elderly people 御牧紗代1, 田中旬2, 小松俊介2, 鉄谷祥子3, 吉岡まみ1, 平山晶子1, 村田七海1, 前田陽平1, 森淑子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

It is the relation of the use situation and the ward pharmacist of the pain-killer after the operation for the 27-P4AM-066 decreased renal function patients
永野浩之1, 小岩まの1, 野田幸一1, 貝嶋亮1, 長島章1, 阿曽秀美1, 宮原宣博1, 立川恵美子1, 眞壁秀樹1, 河野義彦2, 井上勉3, 織田弘美2, 北澤貴樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

	Action to the proper use of 27-P4AM-067 gadolinium contrast media 長澤欣弘, 嶋崎千絵, 羽生智宏, 森山亜矢子, 尾形美絵, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

	Use situation investigation of the aciclovir injection in the 27-P4AM-068 Kumamoto forest metropolis General Hospital dermatology ward 畑田万紀子, 須古杏子, 宮本浩子, 森岡淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

	Study implementation situation investigation of the drug needing the testing that it is like 27-P4AM-069 regularly 上岡彩佳, 山崎由美子, 千葉達夫, 木村麗砂, 日浦寿美子, 横井妙子, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

	Analysis of the proper use risk factor based on the questionary survey for the use of 27-P4AM-070 patch patients 竹下絵梨香1, 橋本はるみ2, 山根由恵2, 寺本あゆみ2,3, 松寺友里恵2,3, 植沢芳広1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2014.

	About an injection at study on consciousness - eating out of the insulin nonuser for the 27-P4AM-071 insulin self injection - 堀尾理紗, 河野修治, 津島美幸, 橋詰勉, 高山明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	The drug use situation of patients with type 2 diabetes in the 27-P4AM-072 Okayama Red Cross hospital 石橋真実1, 大森麻江1, 宮下雄博2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	Action of the bringing medicine management in our 27-P4AM-073 House 大石貴裕, 柏田匡広, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	Bringing medicine database construction and use in our 27-P4AM-074 House 北川禎二, 冨田祐作, 林真三子, 中島瑞紀, 松浦ゆきみ, 伊東健司, 金原亜紀, 佐藤真理子, 佐野吉嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	Action to safe security about the bringing medicine in our 27-P4AM-075 House 三宅麻文, 伊東祐喜子, 阿賀千香子, 高橋友梨, 門脇祐子, 近藤瑛子, 岡島万記子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	Risk aversion by the 27-P4AM-076 bringing medicine administrative work and medical economic effect 北浦円, 安藤陽子, 森岡想 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2014.

	About use of the bringing medicine in the 27-P4AM-077 University of Occupational and Environmental Health Hospital 井手飛香, 篠原義剛, 蒲池英博, 齋藤暢人, 實松絵美子, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	Action of the bringing medicine management in the cottage-hospital out of 27-P4AM-078 前嶋由里子, 橋爪雅代, 古儀智美, 中山甲矢子, 秦毅司, 川合甲祐, 各務均, 中野真行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	About bringing medicine duties in the 27-P4AM-079 Yasuo society Takeda Hospital than ... physician, the questionary survey to a nurse ... 舛井美奈子, 荒井早穂, 矢沢麻貴, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	Estrangement with bringing medicine and the document information in the 27-P4AM-080 bringing medicine management 清川明慶, 西川眞佐人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	Bringing medicine management in the 27-P4AM-081 district core local government Hospital and medical safety management 田中敏, 佐藤益男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	Examination of deadline time setting for the purpose of the 27-P4AM-082 bringing medicine discriminant efficiency and the effect 羽賀博昭, 上村賢介, 間宵聖太, 瀬野雄太, 鈴木光幸, 高橋成博, 横山裕貴, 茂木武, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2014.

	About an action for the bringing medicine of the planned inpatient in our 27-P4AM-083 House 辻村啓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

	Problems of a drug and the information in 27-P4AM-084 bringing medicine differentiation duties 大久保利成, 飯島直樹, 古田涼, 唯野晃弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

	Action to 27-P4AM-085 hospitalization and release, confirmation in preoperation in the medical cooperation center before medical examination of the cancellation medicine 佐藤香織, 四方公亮, 菅野美紗樹, 出雲正治, 加藤潤一郎, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

Safety management ... by confirmation and the doubt inquiry such as the appropriate discontinuation instructions of duties - antithrombotic drug in the 27-P4AM-086 bringing medicine center
蓑谷環, 西條雅美, 向後絢, 宇佐見まみ, 四宮奈津美, 飯田真由巳, 湯浅美智代, 三室純子, 本田一春, 芝崎健志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

Relation of the pharmacist in the remedy medicine differentiation investigation before surgery, testing in the 27-P4AM-087 outpatient department
橋田真衣1, 佐々木善江1, 大成政揮1, 小野雅文1, 松下香織1, 伊丹元治1, 福田博音1, 真鍋憲司1, 面田恵2, 川嵜英二1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

	About problems of the on admission bringing medicine confirmation in our 27-P4AM-088 House circulatory organ department of internal medicine 田中聡之, 岩井由佳, 福西均, 安田陽子, 尾垣光彦, 岩本千絵, 萩野訓子, 森垣和馬, 畑中智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2014.

One case of the chronic myelogenous leukemia that supported the fertility hope of the 27-P4AM-089 imatinib remedy patients
大澤友裕1, 高橋健2, 安田昌宏1, 梅田道1, 長屋雄大1, 舘知也3, 水井貴詞1, 小林健司1, 佐橋誠1, 後藤英子4, 笠原千嗣4, 寺町ひとみ3, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	Example that participated in the 27-P4AM-090 crizotinib introduction patients 中野祐樹, 井上和洋, 蓮輪博嗣, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	The need of discussion and the TDM about the clinical dose and blood level of the 27-P4AM-091 Aki Shichi nib 大久保節子1, 大久保正2,3, 田中真理子3, 大久保七枝4, 久保田洋子5, 大久保美穂6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	Aki Shichi nib case analysis in the 27-P4AM-092 Kyoto Municipal Hospital 熊谷恭子, 目黒裕史, 本多伸二, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	A side effect investigation and measures in the 27-P4AM-093 R-CHOP and R-THP-COP therapy 祖父江伸匡, 堀敦雄, 西嶋長 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	The clinical experience and adverse event expression situation of the crizotinib in our 27-P4AM-094 House 名坂輝子1, 新井裕子1, 石原真一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2014.

	A present conditions investigation and patients support of the taste disturbance in the patients during the 27-P4AM-095 chemotherapy enforcement 若月淳一郎1,2, 木村緑1, 中條倫成1, 中村和代1, 内田亮1, 松本香織2, 田原計子2, 磯部克彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

	Examination about the consciousness for medication ad here Lance and the medicine of the 27-P4AM-096 oral anticancer agent 中尾俊也1, 木村美智男1, 宇佐美英績1, 岩井美奈1, 吉村知哲1, 森博美1, 寺町ひとみ2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

	The actual situation of the medication counseling by the nurse at oral opioid analgesic introduction in the 27-P4AM-097 metropolis and districts cancer practice cooperation base Hospital 片倉佐央里1,2, 濱本洋子2, 佐藤鈴子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

	The present conditions of the doubt inquiry in our 27-P4AM-098 House going to hospital treatment center 眞下惠次1,2, 藤原大一朗1,2, 木村佳世1, 野田明宏1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

	Examination of the patients needs in the medication counseling of the 27-P4AM-099 chemotherapy 古田知子1, 山添喜久雄1, 中嶋早苗2, 久米真2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

	Action of the pharmacist cancer chemotherapy team in the 27-P4AM-100 area cancer practice cooperation base Hospital 安達亮平, 木本真司, 熊谷修一, 石崎勝彦, 河原史明, 香内綾, 安齊泰裕, 長野満帆, 塩川秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2014.

The duties support tool making based on 27-P4AM-101 cancer practice guidelines and investigation of the usefulness
平松久典1,10, 江崎秀樹2,10, 齋藤明子3,10, 土田大輔4,10, 寺西二三代5,10, 遠山幸男6,10, 山本倫久7,10, 長谷川功1, 板倉由縁8,10, 勝見章男9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

	Relation of the pharmacist in the chemotherapy introduction of the 27-P4AM-102 HBs antigen (+) patients 杉村奈美1, 向一美1, 地野幹子1, 森下実2, 坂下俊樹3, 増永高晴3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

Preference for a level of the patience of the side effect in patients with 27-P4AM-103 cancer and the high-risk treatment
飯原なおみ1,2, 西尾貴之2,3, 桐野豊1,2, 合田哲子4, 六車浩史4, 住吉加奈4, 安西英明4,5, 松岡栄徳6, 香川雅俊6, 磯部芳江7, 鈴木聖7, 水川奈己7, 芳地一7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

	Examination of the day after day medication counseling in 27-P4AM-104 breast cancer FEC therapy patients 谷口潤, 山口絢子, 築田晃直, 溝田繁治, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

	Introduction of the safe FOLFIRINOX therapy using the pass for the 27-P4AM-105 patients 金井友規恵1, 藤井千賀1, 柳下祐貴子1, 安井友佳子1, 山本為義2, 石坂敏彦1, 八野芳已1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

	Pharmaceutical intervention investigation for patients who received 27-P4AM-106 outpatient department cancer chemotherapy 松本奈都美, 幕内麻里, 藤田真理維, 湊川紘子, 伊藤由香, 増原慶壮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2014.

Evaluation of the pharmaceutical intervention example in the 27-P4AM-107 outpatient department chemotherapy room
柿本秀樹1, 西田恵美1, 久保田知佳1, 上田裕1, 内山将伸1, 川原義弘1, 福田まひる2, 小田真由美2, 茂木愛3, 田中俊裕3, 高松泰3, 田村和夫3, 緒方憲太郎4, 二神幸次郎1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

Evaluation of drug control instruction duties to perform on all intravenous feeding anticancer agent administration day for 27-P4AM-108 outpatient department cancer chemotherapy patients
川田史朗, 林すみれ, 緑川武志, 山本健, 飯塚真至, 本多義弘, 中村彰子, 池田裕太郎, 前田悠佑, 前田拓哉, 三上二郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

	Timing of supportive care support and the intervention by the pharmacist in the 27-P4AM-109 outpatient department chemotherapy 坂井由紀, 山内可南子, 外山聡, 佐藤博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

	Examination about the need of the drug control instruction for patients with 27-P4AM-110 outpatient department cancer 川尻尚子, 今井洋志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

	We look at the rear about the need of the pharmacist intervention in the 27-P4AM-111 outpatient department cancer instruction to patient and investigate a mark 大澤万智子, 上田宏, 五十嵐努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

	An action and examination of the pharmacist outpatient department for the cancer chemotherapy in the scale hospital out of 27-P4AM-112 中條恵美, 生田紀美, 下雅意彩, 竹村敏也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2014.

	Action to CDTM of the foreign cancer chemotherapy in the small hospital out of 27-P4AM-113 清水範子1, 新井克明1, 杉山奈津子1, 真家佑介1, 菊地麻希1, 須藤寛1, 加藤貴康2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	About usefulness of the pharmacist intervention in the treatment with oral molecular target medicine in the 27-P4AM-114 outpatient department 渡邉貴子, 阿部理映子, 羽田真理子, 山口麻美, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	The present conditions of our House about the 27-P4AM-115 cancer instruction to patient management charges 3 calculation 辻直子, 大本奈緒子, 浅井茂夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	Action to 27-P4AM-116 cancer care instruction charges calculation 浦川龍太, 橋本早苗, 廣畑秀記, 酒井克紀, 松浦佳代, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	Requirements maintenance and problem of the cancer instruction to patient administrative work utilized the experience of the 27-P4AM-117 pharmacist outpatient department 平畠正樹, 森本茂文, 山本晴菜, 北田徳昭, 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	Action to the calculation acquisition with the new establishment of 27-P4AM-118 "cancer instruction to patient management charges" 田井浩子, 田代美佳, 大河万顕, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2014.

	Action of the medicine medicine cooperation in the 27-P4AM-119 outpatient department chemotherapy room 中島彩子, 宮崎和浩, 吉村和晃, 岩崎明子, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

	Construction of the offer documentation tool in the 27-P4AM-120 cancer care instruction charges calculation 畠山卓, 目黒正明, 植木芳明, 重松恭祐, 八木原栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

	Examination about the tolerability of the crizotinib in the 27-P4AM-121 true clinical practice 藤井良平1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

	Example that tolvaptan was useful for a low Na blood symptom due to the 27-P4AM-122 syndrome of inapp ADH secretion 高橋紗英子, 岡田浩司, 大村雅之, 増田晃, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

	Examination of the factor involved in positioning and myelosuppression expression of paclitaxel (albumin suspension type) by the lung cancer chemotherapy in our 27-P4AM-123 House 鈴木訓史, 後藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

1 case that was given combination chemotherapy of carboplatin and etoposide to haemodialysis patients who had the 27-P4AM-124 small-cell lung cancer
高崎美和1, 杉本浩子1, 河原佑樹1, 藤原研太郎2, 浦田健太郎2, 村木優一1, 岩本卓也1, 田口修2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2014.

	Elucidation of the cytotoxic mechanism for the human cancer of the esophagus cell line of 27-P4AM-125 bisphosphonate drugs 峯垣哲也, 森岡千尋, 福島沙織, 高梨仁美, 宇野順騎, 辻栞, 山本知志, 渡邉愛梨, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	Clinical evaluations of MTC meta-analysis for cancer medical treatment using 27-P4AM-126 Bayes statistics 伊與田友和1,2, 山本渉3, 上塚芳郎2, 井上忠夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	Examination of the usefulness of the DCS therapy in the 27-P4AM-127 progress stomach cancer impossible of excision 船越幸代1, 山崎美保1, 福澤正隆1, 畝知己1, 松本篤1, 久賀祥男2, 守屋尚2, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	The effect that hydronephrosis due to the 27-P4AM-128 gastric cancer gives to side effect expression of irinotecan 橋本千明1, 高林真貴子1, 原祐輔1, 木下淳2, 尾山勝信2, 伏田幸夫2, 崔吉道1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	27-P4AM-129 Investigation of the safety of trastuzumab combination chemotherapy in HER2-positive advanced gastric cancer 小林安里奈1, 市倉大輔1, 杉沢諭2, 小林功治3, 齊藤佑介3, 滝西安隆3, 関川高志3, 坂田穣1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	Examination about usefulness and the acceptability of two regimens varying in a dose intensity in 27-P4AM-130 stomach cancer treatment 荒川裕貴, 中西敏博, 松岡加恵, 桂川健司, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2014.

	The 27-P4AM-131 SP in progress, patients with recurrent stomach cancer impossible of excision and clinical evaluations of the XP therapy 永瀬怜司1, 菅野浩1, 伊與田友和2, 上塚芳郎3, 井上忠夫4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

	Adverse event expression and the treatment continuation situation in 27-P4AM-132 regorafenib treated patients 安藤純子1,2,3, 丸山真一1, 吉野早紀1, 建持岳史2, 江川智久3, 菅野浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

We look at the duration of treatment of the administration method and the every other week administration method and the rear about the safety in 27-P4AM-133 cetuximab every week and investigate a mark
市倉大輔1,2, 縄田修一1,2, 清水久範3, 石井亜矢子2, 杉沢諭2, 小林功治4, 齋藤佑介4, 滝西安隆4, 関川高志4, 坂田穣1, 村山純一郎2,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

	A change of blood pressure Grade2 due to the 27-P4AM-134 ABBA's Japanese spaniel or less and proteinuria, change of eGFR 石崎文子, 相原敏彦, 三塚晴彦, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

Examination of the setting between the CA 19-9 rate of decline golden periods in patients with 27-P4AM-135 gemcitabine enforcement pancreatic cancer impossible of excision
羽鳥正浩1, 辻大樹1, 多久佳成2, 池田翠1, 幕田龍1, 大嶽亜季1, 横井茉里1, 平井啓太1, 井上和幸1, 伊藤邦彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

Association between treatment rate of discontinuation and renal function in the 27-P4AM-136 gemcitabine hydrochloride monotherapy
能登数馬, 谷口知明, 新家麻美, 山下友輝, 須藤大雄, 道下美穂, 佐久間孝博, 田中悠季, 小林龍, 小原秀治, 下山光一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2014.

	Participation for patients with unresectable progress recurrent pancreatic carcinoma which 27-P4AM-137 FOLFIRINOX was indicated for 木村謙吾, 坂倉由美, 伊藤健人, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	Examination of introduction of the FOLFIRINOX therapy for patients with 27-P4AM-138 pancreatic cancer impossible of excision and the pharmaceutical management 石川雄大, 龍伸和, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	1 case of the allergy to beef history that 27-P4AM-139 cetuximab caused moderate hypersensitivity reaction 下村由貴1, 池田知子1, 持永早希子1, 嶋崎絵里子2, 門司幹男2, 倉富勇一郎2, 荒金尚子1,3, 木村晋也3, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	Side effect comparison between 27-P4AM-140 nab- paclitaxel and paclitaxel 谷沢克弥1, 仲村美帆1, 足立茂樹2, 新谷俊一1, 遠藤秀治1, 長尾育子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	Relation of the drug department in the 27-P4AM-141 breast cancer merger pregnant woman 鶴崎泰史, 渡辺健二, 東島幸道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	Investigation of the adverse event to become cancellation, the postponement in the eribulin administration in progress recurrent breast cancer treatment in our 27-P4AM-142 House 阿部多一, 住谷達也, 柳内亮祐, 落合里枝, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2014.

	Examination of the effect on 27-P4AM-143 breast cancer factor about adverse effect analysis and the treatment continuation of the eribulin therapy 高橋克之1, 橋野美穂2, 豕瀬諒1, 川口博資1, 須田泰記1, 中村安孝1, 西川武司1, 高島勉3, 永山勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

Examination of the investigation of the adverse event to affect cisplatin and the successful execution rate in the 27-P4AM-144 uterine cervix cancer of the radiation simultaneous combination therapy and the measures
木瀬大輔1, 藤原聡子2, 鍛冶園誠2, 蔵田靖子2, 佐田光2, 川上恭弘3, 千堂年昭2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

	Tolerability investigation of patients with malignant glioma given 27-P4AM-145 bevacizumab temozolomide combination radiotherapy 伊藤健人, 樋口浩輔, 坂倉有美, 木村謙吾, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

	Examination about the taking Tegafur gimeracil oteracil potassium combination lock period by the 27-P4AM-146 nutrient for intestinal administration combination 古元俊徳, 佐々木紀彰, 熊澤崇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

	Fact-finding about the feeling of remedy and taking 27-P4AM-147 tea S one combination OD lock method 草谷朋子, 長佐古和子, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

	Fact-finding of S-1 doses depending on the renal function in the 27-P4AM-148 outpatient 高橋久樹1, 佐藤浩保2, 鈴木幸造1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2014.

	The construction of the HBV marker check system at the 27-P4AM-149 tea S one start and the evaluation 山下愛子, 市川洋一, 西健太郎, 佐々扶美, 北岡朋子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

	Imatinib body change at the imatinib 100 mg / day administration in patients with 27-P4AM-150 progress, recurrent GIST 冨山成章1, 日高宗明3, 田實裕介1, 中村千鶴子4, 鈴木彰人3, 花田法久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

	Management of the treatment with oral anticancer agent by the unionization of 27-P4AM-151 clinical record mention 小島唯1, 辻村秀樹2, 石原優1, 浅子恵利1, 近藤忠3, 近藤芳弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

	Action of relation and medicine - medicine cooperation of the pharmacist for the 27-P4AM-152 foreign oral anticancer medicine prescription 川原裕, 西塔志織, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

Relation (a present conditions investigation and the prospects that assumed internal use TS1 a case) of the pharmacist in the 27-P4AM-153 outpatient department chemotherapy
河野健1,2,3,4,5, 佐々木優1, 沢田亜幸1, 櫻谷美貴子2, 稲葉博之3, 村上優4, 湯本哲郎1,5, 稲葉健二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

	Use experience of the regorafenib in the 27-P4AM-154 our hospital and participation of the pharmacist 益田宏代, 古野由美子, 合田明博, 田中和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2014.

	Analysis of the factor to have an influence on the treatment continuation of the 27-P4AM-155 sunitinib 宮原志帆1, 大野雄太2, 今西義紀2, 小林亮2, 鈴木昭夫2, 杉山正1, 伊藤善規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	Examination about the sorafenib early cancellation factor in patients with 27-P4AM-156 hepatocellular carcinoma impossible of excision 槇田崇志, 神崎浩孝, 正岡康幸, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	Examination about the expression situation and the prevention of the low Ca blood symptom by the 27-P4AM-157 denosumab 波多野真弓, 江口善美, 合田愛美, 伊藤香苗, 石井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	Tolerability investigation of the cisplatin combination chemotherapy by the 27-P4AM-158 shortstop hydration method 有賀敦1, 立松三千子2, 大久保吉弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	Examination for the vascular pain in the 27-P4AM-159 hydrochloric acid gemcitabine liquid introduction 渥美仁1, 浅井澄子1, 中山貴美子1, 澤口和代1, 岡田みどり2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	About the intervention of the testing situation and the pharmacist with the cancer chemotherapy in the 27-P4AM-160 outpatient department chemotherapy 近藤万友美1, 正置耕一1, 森田聡子1, 橋本百世1, 吉田こずえ2, 清水義文3, 岡本隆弘3, 辻隆志1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2014.

	Examination about the effectiveness and dermatopathy of 27-P4AM-161 cetuximab and the readministration 清水幸宏, 相澤雄介, 南真進, 矢島功, 曽根原亘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	An enforcement investigation and measures about the HBV-related marker screening in the 27-P4AM-162 cancer chemotherapy 近藤貴也, 佐々木英雄, 成瀬国男, 中尾圭介, 伊藤匡伸, 大石えりか, 中平桂子, 藤井里奈, 吉橋幸美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	Effect to give neutrophils with the oxaliplatin administration at the 27-P4AM-163 decreased renal function and a platelet count 岩下佳敬, 中尾承司, 岩崎公美, 薗田晃弘, 桑鶴麻代, 川畑綾, 永田春香, 高田侑那 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	One discussion about the 27-P4AM-164 infusion reaction expression situation 大信紀明, 黒澤亮太, 齋藤真理, 色川正憲, 大谷俊裕, 猪瀬成史, 堀越建一, 常盤英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	Examination of the factor which has an influence on the thrombocytopenia in 27-P4AM-165 temozolomide, the radiation combination therapy 市江敏和1,3, 高橋弘泰1, 山関智恵1, 鈴木大介1,3, 岡田健2, 小林望2, 林秀樹3, 杉浦洋二1, 杉山正3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	Investigation, examination of the adverse event expression situation and the expression factor to need an administration schedule change in the 27-P4AM-166 Bortezomib treatment 山下良子1, 神山秀一1, 結城祥充1, 上田晃1, 川本由加里1, 後藤仁和1, 山本聡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2014.

	Investigation of the background factor by the administration cancellation in the 27-P4AM-167 cancer chemotherapy 渡邉基之, 小倉洋平, 諸星総一, 男鹿宏和, 小坂好男, 倉持英和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

Examination about the effect to a survival period by the difference in cancellation reason of patients with 27-P4AM-168 progress recurrence colon cancer
田路章博1, 山本裕美4, 小市海鈴4, 山元弘4, 福島昭二4, 續木康夫3, 森田吉多佳2, 関本裕美1, 岡田博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

	Effect to give to drug interactions - blood clotting ability of 27-P4AM-169 gemcitabine and warfarin 櫛原朋恵1, 櫛原秀之1, 天野真由美2, 濱嶋なぎさ2, 近藤千紘3, 長瀬通隆3, 福井佳明1, 水谷年男1, 野村史郎3, 森一博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

One case that produced a use investigation of the denosumab for the metastases to bone of patients with 27-P4AM-170 cancer and serious hypocalcemia
榎南祥太, 牧沢志保, 安倍知里, 高田奈央, 森智沙, 長谷川広樹, 笹倉青葉, 松尾彬宏, 和田恭子, 高橋宏幸, 百海有二
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

	Examination of the short hydration in the 27-P4AM-171 malignant lymphoma - GDP therapy 上手真梨子1, 椙山聡一郎1, 藤澤信2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

	A dose evaluation by the VCD induction therapy for the 27-P4AM-172 multiple myeloma and safe examination 水上皓喜1, 櫻下弘志2, 泉谷悟2, 佐伯康之2, 日浦和徳1, 木平健治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2014.

Study on effect on doubt inquiry by the 27-P4AM-173 anticancer agent doses calculation supporting system introduction
長屋雄大, 牧野哲平, 大澤友裕, 青山智, 川島あずさ, 安田昌宏, 梅田道, 渡邉久高, 大野佑城, 市橋厚司, 水井貴詞, 後藤千寿
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

	Investigation about the dose of the anticancer agent for patients with 27-P4AM-174 obesity cancer 藤井友和, 西川隆一, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

	The dose of the anticancer agent in patients with 27-P4AM-175 obesity and safe investigation 富士谷昌典1, 小泉祐一1, 野村真美1, 中多陽子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

	Investigation of the actual situation and the deferasirox administration situation of the posttransfusion hyperferremia in our 27-P4AM-176 House 水野貴仁1, 深津昌弘1, 梅村拓巳1, 山田哲也1, 竹内達哉3, 大野稔人2, 鷹見繁宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

The effect that a side effect in the 27-P4AM-177 breast cancer outpatient department chemotherapy gives to daily activity, costs loss
田中和秀1,2,3,4, 浅野祥子2, 舘知也2, 大澤友裕1, 川島あずさ1, 安田昌宏1, 水井貴詞1, 中田琢巳3, 土屋照雄4, 寺町ひとみ2, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

	The present conditions and problem of the medicine medicine cooperation in our 27-P4AM-178 House 鈴木薫1, 松田美樹子1, 小野裕紀1, 結城正幸2, 小林由佳3, 押切翼1, 萬年琢也1, 佐藤弘子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2014.

	About the emergency consultation of 27-P4AM-179 cancer chemotherapy patients 星野真之1, 星野寿恵1, 生田直人1, 小池恭士1, 藤田恵子1, 澁川知成1, 伊藤祐太1, 鈴木伶織1, 堀井春美2, 富岡葉子2, 大塚園子2, 篠塚一美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	Action of the pharmacist for the high quality medical system in the 27-P4AM-180 outpatient department chemotherapy room 川野昭, 上杉聡美, 福重昇吾, 平野俊訓, 大石泰也, 大竹弘之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	Change of the quality of life by conducting patients explanation before 27-P4AM-181 chemotherapy introduction 清水浩幸, 廣岡賢輔, 米田栄子, 前田祥花 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	Pharmacist questionary survey before 27-P4AM-182 cancer medical therapy start about 田村悟, 小森谷友宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	The exclusive duty pharmacist intervention effect to cancer chemotherapy patients in the core Hospital in 27-P4AM-183 remote place and future problem 神山知也, 中村直美, 平松剛, 吉水秀子, 藤村由紀子, 小田仁子, 大和未果, 延東正一, 笠波生也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	Case of patients with rheumatoid arthritis that developed a lymphoproliferative disorder during 27-P4AM-184 methotrexate remedy 蓮尾憲作1, 村本慎吾1, 眞田功2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2014.

	About the line anticancer medicine pollution of the pump for the 27-P4AM-185 fluorouracil (5-FU) note continual infusion 辻井愛香1, 小林由佳1,2, 岩根裕紀1,2, 中西弘和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	Competitive review of the 27-P4AM-186 5-FU portable chronofuser 野口祥紀1, 三宅知宏1, 中西由衣1, 前山恵里加1, 服部公紀1, 伊藤美南子1, 和田亜希1, 中村晴代2, 谷村学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	The case that became the administration interruption by incompatibility of the 27-P4AM-187 docetaxel preparation 永渕学, 冨岡隆史, 野中愛美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	Examination of the response pattern in the water solution of 27-P4AM-188 anticancer drug cisplatin 小畠大輝1, 加藤隆児1, 小川恭平1, 小川高広1, 香川祐哉1, 佐藤卓史2, 井尻好雄1, 三野芳紀2, 林哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	Examination of survival, the increase through the Wnt signal course in 27-P4AM-189 stromal dependent leukemia cell line TRL-01 丹羽洋介1,2,3, 南陽介2,4, 安部明弘2,5, 早川文彦2, 山田清文3, 直江知樹2,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	Examination about the use situation and the proper use of the daptomycin in our 27-P4AM-190 House 伊藤智一, 阪上貴子, 中川綾, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2014.

	Use fact-finding of the antiMRSA medicine daptomycin in the 27-P4AM-191 Iizuka Hospital 梅田勇一, 内田守次, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

	Use evaluation of the 27-P4AM-192 daptomycin 太田登志子1, 大塚昌信2, 中山晴雄2, 加藤裕芳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

	Examination of the adverse event with the 27-P4AM-193 daptomycin administration 清治翔伍, 藤居賢, 國本雄介, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

	About the result that the active intervention to patients receiving 27-P4AM-194 vancomycin results in 井出和男1, 加藤英明2, 西村富啓1, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

27-P4AM-195 Examination of the proper use of the vancomycin hydrochloride for Clostridium difficile-related loose bowels
石井杏奈1, 松尾和廣1, 平山忍2, 木村伊都紀2, 横尾卓也2, 花井雄貴2, 佐々木英久1, 渡辺朋子1, 篠原悦子1, 小杉隆祥2, 西澤健司2, 吉尾隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

	Examination about the proper use of vancomycin hydrochloride (VCM) for the 27-P4AM-196 MRSA infection 木村佳美1,6, 小田真澄1, 安原梨恵1, 中田早苗1, 稲葉佳南1, 藤田昌美2,6, 渡邉英子3,6, 矢木真一4,6, 森幸威5,6, 市川大介1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2014.

	The thrombocytopenia in the 27-P4AM-197 linezolid administration case and examination about the administration days 竹内絵美, 伊賀正典, 小塊夏紀, 藤掛佳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

	Use investigation of our 27-P4AM-198 House antiMRSA medicine 朴井三矢1, 藤村尚子1, 福田良子1, 河合実1, 玉田太志1, 北村良雄1, 志馬伸朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

Examination for the effect of an investigation of the use situation of the antiMRSA medicine by the 27-P4AM-199 infection control team and the intervention to a long-term use case
廣瀬祥子1,2, 木村有揮1,2, 西村富啓3, 石志絋2, 青木康子2, 尾本健一郎2, 森伸晃2, 福元大介2, 柏倉佐江子2, 黒田美徳2, 樋口晶子2, 香川成人2, 吉田ひろみ2, モリソン朋子2, 近藤直樹1, 久保田篤司1, 千田昌之1,2, 鈴木義彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

	The antimicrobial consumption change by intervening in a drug targeted for a use of 27-P4AM-200 antimicrobial registration system and effect on resistant bacteria 杢保貴幸1,4, 徳竹裕貴1, 石井康友2,4, 植田宏冶3,4, 石原一惠1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

Pharmacist intervention for 27-P4AM-201 antimicrobial proper use and the evaluation
加藤未紗1, 松岡知子2, 森卓之2, 吉田真也2, 大橋健吾2, 篠田康孝2, 臼井一将1, 浅野祥子1, 横井貴文1, 野口義紘1, 舘知也1, 吉村知哲2, 森博美2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

	Inspection of the antimicrobial proper use that assumed 27-P4AM-202 AUD an index 池崎友明, 小関真樹, 山谷香織, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2014.

	Investigation about the change of the use of antimicrobial by the use of 27-P4AM-203 antimicrobial registration system change 小林義和1, 藤岡貴光1, 阿部真也1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	Action of the 27-P4AM-204 antimicrobial proper use conference 瀬戸崇光1,2, 中村翔吾1, 北里実義2, 寺沢匡史1, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	About an effect by the pharmacist intervention of the use of non-appropriate drug by the 27-P4AM-205 outpatient department antimicrobial IV therapy 田井達也, 山口佳津騎, 田中裕章, 篠原尚樹, 渡邊政博, 谷久美子, 山本理恵, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	Inspection ... of the effect of action ... use registration system and ward drug duties to antimicrobial proper use in the cottage-hospital out of 27-P4AM-206 石倉久美子, 有田順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	Action of our House for the 27-P4AM-207 levofloxacin proper use 猪狩千恵1, 比佐孝之1, 横山千秋1, 山内真理1, 阿部俊介1, 田口景子1, 内田智1, 加藤陽子2, 田中啓幹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	Action to the antimicrobial proper use in our 27-P4AM-208 House 相川祐貴 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2014.

	About intervention to infection treatment that utilized the physical assessment in the 27-P4AM-209 medical treatment sickbed 倉林誠1, 高倉みなみ1, 高木淳子1, 池井良貴1, 山田英俊1, 赤石康弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	Investigation of compliance and the effect of treatment of pneumonia guidelines by the 27-P4AM-210 ICT round enforcement 山下知香1, 上田浩貴2, 辰見明俊1, 眞継賢一2, 濱口常夫1, 濱口良彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	Safe examination in the 27-P4AM-211 Gentamicin administration 山崎晃憲, 芳賀貴史, 山中崇史, 本郷文教 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	The present conditions of the medical treatment of the infective endocarditis in the hospital attached to the 27-P4AM-212 Hirosaki University School of Medicine 太田真帆1, 岡村祐嗣1, 板垣史郎1, 萱場広之2, 早狩誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	Evaluation report of the sensitive rate of injectable antimicrobial consumption and Pseudomonas aeruginosa in our 27-P4AM-213 House 久田瑛吉, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	The effect that intervention gives to Pseudomonas aeruginosa sensitivity on specific antimicrobial long-term use by the cooperation of 27-P4AM-214 ICT and the ward pharmacist 大澤雄一郎1,2, 村井いずみ1, 天野永生1, 長山直実1, 米丸明子1,2, 岸野亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2014.

	Use situation investigation for the 27-P4AM-215 azithromycin infusion 岩切啓太1, 丸山久美子1, 田中麗苗2, 安道誠2, 深田章1, 石田英明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

	To make the hospital pharmacy where 27-P4AM-216 resists; - to effectively utilize it of - BSC (balun strike scorecard) 川名賢一郎1,2, 小山晃紀1, 眞保淳子1, 高山慎司1, 阿部猛1, 後藤一美1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

Reflection of the pharmacy management - first year using balun strike scorecard (BSC) for the 27-P4AM-217 hospital pharmacy gate and discussion ... toward the second year
金田昌之1, 奈良部修弘1, 畠山英司1, 藤田明宏1, 田邉晃子1, 三田村朋1, 小野絢子1, 舟越亮寛2, 赤瀬朋秀3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

	Inflection ... of action ... balun strike scorecard (BSC) for the common management tool introduction in the 27-P4AM-218 group hospital pharmacy gate 飯塚真至1,4, 小田切正美1,4, 前田拓哉1,4, 大久保淑子1,2, 三上二郎1,4, 山内泰一1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

	Result and the results of the pharmacy management using 27-P4AM-219 Shimmatsudo Chuo General Hospital balun strike scorecard (BSC) to be able to put 大久保淑子, 大野弘貴, 田中統子, 坂井安希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

27-P4AM-220 Evaluation of the drug department of management by Balanced Scorecard introduced in IMS Memorial Hospital : The results of six months after the BSC introduction
田中秀典1, 伊藤仁美1, 片桐高子1, 定村洋士1, 中村葉月2, 赤瀬朋秀3,4, 大久保淑子5, 山内泰一6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2014.

	Action to duties improvement using balun strike scorecard (BSC) in the 27-P4AM-221 Yokohama new capital city department of neurosurgery Hospital 小串興平, 根本郁子, 関澤奈実子, 後藤卓哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

	Result and problems of the balun strike scorecard (BSC) introduction in our 27-P4AM-222 House pharmacy 清水淳一1, 間宮伸幸1, 赤瀬朋秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

	An action and problem (for crush formulations 0) that were carried out after 27-P4AM-223 BSC seminar in Tsurukawa sanitarium Hospital 関本司, 山崎麻里, 山田文子, 森かをり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

	Practice of the drugstore management that utilized 27-P4AM-224 balun strike scorecard (BSC) 井口恵美子1, 平田周祐1, 高橋弘充2, 猪股克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

	Evaluation of duties using balun strike scorecard (BSC) in the 27-P4AM-225 Kushiro Red Cross hospital pharmacy 渡邊清人, 近江令司, 澁谷基宏, 田中康裕, 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

	A new action for the securing of pharmacist in the hospital attached to the 27-P4AM-226 Mie University School of Medicine and the effect 佐々木典子, 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2014.

The effect that the system establishment of ward drug duties to begin after 27-P4AM-227 accession gives for securing of staff
黄前尚樹, 中村美樹, 仲西未佳, 平田貴大, 岸敬子, 松山芽衣, 谷車彩夏, 常村弥生, 西田彩織, 廣本真里, 勝部智子, 宮崎彩花, 多胡和樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

Search of the factor necessary for the present conditions and the addition acquisition of the 27-P4AM-228 ward drug duties enforcement addition acquisition
前田拓哉1,2, 濃沼政美1,3, 藤原久登1,4, 瀧本淳1, 小林求1, 飯田純一1, 綾部由紀乃1, 湯本哲郎1,5, 金田光正1, 宮崎美子1, 高尾良洋1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

Proper use of the glycopyrronium bromide / indacaterol in the 27-P1PM-001 COPD and situation investigation of the side effect expression
三上祥博1, 河田清志1, 杉谷祐紀1, 堀良行1, 金野衣久美1, 村中美幸1, 小松裕輔1, 畑中紀世彦1, 新野智与1, 前川雅代1, 山木利恵子1, 菅原夏実1, 藤内智2, 武田昭範1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

	About the use situation of the beta 2 stimulant drug in the 27-P1PM-002 Fukui Prefectural hospital 辻愛美, 吉川弘毅, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

	Can push the fixed-quantity aerosol-type inhaler in the 27-P1PM-003 children bronchial asthma with oneself from how old; or is ... for the independence from ... protector 青木彩, 青野珠可 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

	Study about a change of a feeling of remedy with the drug in 27-P1PM-004 children and the medication counseling to patients with allergy 鳥井真緒1, 飯嶋久志2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2014.

	Action - medication situation investigation - of the pharmacist for 27-P1PM-005 children medication ad here Lance improvement 佐々木美織, 佐藤圭吾, 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	About a problem of a tendency to prescription and the medication counseling of the 27-P1PM-006 methotrexate preparation 畠山規明, 大萱豊秋, 松野英子, 桑原泰則, 星谷卓男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	Use of osteoporotic therapeutic drug situation investigation in the patients during 27-P1PM-007 steroid long-term use 森内葉子1, 白井僚一1, 大丸英昭1, 塩孜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	Use fact-finding of the 27-P1PM-008 teriparatide subcutaneous injection kit 平嶋優一1, 寺原史貴2, 保科くるみ2, 西牧武志2, 勝股祐美2, 齋藤俊一郎2, 佐藤公人2, 田村広志2, 下山光一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	Consciousness for the use of medicine notebook with 27-P1PM-009 ethical drug, a nonprescription drug and the supplement 浅野祥子1, 舘知也1, 吉田達彦2, 横井貴文1, 加藤未紗1, 臼井一将1, 野口義紘1, 水井貴詞3, 後藤千寿3, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	Participate in relation ... summer camp of patients with 27-P1PM-010 hemophilia and the pharmacist; and ... 三浦直子, 平尾鮎子, 加賀谷隆彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2014.

	We estimate 27-P1PM-011 as analysis about the "visualization of the pharmacist" and "pharmacist with a view of the face" exercise 小野寺健1,3, 南川賢治1,3, 三浦清明2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

	Consciousness change for the 27-P1PM-012 new pharmaceutical products sale system 鈴木俊之1, 梅津亮冴1, 加藤大和1, 中山蓉子1, 上田夏実1, 阿部純子1,2, 土屋照雄3, 中村光浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

	Use fact-finding of hydroxyethylated starch preparation and the albumin preparation in the 27-P1PM-013 operating room 中澤香子1, 吉野太朗1, 牛木隆志2, 三澤昭彦1, 荒川圭子1, 外山聡1, 佐藤博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

	Fact-finding - by action - inventory survey that the 27-P1PM-014 patients manage the information about one's health 田代朋子1, 折井孝男2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

Fact-finding about the amount of drinking at the 27-P1PM-015 pharmaceutical products remedy
首藤誠1, 宮崎珠美1, 小森浩二1, 中嶋香里2, 東川伸一2, 堀口道子2, 牧敬太郎3, 藤田知子3, 木村真弓4, 星山雄大4, 榎本初音5, 立木秀尚5, 恩田光子6, 山下伸二7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

	Prescription fact-finding of 120 mg of denosumab preparation in our 27-P1PM-016 House 青山一紀, 立原茂樹, 谷中敦美, 黒澤豊彦, 武井敬司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2014.

	Use fact-finding of the rasburicase in the 27-P1PM-017 our hospital 島田友里奈1, 宮本浩子1, 藤本哲広2, 下村泰三2, 鈴島仁2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

	Use situation investigation of the aperient in the use of oral opioid analgesic patients in our 27-P1PM-018 House 高山喜光, 深尾彰平, 吉田真人, 近藤匡慶, 淡路健作, 堀川佳津美, 村田和也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

	The laboratory study enforcement situation of the drug that 27-P1PM-019 needs testing regularly 鈴木悠加, 臼窪一平, 中村友香, 下山あさ子, 亀井浩二郎, 高木明彦, 小原郁司, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

	Present conditions report in hypermagnesemia with the 27-P1PM-020 magnesium oxide preparation and our House 末吉真樹, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

Comparison of the examination of coronary contrasting hospitalization pass in the 27-P1PM-021 neighborhood 7 Hospital
中島優子1, 赤木祐貴2, 池田祐司3, 伊奈川愛理2, 榎木瑞穂4, 小河原由佳4, 木村有揮2, 清水忠洋5, 武石愛子6, 千葉達夫6, 葉梨美和7, 加藤裕芳6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

	Analysis based on the questionary survey of the pharmacist duties enlightenment activity to give to an allowable standard of the waiting time in the 27-P1PM-022 ethical pharmacy 久保田健人1, 寺田洋2, 植沢芳広1, 服部豊示1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2014.

	Investigations such as the test value that a dosage form change of the carnitine preparation in 27-P2PM-001 haemodialysis patients gives it to 小沼絵美, 池上聖, 川岸輸佳, 高山慎太郎, 風間正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Search of the factor associated with the C/D ratio of the tacrolimus preparation in the 27-P2PM-002 hematopoietic stem cell transplantation patients 三村享1,2, 池村憲明3, 松澤直樹3, 勝山善彦3, 山折大2,3, 大森栄1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Relation of the pharmacist in the 27-P2PM-003 convalescent rehabilitation hospital 金子守1, 岡添進1, 矢嶋美樹2, 林宏行3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Examination of the need of the pharmacist intervention in the use of sleeping drug security for 27-P2PM-004 elderly people 磯田明宏1,2,3, 井上裕2, 岩崎友香2, 金本郁男2, 勅使河原正敏3, 井澤正義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Action (the second report) of our House for the 27-P2PM-005 generic name prescription addition 星野有吾, 宮本拓人, 森真澄, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Action of the group preoperation explanation in our House for the patients undergoing 27-P2PM-006 cataract surgery 颯田真子, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2014.

	Inflection in the use situation and the ward of the Chinese medicine in the hospital attached to the 27-P2PM-007 Tokai University School of Medicine 矢野忠1, 平綿洋子1, 橋本昌宜1, 岸川悦子1, 市川訓1, 宮坂宗男1, 日置智津子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

About an action given information sharing with a specialist based on the investigation of the ward pharmacist about the use of the dopamine agonist to patients with 27-P2PM-008 Parkinson's disease
近藤水生1, 多賀麻衣1, 岡田恵果1, 桑山結子1, 大野愛1, 米山英二1, 久保田敏行1, 川上治2, 勝見章男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

About successive change and factorial experiments of the dispensing error development by the introduction of the 27-P2PM-009 bar code formulations system
上野ひとみ1,2,3,4,5,6,7,8,9, 廣田憲威2, 北條雄也3, 松村直美4, 伊戸郷美5, 山本京6, 冨士代真希7, 玉城由実加8, 梅津怜恵9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

	The effect that the hue of the 27-P2PM-010 hyperalimentation preparation container gives in the visibility at formulations 安藤崇仁1, 佐藤栄輔2, 貝澤正浩3, 近藤幸男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

	Examination of pre-Abo id report contents by the 27-P2PM-011 ward drug duties introduction 増田晃, 岡田浩司, 白畑政憲, 鈴木千絵, 松井伯之, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

	Effect on drug control instruction duties by promoting 27-P2PM-012 ward drug duties and drug-related incident 田中恒明1, 竹内昌司2, 橋田亨3, 小竹慶子4, 内川清次5, 今泉幸久6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2014.

The trend of the incident report before and after the ward exclusive duty pharmacist placement in the hospital attached to the 27-P2PM-013 Mie University School of Medicine and future problem
濱口直美1,2, 村木優一1, 水谷泰子2, 兼児敏浩2, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

	An investigation and analysis of the incident report by the 27-P2PM-014 pharmacy business trainee 金田絢子1, 新井成俊2, 佐伯俊明2, 村田勇1, 井上裕1, 木村昌行1, 金本郁男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

Analysis ... of a change and report contents of the number of contribution second report ... pre-Abo id reports to the patients security of the ward pharmacist with the 27-P2PM-015 ward drug duties enforcement addition calculation
上村忠聖, 鈴木信也, 関山正夫, 安藤栄輝
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

	Evaluation of the ward drug duties in the medical treatment sickbed judging from 27-P2PM-016 pre-Abo id report 足岡秀樹, 石倉優子, 柳原美夏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

	Contribution - to medical security by the 27-P2PM-017 pre-Abo id, present conditions investigation of the pharmaceutical intervention case and the enforcement of utilization - case conference 辻佑香里, 高森智敬, 安尾哲郎, 滝波昇悟, 監物英男, 今村明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

	Contribution to the patients by the 27-P2PM-018 "ward drug duties enforcement addition" 矢吹直寛, 織本桂, 関根仁彦, 吉田友和, 岡平将志, 吉田憲司, 清水裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2014.

	Approach - from an action - medical care security room to Distribution of medicine duties for the drug cold water re-hat decrease in the 27-P2PM-019 ward 我妻禎1,2, 渡部洋一2, 阿部美幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

	Incident measures of the self-care medicine by the 27-P2PM-020 ward exclusive duty pharmacist 赤城那奈, 大谷道輝, 松元美香, 稲村澄子, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

	The examination of the oral medicine management method in the 27-P2PM-021 surgery system mixture ward and future problem 神谷法子, 近藤洋一, 滝本典夫, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

Inspection of an action to the oral medicine incident decrease by the 27-P2PM-022 ward safety measures team and the effect
飯田慎也1, 小野尚志1, 細井美奈子2, 伏見亜由美2, 金絵理2, 古澤亜矢子2, 石関哉生3, 齋藤司4, 金田豊子2, 山下恭範1, 原千恵子1, 小川聡1, 粟屋敏雄1, 福土将秀1, 松原和夫5, 田崎嘉一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

	The effect that 27-P2PM-023 ward drug duties give to doubt inquiry 井坂由佳, 前島多絵, 渡邊雅明, 堀内学, 細野智美, 小西久美, 鈴木嘉治, 中島綾, 中島正人, 熊田美由紀, 神林泰行, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

	Action to prevention of bringing medicine-related incident in the 27-P2PM-024 cosmetic surgery ward 小林義政1,2,3, 今高多佳子1, 高木祥子1, 田宮真一1, 青山智彦1, 世木直喜2, 安藤智洋2, 林悟司3, 長尾佳世子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2014.

	From the viewpoint of medical security with action ... bringing medicine of the ward permanent residence of the pharmacist in the 27-P2PM-025 Saga Hospital 副島啓司, 渡辺健二, 東島幸道, 鶴崎泰史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

	Evaluation for bringing medicine initial instructions by the pharmacist in the 27-P2PM-026 pharmaceutical viewpoint 伊藤美南子, 山口高雅, 瀬田尚子, 大谷徹, 中井貴映子, 三宅知宏, 森慶喜, 谷村学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

	It is ... mainly on contribution to ward drug duties - medical therapy in the 27-P2PM-027 Ogura memory hospital cardiovascular surgery 曽我弘道, 前田朱香, 富田敏章, 福島将友, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

	Remedy of fact-finding and the omission of of the drug needing the preoperation discontinuation in the cardiovascular surgery ward of our 27-P2PM-028 House discontinuation 金澤正智, 中野公, 寿伸一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

	Action of the checking prescription for the decreased renal function patients in 27-P2PM-029 ward drug duties 菅野美紗樹, 一杉俊輔, 四方公亮, 佐藤香織, 出雲正治, 加藤潤一郎, 長谷川英雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

Comparison - of search - logistic-regression analysis and the decision tree analysis of the analytical procedure necessary for the medication self-care introduction of patients with 27-P2PM-030 stroke
藤原久登1,2, 向後麻里1,3, 田中絵里子2, 大川桂子2, 泉真由美2, 水間正澄4, 鈴木寛子2, 村山純一郎1,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2014.

	Examination of the pre-Abo id report about the 27-P2PM-031 anticancer medicine 原田哲彦, 西井玲奈, 町支優和, 隅田徹, 鈴木善貴, 石川元章, 石田隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

	Summary of the pre-Abo id report of 27-P2PM-032 two years 中村和宏, 筒井信博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

Evaluation of the remedy about the present conditions and the bringing medicine discriminant cold water re-hat of the 27-P2PM-033 inspection time cold water re-hat
池ノ上知世, 野間口寛, 桐野玲子, 柿本智広, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 中島誠, 福元裕介, 坂元優太, 平田りか, 寺師守彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

	The early detection of side effect by pharmacist in the 27-P2PM-034 team approach in medical care and intervention effect on becoming severe evasion 今浦将治, 山谷武司, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

Action about the change of the hypnotic drug for the purpose of the fall accident prevention in the 27-P2PM-035 inpatient
岩田一史1, 江島智彦1, 上田賢太郎1, 平田憲史郎1, 合澤啓二1, モーエン智子2, 采田志麻3, 武井宣之3, 吉田稔3, 陣上祥子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

	Examination about preventive measures against re-falls about search and pharmacist duties of the 27-P2PM-036 re-fall factor 藤井信大郎1, 佐原篤1, 大野正裕1, 三角ひかる1, 長谷川豊1, 波多江崇1, 福田英克2, 南波勝栄2, 濱口常男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2014.

	The activity of the fall fall measures team in the 27-P2PM-037 Kanazawa Red Cross hospital and participation (the first report) of the pharmacist 高橋怜史1, 大川浩子1, 山口亜矢1, 岡田睦子1, 川原繁2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

	Attitude survey about the administration for the nurse of the 27-P2PM-038 national hospital mechanism Kumamoto south Hospital 西本辰徳1, 垣瀬順予2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

	Attitude survey of the label with the 27-P2PM-039 second piece 浦西洋彰, 和田良浩, 池田和之, 辻力夫, 山添雅之, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

	Accident prevention using the mishaps in medical practice example database by the report from 27-P2PM-040 whole country medical institution, search of the factor to be serious, and to lead to evasion 愛知佑香, 大津史子, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

Construction and evaluation ... of enforcement and the action (1) - prescription mention standardization-response system of the 27-P2PM-041 oral medicine prescription mention method standardization of the pharmacy
椎木芳和1, 安達真紀子1, 金田達也1, 小川勝弘1, 涌嶋伴之助1, 森木邦明1, 村田貴弘2, 寺本圭2, 佐藤裕也3, 高根浩1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

Enforcement of the 27-P2PM-042 oral medicine prescription mention method standardization and medical safety measures in the action (2) - pharmacy of the pharmacy and evaluation ...
安達真紀子1, 椎木芳和1, 小川勝弘1, 金田達也1, 足塚則子2, 齋藤憲輝2, 池口正英2, 高根浩1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2014.

Importance ... of enforcement of the 27-P2PM-043 oral medicine prescription mention method standardization and the action (3) - medicine medicine cooperation of the pharmacy
金田達也1, 涌嶋伴之助1, 長谷川真紀2, 平井和也3, 氏原浩善4, 椎木芳和1, 安達真紀子1, 小川勝弘1, 高根浩1, 島田美樹1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

	Evasion ... of the polypharmacy in effect - convalescence rehabilitation ward which the prescription review by the 27-P2PM-044 pharmacist gives for prescription adequacy 秋田章裕, 福田詩織, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

	Examination about the method of alerting it to floor nurse such as the 27-P2PM-045 high risk medicine 田村賢士1,2, 金子智一1, 若海八州雄1,2, 鈴木秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

Review, improvement ... of the style such as preventive measures against mishaps in medical practice - prescriptions about pharmaceutical products of our 27-P2PM-046 House
三木郁帆, 植野聖子, 入山奈央, 岸本侑子, 寺井易子, 橋本恵梨花, 神農理衣, 村上賢次, 小森正貴, 井本陽子, 吉田尚史, 山口千賀子, 守谷顕人, 津田里香, 宅和真由美, 平田敦宏
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

	Safety measures (the fourth report) in the 27-P2PM-047 drug section - Reliability (from a series system) of compounding of medicines duties - 添田真司, 原尚美, 木村康人, 堀明子, 尾崎昌大, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

	- that one is necessary for one tablet or thinks about the bar code of the 27-P2PM-048 pharmaceutical products sheet from the present conditions of the - tablet sheet 池田和之, 辻力夫, 山添雅之, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2014.

	Construction of the anticancer medicine parenteral injection formulations support system which utilized ethical drug bar code for 27-P2PM-049 medical care security 外山智章, 岩瀬利康, 森田美江子, 伊藤好夫, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

	The real condition of the medical safety management system in the hospital under 27-P2PM-050 Kagoshima 屋地慶子1,2, 福岡龍一1,3, 中村千鶴子1,4, 岸本真1,5, 立和田ともね1,6, 百原譲治1,7, 山本佳代子1,8, 武田泰生2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

	Hospital Evaluation of function general hospital 1 <3rdG from a viewpoint of the 27-P2PM-051 medical care security: Ver.1.0> Action of the auditee 田原雅子, 平昭圭介, 花田徳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

Effect to give to the intravenous feeding speed of the type infusion pump that study polyvinyl chloride about the proper use of the 27-P2PM-052 medical care device and infusion set made of polybutadiene flow control
梅村雅之1, 新井大地1, 前田佳奈絵1, 重野克郎2, 脇屋義文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

	The use situation investigation of the medical pump by the 27-P2PM-053 patrol and promotion of the appropriate administration of injection drug 阿藤友美1, 大沢幸嗣1,3, 大谷道輝1, 木村裕之2, 山村喜一1, 寺島裕夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

	Action of preventive measures against malpractice by the 27-P2PM-054 infusion industry 藤冨徹, 広野敏博, 福岡誠次, 田中修一, 正木久典, 多田義孝, 籾井明, 坂本勝博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2014.

	Application to renal failure treatment of the 27-P3PM-001 health food: Quantitative analysis of the antioxidant action of the chitosan in patients on dialysis 安楽誠1, 田中元子2, 南雲恒平3, 渡邊博志3, 庵原大輔1, 平山文俊1, 丸山徹3, 小田切優樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	Effect to give to a longevity-related gene of the black vinegar made with 27-P3PM-002 pot and non-alcoholic fatty liver 柴山良彦1, 長野正信2, 藤井暁2, 橋口和典2, 菱田直人2, 井関健3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	Effect of the dietary fiber on in vitro agent amount of resources of the 27-P3PM-003 diabetes therapeutic drug 岩崎綾乃, 中川みなみ, 今井公江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	Safety profile in the cells level of the quercetin which is 27-P3PM-004 flavonoid 岡野善郎1, 石田志朗2, 小山保夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	It is ... about patients with consumer awareness investigation ... next situation for 27-P3PM-005 OTC pharmaceutical products 木村美咲1, 坂田菜摘1, 黒沢智佳子2, 幸田真純1,3, 黒木光良3, 高橋眞生3, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	Attitude survey about the reporting at the 27-P3PM-006 nonprescription drug sale 川崎淳史1, 加茂恵代2, 澤田康裕2, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2014.

	Factor investigation of the OTC sales promotion in the 27-P3PM-007 health insurance pharmacy 横井正之1,2, 古田佳典2, 水野ちはる3, 田邉甫樹3, 一川暢宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

	Consumers questionnaire - about palatability - taste bitter of a feeling of remedy and the consumers of the 27-P3PM-008 nonprescription drug 山崎啓之1, 西本光宏2, 田口和明1, 瀬尾量1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

	A milk concentration and infants views of labetalol in patients with 27-P3PM-009 pregnancy-induced hypertension syndrome 植松和子1, 勝本絵美1, 鴻丸晴菜1, 小林映子1, 川合聡子1, 安藤一道2, 杉本充弘2, 川上義2, 木津純子3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

	Making of the mother's milk transitivity information information database for the 27-P3PM-010 nursing mother 木下里紗1,2, 森田真樹子2, 萱野勇一郎2, 矢野育子2, 小林政彦1, 松原和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

	Role of a pregnant woman, the nursing mother medical therapy authorization pharmacist in the 27-P3PM-011 mother's milk class 清水ゆかり1, 古清水浩子2, 大井徹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

Examination of the drug evaluation about the medication at nursing in 27-P3PM-012 Drugs in Pregnancy and Lactation (GeraldG. Briggs, et al.)
増田寛樹1, 井上拓也1, 永井香織1, 角田義典1, 宮下由理1, 前田恵里1, 岡田裕子1, 若本太郎2, 外山聡2, 佐藤博2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2014.

	Study on use of antidiabetic drug during the 27-P3PM-013 pregnancy 高安芽衣子1, 栗林芽衣1, 刈込博2, 後藤一美2, 櫻田大也1, 小林江梨子1, 佐藤信範1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	The present conditions and the prospects of the medical therapy for the digestive organ symptom during the 27-P3PM-014 pregnancy 野村文香1, 阪中美紀1, 金本賢枝1, 林香里2, 辻俊一郎2, 小野哲男2, 石河顕子2, 喜多伸幸2, 寺田智祐1, 村上節2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	Use fact-finding of pharmaceutical products postpartum before the product in our 27-P3PM-015 House pregnant woman 三角真由, 北岡晃, 齋藤亜紗子, 佐藤透 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	It is investigation ... about the mother's milk transitivity of the use pharmaceutical products in ... operation for improvement of preoperation reporting to patients who underwent 27-P3PM-016 cesarean section 堀井徳光, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	Examination about the sewing spare frequency due to phlebitis with the 5% carbohydrate solution and 5% xylitol liquid in 27-P3PM-017 ritodrine hydrochloride continuous infusions 佐藤裕美, 諸岡真梨子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	Examination of the effect on children with the ampicillin sodium administration at the 27-P3PM-018 delivery 松下久美1, 後藤貴裕1, 福井佳重2, 嵯峨こずえ3, 瀧祐介1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2014.

	A tendency and analysis of the consultation example in "the pregnancy and the medicine outpatient department" of our 27-P3PM-019 House 渡邊真理恵1, 川邉桂1, 小池博文1, 浜之上はるか2, 平原史樹2, 西川能治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

	Examination about the rubella vaccine inoculation based on the rubella antibody titers of the 27-P3PM-020 pregnant woman 金光佳織1,3, 北田徳昭1, 森本茂文1, 青木卓哉2, 北正人2, 片岡和三郎3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

	Action of our center for the 27-P4PM-001 ward drug duties enforcement addition 成田千香子, 八代佳子, 金美紀, 吹谷真紀子, 篠田菜美子, 佐藤恵葉, 鈴木ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

Evaluation of a physician for the pharmacist duties improvement with the 27-P4PM-002 ward drug duties enforcement and the nurse
長崎志津1, 森田靖代1, 野村政孝1, 岡崎雅史1, 小松仁美1, 齋藤雅恵1, 岡崎萌水1, 依岡千恵子1, 仲井めぐみ1, 八木祐助1, 橋田和佳1, 門田亜紀1, 楠瀬正彦1, 市原和彦1, 横田淳子1, 吉岡三郎2, 宮村充彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

The role of the pharmacist in rounds duties of the 27-P4PM-003 digestive organ surgery and evaluation from other types of industry
菊池大輔1, 布施克浩1, 阿部友紀1, 福士素子1, 伊藤佳代1, 上岡泰弘1, 紫桃裕造1, 日野弥栄子2, 岩指元3, 畑中貞雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

	Physician, nurse evaluation of ward drug duties in the 27-P4PM-004 Tokyo health medical care public corporation 6 Hospital 松本啓一1, 八木原栄2, 越田晃3, 廣井順子4, 中村英子5, 小竹慶子6, 川崎寛一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2014.

	Action of the ward drug duties in our 27-P4PM-005 House 佐藤佳華1, 藤原陽子1, 堀金妙子1, 岸元麻紀1, 日下部鮎子1, 菊池一樹1, 大江利治4, 明田克之3, 江副英理2, 八十島孝博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	27-P4PM-006 ward permanent residence about the questionary survey for ward drug duties after becoming it 永井賢作, 石原留美子, 金城雄一, 金城清二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	Action to the ward drug duties through the oral medicine system of administration in the 27-P4PM-007 convalescent rehabilitation ward 西塚亨1, 小土井亮介1, 宮原美保2, 真辺和文3, 平松和嗣久3, 田原雅子4, 安藤哲信5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	Action of drug incident analysis in the 27-P4PM-008 circulatory organ medical service and future ward duties 中村愛, 永野真久, 高田正温, 平木洋一, 真鍋健一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	Evaluation (from a physician) from other types of job before the 27-P4PM-009 "ward drug duties enforcement addition" introduction 大西祥代, 安藤智美, 高儀佳代子, 細川朋弘, 清水けいこ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	Making of the high-risk medicine side effect monitoring sheet in 27-P4PM-010 ward drug duties 渡辺智康, 難波良平, 山崎恵, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2014.

	The present conditions and problems of NST, the nourishment management in 27-P4PM-011 ward duties 田中大輔, 佐藤拓也, 田中庸, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

	Action to on admission bringing medicine for 27-P4PM-012 pharmacist management by the essential function 高塚亮1, 富岡佳久2, 武藤浩司3, 金親正知4, 今井博久5, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

	Enforcement of the conference in the duties time of the 27-P4PM-013 pharmacist and the evaluation 寺沢匡史, 坂本愛, 鈴木愛美, 片山智章, 中村翔吾, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

	About the essential function of the pharmacist by the investigation analysis of the change of prescription of the 27-P4PM-014 inpatient 大木稔也1, 庄野あい子2, 土屋文人3, 加勢泰子4, 山内泰一5, 鈴木洋子1, 今井博久6, 佐藤秀昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

	Action for the skill up of 27-P4PM-015 ward drug duties 西谷友紀, 久岡清子, 合田さやか, 佐々木健志, 川上尚美, 植谷未稀, 間千晴, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

	Examination of the drug control method at the 27-P4PM-016 hospitalization 市原航1, 田辺寿一2, 福井宗憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2014.

Trial of the analysis of the prescription intervention contents in 27-P4PM-017 ward drug duties and the medical treatment management based on the protocol
佐村優, 倉田武徳, 廣瀬直樹, 鯉淵寛之, 石井淳一, 南雲史雄, 腰岡桜, 育木均文, 八木下純子, 内田仁樹, 関根寿一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	Analysis of the pharmaceutical intervention in 27-P4PM-018 ward drug duties and future problem 小材なおと, 大熊範和, 橋本碧, 田子尚史, 村田文, 森田淳介, 田子加代子, 新木美枝, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	Action to the bringing medicine prescription order representation by the 27-P4PM-019 ward exclusive duty pharmacist 溝田繁治, 中村敦士, 谷口潤, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	About the ward drug duties in the 27-P4PM-020 orthopedics ward 中田恭子, 笠原庸子, 今津邦智, 森田眞吾, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	Examination of the contribution to the pharmaceutical products proper use by the start of the drug information offer in the 27-P4PM-021 electronic chart 牛島智子, 本田修一, 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	27-P4PM-022 otolaryngology, ward drug duties in the head and neck surgery ward 西村健二, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2014.

	Relation to the use of valproic acid Na patients in 27-P4PM-023 ward drug duties 後藤渉, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

	The prescription suggestion in 27-P4PM-024 ward drug duties and the evaluation 延川正雄, 西村孝一郎, 松田圭一郎, 菅原拓也, 齋藤順, 関口徳志, 後藤純一, 江口亜耶, 佐東未咲, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

An action and evaluation to 27-P4PM-025 ward drug duties
門脇裕子1, 山本智也1,2, 小西智恵1, 山上聡子1, 細川祐岐1, 杉浦知佳1, 衣笠裕香1, 粂紀衣1, 谷原愛加1, 新谷拓也1, 薮野佳小里1, 小門諒平1, 村地康1, 川本祐子1, 関菜美1, 山口みほ1, 井上頌子1, 岡谷梨沙1, 中塚美穂1, 上野耕司1, 原伸輔1, 有持潤子1, 澤田昌良1, 竹上学1, 三輪芳弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

	The ward permanent residence of the 27-P4PM-026 pharmacist produces result it or more at time 山室栄一, 遠山幸男, 桜井陽平, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

Trial - of the ward drug duties standardization by the suggestion example analysis at action - drug control instruction for the ward drug duties enforcement in the 27-P4PM-027 Kochi medical center
高平豊, 橋田真佐, 川田敬, 田中広大, 松本尚子, 岡崎弘志, 宮本典文, 山本創一, 服部暁昌
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

	The present conditions of the ward drug duties of our 27-P4PM-028 House 佐藤拓也, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2014.

	Action to prescription participation by the ward placement of the 27-P4PM-029 pharmacist 新田亮1, 古川順章1, 水津智樹2, 坂本泰一1, 小林勝昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	Effect of ward drug duties judging from 27-P4PM-030 change of prescription example 山瀬大雄, 林淳雄, 中西涼子, 小平いく子, 籠本基成, 土井孝尚, 小林政彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	1 case that developed drug-induced thrombocytopenia by Oxaliplatin during 27-P4PM-031 mFOLFOX6 therapy 長谷康史, 加藤加奈恵, 計良貴之, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	2 cases that produced an adverse event of the bleeding by 27-P4PM-032 Cetuximab administration 竹田健志, 藤江直輝, 仲野千恵, 佐藤了, 新井花緒, 阿久津亜紀子, 谷本祐子, 高木麻里, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	One case that we presented with drug-related interstitial pneumonia with 27-P4PM-033 lenalidomide and changed to thalidomide 田中広大, 山脇まり絵, 岡崎弘志, 松本尚子, 川田敬, 橋田真佐, 高平豊, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	One case of the interstitial pneumonia with suspected interaction of 27-P4PM-034 sunitinib and the radiation exposure 本西哲, 本間信次, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2014.

	Adverse event report (led by a liver damage, a fatal case due to the interstitial pneumonia) of the 27-P4PM-035 regorafenib 坪谷綾子1, 小形厚貴1, 町野怜子1, 白土阿貴恵1, 坂下裕子1, 朝倉武士2, 増原慶壮1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

One patient who was thought to present with interstitial pneumonia by G-CSF administration after the docetaxel therapy for the 27-P4PM-036 prostate cancer
佐道紳一1, 植木菜美1, 鶴田孝義1, 藤田有紀子1, 森善洋1, 木下真理子1, 吉岡大樹1, 吉村敏朗1, 松尾信子2, 塚元和弘3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

	Research of the side effect development situation of the mogamulizumab using 27-P4PM-037 adverse drug reaction database (JADER) 井口祐美子, 小川喜寛, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

	Relative examination of an adverse effect in the antitumor agents for the 27-P4PM-038 injection and the physicochemical nature 板垣文雄, 高谷淑麗, 米沢梨加, 中川幸子, 飯島亮介, 渡邊真知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

	In malignant glioma treatment in our 27-P4PM-039 center about a tendency of the lymphocyte counts decrease at temozolomide and radiotherapy combination 小西敦子, 田中あゆみ, 金川明裕, 吉野宗宏, 橋本博史, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

	Onset of liver damage situation investigation with flutamide in our 27-P4PM-040 House 加納沙代子, 長尾由佳, 赤木晋介, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2014.

	One case that developed Fanconi syndrome by chronic administration of the 27-P4PM-041 Adefovir 喜多春菜1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	Examination of the valganciclovir prophylaxis depending on the renal function in the 27-P4PM-042 lung transplantation patients 川西秀明1, 村川公央1, 北村佳久1, 岡田真典2, 三好健太郎2, 杉本誠一郎1, 山根正修2, 大藤剛宏2, 千堂年昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	Liver function test situation investigation at the pharmaceutical products administration with the 27-P4PM-043 immunosuppressive action 吉田陽子, 宍野友紀, 田中亮裕, 田中守, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	It is one patient of patients with tuberculosis with suspected heparin origin-related thrombocytopenia by 27-P4PM-044 heparin lock 松下直樹1, 長谷川徹1, 久田純生1, 河井和子1, 伊藤和幸1, 磯谷聡1, 龍華祥雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	Investigation about the onset situation of 27-P4PM-045 heparin origin-related thrombocytopenia 宇野洋司, 徳丸隼平, 牛島大介, 上手真梨子, 菊池雄一, 小島昌徳, 橋本真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	Investigation about the prescription actual situation of the rivaroxaban in the 27-P4PM-046 City Sapporo hospital and the bleeding event 二木祐輔, 安田美咲, 尾崎尚子, 大下直宏, 上田晃, 川本由加里, 後藤仁和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2014.

	The effect that a taking 27-P4PM-047 dabigatran method gives to an alimentary system adverse event 雪田拓1,2, 渕上俊介1, 安土菜美1, 陶山明菜1, 樋浦一哉1, 稲垣貴裕2, 今井隆人1, 渡辺浩明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	Examination ... to use situation second report - recommended administration of the dabigatran in our 27-P4PM-048 House 中井聖子, 平井満子, 古田有紀子, 佐藤倫由 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	Side effect investigation of the 27-P4PM-049 argatroban cerebral thrombosis acute phase therapy 河野祐輔1, 松尾美幸1, 中尾恵美1, 石橋章2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	Platelet body change at 27-P4PM-050 drug-related thrombocytopenia 福永修司, 佐伯康弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	Search of the symptom for a risk factor and early detection of the 27-P4PM-051 drug-related extrapyramidal disorder 岸早奈恵1, 大津史子1, 矢野玲子2, 榊原仁作1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	Effect to give to the motor behavior of the mouse of the 27-P4PM-052 H1 receptor blocker 小原成晃1, 天神久実1, 黒田裕子1, 松元一明1, 堀誠治2, 木津純子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2014.

	The side effect of 27-P4PM-053 Prescription Sequence Symmetry Analysis (PSSA) signal detection of the lower urinary tract functional disorder cause medicine 橋本昌子1, 橋本佳奈子1, 長瀬啓介2, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	Examination about the blood level of L-DOPA in patients with advanced Parkinson's disease that used 27-P4PM-054 amantadine hydrochloride together and the L-DOPA metabolite 佐藤光利1, 葛生亜美1, 平井成和2, 土井啓員2, 真坂亙2, 榊原隆次3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	Investigation about patients with onset of the haemorrhagic ulcer due to 27-P4PM-055 NSAIDs administration 藤田仁美1,2, 濱宏仁2, 巽弥生2, 嶋本藍2, 福島昭二1, 新眞理子1, 田中詳二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	Study on small intestine inflammation model and dry skin expression with the 27-P4PM-056 indometacin administration 小山真由, 平本恵一, 小川文歌, 浅野竜之介, 横山聡, 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	Side effect expression of diclofenac local site cutaneous administration preparation using the large-scale data of the 27-P4PM-057 drugstore and examination about the risk factor 大山勝宏1,3, 高橋真二2, 福岡勝志2, 清水万紀子3, 山崎浩史3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	One case of aplastic anemia that showed the rise of a liver enzyme level and the serum ferritin level during 27-P4PM-058 hyperferremia treatment 内海裕美1, 西山徳人1, 田中雅幸1,2, 打谷和記1, 廣田育彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2014.

	Examination about the risk factor of the onset of hepatic dysfunction with 27-P4PM-059 Caspofungin 名賀梨沙, 中村豪志, 田中邦佳, 室親明, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

Examination of the risk of the liver damage with the 27-P4PM-060 proton pump inhibitor administration
山田梨紗子1, 脇田真実子1, 柴北健佑1, 岡田佑輔1, 松村治穂1, 近藤勝弘3, 江崎哲夫3, 木村和哲3, 飯田真介4, 頭金正博1, 中村克徳2,5, 松永民秀2,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

	Interaction of 27-P4PM-061 morphine and diclofenac 無量井昂樹1, 栗山航一1, 木村嘉明2, 尾崎紀之3, 荒井國三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

Retrospective study investigation about the effect of the proton pump inhibitor about the excretion delay of the methotrexate in the 27-P4PM-062 Miyakonojo Hospital
西村尚芳, 福石和久, 津曲恭一, 田中基稔, 大津貴寛, 吉田裕生, 末永亘, 戸切祥恵, 古里あかね
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

	Investigation about the interaction of 27-P4PM-063 pyrimidine system anticancer agent and warfarin tablets fluoride 草信晴美, 水嶋萌美, 監物英男, 今村明正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

	1 case of the GIST with suspected effect reinforcement of warfarin with 27-P4PM-064 imatinib 羽生智宏, 尾形美絵, 嶋崎千絵, 長澤欣弘, 森山亜矢子, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2014.

	The case that an anticoagulant effect was prolonged by combination of 27-P4PM-065 alleviation of fever sedative antiphlogistic and warfarin 渡辺篤, 佐々木麻里, 藤井静香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

	Change investigation of the PT-INR level in 27-P4PM-066 Fosaprepitant and the warfarin combination case 吉野新太郎, 児玉暁人, 今井兼貴, 竹村充代, 野村文子, 岩田智津子, 高橋文香, 高田文, 上原哲, 遠藤雅久, 八尾祥子, 森信介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

	Comparison of the prescription actual situation and the solidification ability of 27-P4PM-067 warfarin and the proton pump inhibitor combination 須藤頌, 前淳之介, 若松亜耶香, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

The effect that use of the linezolid gives for warfarin control in the 27-P4PM-068 left ventricle ventricular assist device wearing patients
木下佐昌子1,2, 和田恭一1, 松田紗知1, 越智純子1, 岩澤真紀子1, 粉川俊則1, 中村慶1, 桑原健1, 坪井志穂2, 堀由美子2, 中島誠子2, 角南春樹2, 佐藤琢真2, 瀬口理2, 簗瀬正伸2, 中谷武嗣2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

	May 27-P4PM-069 linezolid and the interaction of warfarin occur? 田村勝彦, 西圭史, 篠原高雄, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

	Examination about the anticoagulant effect reinforcement of warfarin at the 27-P4PM-070 TS-1 combination 河村美弥子, 鈴木直哉, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2014.

	The effect that 27-P4PM-071 antirheumatic drug iguratimod gives to warfarin metabolism 作山佳奈子1, 山折大1,2, 高見健3, 塩澤彩香1,2, 松澤直樹1, 大森栄1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

	27-P4PM-072 Impact on the thyroid hormone by the simultaneous ingestion of levothyroxine and polaprezinc 加藤さや香1, 水谷実佐子2, 牧原俊康1, 林高弘1, 山田成樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

Effect of zinc which gives it to the interaction with the metal cation of the 27-P4PM-073 new quinolone antibacterial
井上結夏1, 高見陽一郎1, 兼光朝子1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 花田貴恵1, 小川壮寛1,2, 島田憲一1, 江川孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

	Effect on internal change of valproic acid with 27-P4PM-074 cyclosporine 守作美咲1, 石崎純子2, 東夏宵1, 菅幸生2, 崔吉道3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

	Examination of the factor that blood cyclosporine levels increased from one case of the 27-P4PM-075 interstitial pneumonia remarkably 金子憲太郎, 杉本誠, 吉川明彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

	Interaction of cyclosporine and itraconazole in patients with 27-P4PM-076 aplastic anemia 山室蕗子1, 喜多岡洋樹1, 吉田愛1, 田中泉1, 後藤由起子1, 末吉栄志1, 近藤元三1, 平野太一2, 辻隆宏2, 山崎浩2, 津田弘之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2014.

1 case of the renal-transplant recipients whom combination of aprepitant was thought to influence for the rise in blood tacrolimus levels at the 27-P4PM-077 oral administration
小田都紀子1, 山崎大輔1, 西川晃平2, 村木優一1, 岩本卓也1, 杉村芳樹2, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	One case that a blood tacrolimus levels drop by the 27-P4PM-078 Caspofungin combination was found in 中山大輔, 山本真悠子, 藤本佳那子, 池嶋孝広, 村中達也, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	The case that developed lithium poisoning by the combination with the 27-P4PM-079 Aziru sultan 山本飛翔, 上塚朋子, 坂上逸孝, 横山美恵子, 増原慶壮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	Examination of the secondary carnitine deficiency of the seriously disabled child (person) during 27-P4PM-080 antiepileptic drug administration 中村豪志1, 中村良子1, 林俊吾1, 八本久仁子1, 大森啓充2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	Effect of the calcium lactate which gives it to levothyroxine replacement therapy after the 27-P4PM-081 thyroid cancer extraction 宮崎浩行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	Adsorptive analysis of the combination attention drug for the 27-P4PM-082 high phosphorus blood symptom therapeutic drug 安部有紀1, 伴野拓巳2, 秋山滋男3,4, 井戸田陽子1, 矢野健太郎1, 荒川大1, 礒野淳一3,4, 林正弘2,4, 荻原琢男2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2014.

	2 cases of the drug-related long QT syndrome with suspected drug interaction of the 27-P4PM-083 clarithromycin 門口直仁, 田中聡, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	Safety management of the cancer chemotherapy patients that 27-P4PM-084 new anticoagulant is combined with 新井孝文1,9, 鈴木善貴2,9, 佐藤琢磨1,9, 江崎秀樹3,9, 寺西二三代4,9, 遠山幸男5,9, 山本倫久6,9, 池上信昭1, 板倉由縁7,9, 勝見章男8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	Examination about the effect of the dihydropyridine-based calcium-channel blocker on myelosuppression in the 27-P4PM-085 carboplatin paclitaxel combination therapy 畠山史朗, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	One patient who raised serious delirium by the drug interactions with the 27-P4PM-086 tram set combination lock 塚田由紀1, 岩瀬利康1, 越川千秋1, 山口重樹2, 山崎龍太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	The effect that the combination of the 27-P4PM-087 azole system antifungal agent gives to a side effect symptom of oxycodone 渡邊雅明1, 百賢二1,2, 小原直2, 千葉滋2, 本間真人1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	The effect that 27-P4PM-088 concomitant drug gives for a calming effect of midazolam 平田憲史郎1, 大柿滋2, 岩田一史1, 浦田由紀乃1, 合澤啓二1, 丸山徹2, 陣上祥子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2014.

	1 case that required increase in quantity of midazolam by cancellation of 27-P4PM-089 voriconazole 中蔵伊知郎, 藤尾弥希, 川戸順之, 上野裕之, 中多泉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	A drinking condition and effect of the physicochemical characteristic of the drug to give to 27-P4PM-090 grapefruit juice interaction 植沢芳広1, 高橋雅弘2, 小野澤慧2, 小川竜一2, 越前宏俊2, 加賀谷肇1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	Comparison evaluation of the predictive index for the AUC change of the drug by 27-P4PM-091 grapefruit juice drinking 高橋雅弘1, 小川竜一1, 植沢芳広2, 越前宏俊1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	Factor of the content drop to be caused when we dilute a liquid for 27-P4PM-092 Aripiprazole with a green tea drink 池田浩人1, 山中雅智1, 高橋翔太1, 川原光喜1, 湯川美穂1, 藤澤雅夫2, 湯川栄二3, 安藝初美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	Basic examination about the solubility of the donepezil hydrochloride which assumed the remedy with the 27-P4PM-093 tea leaves drink 畑武生1,2, 岩永一範1, 中西祐介1, 宮崎誠1, 西原雅美2, 勝間田敬弘2, 永井純也1, 掛見正郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	Action of the ICT pharmacist for the 27-P4PM-094 TDM enforcement reinforcement 浅川由希子1, 古川順章1, 坂本泰一1, 小林勝昭1, 大槻登季子2, 富田睦美2, 露口一成3, 鈴木克洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2014.

	Action of the vancomycin TDM by the 27-P4PM-095 pharmacist intervention 深堀研二1, 縄田英子2, 高田加奈恵4, 平原賢次3, 赤木哲也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	Action for drawing blood order and the TDM all cases enforcement by the 27-P4PM-096 pharmacist 星崎寛子, 福田詩織, 高木大輔, 新枦義之, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	Order TDM rate of use and cancellation reason when we had it substitute by drawing blood for 27-P4PM-097 antiMRSA medicine TDM enforcement a pharmacist 霍間尚樹, 野口まゆみ, 中村博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	Action of the TDM duties introduction promotion in the cottage-hospital in 27-P4PM-098 Kanagawa 蛭田剛俊1,2, 佐村優2, 樋島学2, 小村裕子2, 井上順博2, 高尾良洋3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	Examination of the VCM doses which 27-P4PM-099 pharmacist suggests 大久保真由美, 組橋由記, 堀本厚子, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	Action of the injectable vancomycin proper use by the cooperation of 27-P4PM-100 infection charge pharmacist and the ward charge pharmacist 松井環, 南和志, 田中悠子, 田村健悦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2014.

	The present conditions of the TDM in our 27-P4PM-101 House and future problem 飯尾志帆1, 川根隆志2, 竹原朗2, 亀山礼子2, 船屋諭史2, 八木浩志2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Effect on MRSA infection treatment of intervention contents in the TDM of the 27-P4PM-102 vancomycin hydrochloride 森田俊博1,2, 大田麻紀2, 山本夕美子2, 田中宏明2, 家入一郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Examination about the effect of treatment of an MIC level and MRSA pneumonia of 27-P4PM-103 vancomycin 岩村直矢, 池田祐輔, 曽根本恵美, 溝口晶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Examination of the pulmonary tissue levels simulation after the 27-P4PM-104 vancomycin hydrochloride intravenous administration 鈴木彩香, 田尻千晴, 長岡雅敏, 井上博貴, 和知野千春, 高嶋麻貴, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Examination about the risk factor of the rise in trough value during 27-P4PM-105 vancomycin administration 川島悠吾, 徳山洋子, 大森清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Examination of vancomycin doses and the blood level in the 27-P4PM-106 Kikukawa City general hospital 後藤貴裕, 安藤奈津子, 山崎愛子, 栗原梢, 揚張真利子, 日下豊史, 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2014.

	Inspection of the vancomycin monitor Ling's method for the infusion in the 27-P4PM-107 chronic liver disease 酒井果林1, 松尾史1, 若林巨樹2, 井上知美2, 石渡俊二2, 小竹武2, 吉村尋典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

	Examination of the concentrations simulation out of the ascitic fluid after the 27-P4PM-108 vancomycin hydrochloride intravenous administration 高嶋麻貴, 田尻千晴, 長岡雅敏, 井上博貴, 和知野千春, 鈴木彩香, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

	Pharmacokinetic examination of vancomycin in the 27-P4PM-109 very low birth weight infant 宗佐博子1,2, 椙山聡一郎1, 加藤英明2, 杉山嘉史2, 牛島大介1, 森雅亮2, 金子猛2, 関和男3, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

	Glomerular filtration rate prediction-style evaluation using cystatin C in the 27-P4PM-110 vancomycin initial administration plan 大山裕紀子1, 田中亮裕2, 大塚尚3, 井上智喜3, 末丸克矢1, 荒木博陽2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

Search of the factor contributing to the effectiveness of vancomycin for the febrile neutropenia complicated with 27-P4PM-111 blood malignant disorder and safety
森永裕子1, 鈴木陽介1,2, 時松一成2, 佐藤雄己1,2, 高野久仁子3, 幸野和洋3, 緒方正男3, 平松和史3, 伊東弘樹1, 門田淳一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

	Enforcement of the use situation of 27-P4PM-112 vancomycin and the initial loading 丸岡邦啓, 東朋代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2014.

	Initial dose setting ... of VCM by the multiple regression analysis of estimated renal function level evaluation (1) - D/C by the TDM analysis of 27-P4PM-113 VCM 山口智江1, 宮原兼二1, 中根茂喜1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	Risk ... of eGFR in the estimated renal function level evaluation (2) - drug administration design by the TDM analysis of 27-P4PM-114 VCM 宮原兼二1, 中根茂喜1, 山口智江1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	Interpretation ... of dose guidelines according to the renal function in estimated renal function level evaluation (3) ... elderly people by the TDM analysis on 27-P4PM-115 VCM 中根茂喜1, 宮原兼二1, 山口智江1, 平松久典1, 伊藤功治2, 水谷義勝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	Antimicrobial VCM template introduction as the 27-P4PM-116 Antimicrobial Stewardship promotion and the effect 平井浩二, 桑名史織, 小西寿子, 青山涼重, 中村誓子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	Comparison of impaired renal function frequencies by the effective time of the blood 27-P4PM-117 vancomycin levels analysis 大塩崇次, 川崎浩, 宮川佳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	One case that MRSA became VISA during TDM enforcement for 27-P4PM-118 VCM 片桐将志, 近藤宏樹, 篠永浩, 加地努, 向井栄治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2014.

	Examination of the kidney protection effect at the cisplatin administration by being administered daily of oral 27-P4PM-119 magnesium agent 有田仁紀1, 工藤彰2, 牧野好倫2, 岩瀬治雄2, 林憲一2, 小杉隆祥1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Effect of the quality of the infusion in the renal failure with 27-P4PM-120 cisplatin 中西敏博, 桂川健司, 荒川裕貴, 松岡加恵, 藤岡美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Effect on renal failure by the difference in hydration regimen in the 27-P4PM-121 cisplatin combination chemotherapy 石井和美, 若林雅人, 矢嶋明, 和田秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Investigation of the effect on renal function by the short hydration at the 27-P4PM-122 CDDP administration 桑原清人1, 木内直美1, 浅子恵利1, 近藤芳弘1, 新行内雅斗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Examination of the usefulness as the renal function marker of serum cystatin C at the 27-P4PM-123 cisplatin hydration 関礼輔1, 矢野絹子1, 田島伸介1, 高田佐織2, 横山琢磨2, 篠原高雄1, 永井茂1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Was lactic acid Ringer's solution 500mL appropriate as hydration at the 27-P4PM-124 CDDP 20 mg/m2 administration? 太田一郎, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2014.

	Examination of the protective efficacy for the Cisplatin-induced renal failure of the 27-P4PM-125 magnesium preparation administration 吉開晶一, 赤木晋介, 亀井健人, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

	About acute renal failure protective efficacy and an onset of high Mg blood symptom risk of the FP therapy by the 27-P4PM-126 Mg supplement 杉本亜弥1, 熊倉康郎1, 深谷昌秀2, 梛野正人2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

Examination (the second report) about renal failure at the 27-P4PM-127 high dose CDDP combination chemotherapy and low Na blood symptom measures
林洋平1, 下川福子1, 澤田奈津子1, 野口久美子1, 川端俊介1, 岡田志保1, 清水裕行1, 小山拓弥1, 南原誠1, 安本祥子1, 谷口一成1, 田村茂行2, 池上英文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

	Examination of the usefulness of magnesium for the renal failure in the 27-P4PM-128 cisplatin +S-1 therapy 竹内玲奈, 若林雅人, 矢嶋明, 和田秀一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

Examination of the appropriate supportive care for infusion load quantity and prevention of in the 27-P4PM-129 S1+ cisplatin therapy edema, weight gain
金田典子, 小田剛史, 高田宏文, 河合佐起子, 深海広平, 山下剛史郎, 廣瀬孝一, 丸尾英次, 北村瑞穂, 南橋薫
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

	We look at the rear of the impaired renal function with the GC therapy for patients with 27-P4PM-130 biliary cancer and investigate a mark 洞澤智至1, 小林美沙樹1, 篠原旭1, 清水怜2, 池田公史2, 市田泰彦1, 高橋邦雄1, 齊藤真一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2014.

	The effect that the complications in patients with 27-P4PM-131 progress recurrent lung cancer give to the cisplatin origin renal failure onset 平池美香子, 三好孝法, 三原由記, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	Investigation about the side effect of nutrition index and cancer chemotherapy expression of patients with 27-P4PM-132 progress recurrence lung cancer 三原由記, 三好孝法, 平池美香子, 三角紳博, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	Clinical examination about 27-P4PM-133 bevacizumab-induced proteinuria 沖田健太郎, 近藤真由, 栗原江未, 臼井和明, 中山久美子, 宗本佐知子, 上地純子, 奥美和, 岩武資善, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	Protective efficacy with the actual situation and the RAS inhibitor of the proteinuria development with 27-P4PM-134 bevacizumab 二瓶哲1,2, 佐藤淳也1,2, 森川直人3, 山内広平3, 川口さち子1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	Examination of the onset of proteinuria factor in the 27-P4PM-135 Aki Shichi nib internal use patients 遠藤裕司, 志田敏宏, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	1 case of the malignant glioma which developed impaired renal function by 27-P4PM-136 Temozolomide 成田綾香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2014.

	Example that tolvaptan was effective for syndrome of inapp ADH secretion due to the 27-P4PM-137 small-cell lung cancer 遠藤菜緒1, 伊藤拓1, 小澤純1, 相馬まゆ子1, 今田愛也1,2, 佐々木洋一1, 猪爪信夫2, 藤野通宏3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

	The effect that osmotic pressure of the 27-P4PM-138 oxaliplatin solution gives to vascular pain 前田真奈美1, 菅幸生1, 石崎純子1, 坂口百合野1, 崔吉道2, 松下良1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

	Vascular pain measures and the effectiveness of oxaliplatin in our 27-P4PM-139 House 阿部理映子, 渡邉貴子, 羽田真理子, 山口麻美, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

	About vascular pain due to infusion after the 27-P4PM-140 carboplatin administration 堀部正記, 池井健, 大谷仁士, 安田喜美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

Osmolar effect of vascular pain and the dissolution liquid during 27-P4PM-141 gemcitabine administration
米山英二1, 万塩裕之1, 杉山惠亮1, 築山奈央1, 井原将太1, 野沢孝子1, 中村和行1, 粟田浩文1, 上條史帆里1, 石上仁美1, 間瀬悟1, 有馬順子2, 鈴木景子3, 勝見章男1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

	Evaluation for the onset of vascular pain by the generic medicine change of the 27-P4PM-142 gemcitabine hydrochloride 北本真一, 柳田祐子, 古谷智裕, 白木政博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2014.

	Examination of the refrigeration in phlebitis at the docetaxel administration of the 27-P4PM-143 non-small cell lung cancer 佐々木幸作1, 脇田由紀子2, 立山佳奈子2, 是枝快房3, 中野幸助1, 尾之江剛樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

	Development of vasculitis investigation by the Fosaprepitant by the 27-P4PM-144 epirubicin / cyclophosphamide combination therapy 島田泉, 大野晴香, 彦坂麻美, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

	New prophylaxis of the injection site reaction by the Fosaprepitant in the 27-P4PM-145 EC therapy 相川晴彦1, 嶋田烈1, 加藤弥生2, 天野恵2, 古屋まゆみ2, 松本富夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

	One patient who detected a skin ulcer by 27-P4PM-146 bortezomib subcutaneous administration 佐藤舞1, 中村あゆみ1, 古田美紀2, 後藤拓也1, 宮澤憲治1, 山本秀行3, 飯田浩充3, 永井宏和3, 松本修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

	Examination about the extravasation at hospitalization cancer chemotherapy enforcement in the 27-P4PM-147 urology department, the tumor internal medicine mixture ward 金明俊, 利根川小春, 黒須智博, 小笠原拓也, 立石朝子, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

	The onset of hypersensitivity symptom situation with the readministration after the 27-P4PM-148 Oxaliplatin discontinuation 酒井繁彰, 光永義治, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2014.

Investigation about the onset of allergic reaction situation and the reintroduction of oxaliplatin in the 27-P4PM-149 outpatient department cancer chemotherapy
渡辺祐子, 地主隆文, 鈴木直哉, 藤林遼, 菊地義明, 福井美規子, 吉嶋抄苗, 佐々木佳子, 徳村麻衣子, 高橋橋誠, 青田忠博
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

	Examination of the allergic measures in the use of Oxaliplatin (L-OHP) regimen in our 27-P4PM-150 House 田代美佳, 田井浩子, 大河万顕, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

	Risk review of hypersensitivity with cisplatin in patients with 27-P4PM-151 gastric cancer and cancer of the esophagus 八田喬史, 根來寛, 前田彩菜, 渡辺享平, 矢野良一, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

	Example that presented Stevens-Johnson syndrome during cisplatin administration for 27-P4PM-152 hypopharyngeal cancer 戸水尚希, 安達尚哉, 林誠, 長岡宏一, 後藤一純, 舟木弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

	Analysis of the factor which has an influence on the onset of hypersensitivity with the 27-P4PM-153 Docetaxel administration 池野洋平1, 有井大介1, 原田理香1, 箱守和美1, 室岡邦彦1, 野島美知夫1,2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

	Investigation of the allergy-like symptom onset at the 27-P4PM-154 docetaxel administration 佐々木好美, 岩坪沙奈恵, 和田依子, 樋口美奈子, 檜山智子, 中野行孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2014.

Evaluation of the predictor to affect Infusion reaction expression at the administration in the 27-P4PM-155 Rituximab first time
臼井一将1, 舘知也1, 安田昌宏2, 梅田道2, 加藤未紗1, 浅野祥子1, 横井貴文1, 野口義紘1, 後藤英子3, 笠原干嗣3, 高橋健3, 後藤千寿2, 寺町ひとみ1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	Evaluation of the pre-medication for the purpose of the prevention of infusion reaction in the 27-P4PM-156 mogamulizumab therapy 津曲恭一1, 前田宏一2, 林稔展3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	Examination of the rate of application about the expression of infusion reaction prevention in the 27-P4PM-157 ofatumumab administration 樋口眞宏1, 井上由紀子1, 八木聖子1, 野崎貴之1, 宇野敦子1, 志村和穂2, 野村一之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	Intervention effect of the pharmacist in infusion reaction measures with 27-P4PM-158 cetuximab 岡本明大1, 濱口直美1, 須藤宏文1, 石永一2, 竹内万彦2, 村木優一1, 岩本卓也1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	The effectiveness of duloxetine for peripheral neuropathy of 27-P4PM-159 anticancer agent origin characteristics 林万紀子, 倉橋基尚, 里岩勇人, 上田綾佳, 野々内裕紀, 古場建, 上田浩貴, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	Onset of L-OHP origin-related peripheral neuropathy situation investigation in our 27-P4PM-160 House 平良智, 當真房子, 森脇典子, 山本紗織, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2014.

	Investigation of the development of peripheral neuropathy situation in the paclitaxel preparation of 27-P4PM-161 two kinds 一島知樹, 長谷川晃司, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	Peripheral neuropathy measures of breast cancer nab-PTX by 27-P4PM-162 preventive preparation set prescription and pressurization stockings sleeve (3S) 古岡大樹1, 森善洋1, 木下真理子1, 藤田有紀子1, 佐道紳一1, 小坂幹子2, 大野毅3,4, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	Examination about the effectiveness and the safety of the febuxostat in the 27-P4PM-163 tumor lysis syndrome prevention 長谷悠紀, 岸川春樹, 曽我弘道, 川井友美子, 山口静, 坪根未歩, 平野真健, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	Effect of the uric acid level after the chemotherapy enforcement in 27-P4PM-164 blood-forming organ tumor 東修司1, 中村友香1, 田中悠季2, 鈴木悠加1, 本多有希子1, 後藤悠1, 吉田直哉1, 小原郁司1, 小寺隆二1, 妻木良二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	One discussion of the individualization treatment for the hyperuricaemia of the 27-P4PM-165 oncolysis 簑原豪人1,2, 真家紘一郎3, 小原直3, 千葉滋3, 久賀圭祐1, 本間真人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	Hepatitis B measures to occur by immunodepression, the chemotherapy in the patients after 27-P4PM-166 hematopoietic stem cell transplantation 八木祐子1, 平畠正樹1, 伊藤浩樹2, 野村洋道1, 中西真也1, 松下章子3, 橋田亨1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2014.

	It is the attitude survey for pharmacists toward the self-care introduction of the drug for the 27-P4PM-167 medical care 阿久井千亜紀1, 波多江崇2, 中村豪志1, 高橋幹子1, 岡村佐紀1, 福永智栄3, 乾貴絵3, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

	About the prescription of drug situation of the 27-P4PM-168 palliation and prognostic association 金銅葉子1, 嶋田和貴2, 二神寿美子3, 山東真寿美1, 合屋将2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

	Use fact-finding of the 27-P4PM-169 oxycodone parenteral injection 花城理人1, 岡本禎晃2, 田中育子2, 明石延子2, 竹井清純2, 中嶋真一郎2, 進藤喜予2, 中川左理1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

	The actual situation and usefulness, safety of the midazolam administration in sleep disorder of patients with 27-P4PM-170 end-stage cancer 木村隆志, 杉浦宗敏, 中島由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

Proper use situation investigation of 27-P4PM-171 methadone hydrochloride tablets
塚本早百合, 逸見結衣, 渡邊小百合, 濱谷安希子, 伊勢原祐子, 藤原正幸, 安達嘉織, 小田中みのり, 柴田直子, 中晴徹, 大前隆広, 川高菜緒, 大谷祐子, 見上千昭, 吉田直恵, 奥川斉
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

	The comparison between high-dose acetaminophen bougie and acetaminophen injection in the 27-P4PM-172 palliative care unit and examination of the usefulness 櫛引智子1,2, 宮澤正幸1,2, 平田司1,2, 片町守男2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2014.

	Morphine for dyspnea in patients with 27-P4PM-173 cancer, investigation about the palliation of the fentanyl 西川隆一1, 藤井友和1, 楠泰臣2, 辻博幸1, 塚本久之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	Examination of the usefulness of the flow chart which we made for understanding improvement of the 27-P4PM-174 fentanyl sublingual tablet direction for uses 牧野哲平1, 田中佑佳1,2, 石黒崇2, 長谷川貴昭2, 田村量哉2, 葛谷命2, 杉山保幸2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	Use fact-finding of tramadol in patients with 27-P4PM-175 cancer sharp pain and examination about the merit 竹内美緒1, 加藤博史2, 宮崎雅之2, 椿井朋1, 肥田裕丈1, 毛利彰宏1, 山田清文2, 野田幸裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	Evaluation of the sharp pain control after the 27-P4PM-176 tramadol capsule beginning to use 長谷部千夏, 山口雄士, 上田志穂, 佐野彩女, 兼松友紀, 宮部芳之, 柏毅彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	It is ... from the questionary survey to competitive review results - nurse about the use of rescue medicine in 27-P4PM-177 cancer sharp pain treatment 清水けいこ, 大西祥代, 細川朋弘, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	A present conditions investigation and problems of the drug rescue self-care in the 27-P4PM-178 inpatient 山崎富士子1,7, 林俊吾2,7, 武智宣佳3,7, 綱本優美4,7, 東裕美子5,7, 形部文寛6,7, 八本久仁子2,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2014.

	Action in our House for the patients self-care of the 27-P4PM-179 rescue dose 東裕美子1, 形部文寛2, 八本聖秀1, 淺野耕助3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

	Use experience of the fentanyl rescue medicine for the 27-P4PM-180 cancer prominence ache 山田千代子, 米澤美和, 久保杏奈, 虎瀬和子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

	About the setup of the palliative care team by the 27-P4PM-181 pharmacist leadership 八本久仁子1,4, 藤野和子2,4, 池田政宣3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

	Cooperation of 27-P4PM-182 palliative care team and the ward pharmacist 牛膓沙織1, 吉川朝子2, 安江敦3, 家田秀明3, 池上信昭1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

Action ... for the examination - ward drug duties enforcement about the cooperation of 27-P4PM-183 palliative care team pharmacist and the ward pharmacist
田島紳介1,4, 関礼輔1,4, 矢野絹子1,4, 畔蒜祐一郎1,4, 窪田靖志2,4, 正保智恵美3,4, 篠原高雄1, 永井茂1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

	Trial in the ward rounds of the 27-P4PM-184 Okayama Red Cross hospital palliative care team 浅野志津1, 大道淳二1, 長谷川亜樹2, 渡辺啓太郎2, 喜多嶋拓士2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2014.

Construction of the many types of job cooperation system by the active intervention of the pharmacist in the opioid analgesic introduction of patients with 27-P4PM-185 outpatient department cancer sharp pain
山田正実1, 松村千佳子1,2, 地丸裕美1, 上野理恵1, 矢野義孝2, 高橋一栄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

Examination about the role of the palliative care team exclusive duty pharmacist in the 27-P4PM-186 palliative care internal medicine outpatient department
小野あゆみ1, 和久井卓1, 高橋通規2, 高橋紀子2, 矢吹まゆみ2, 水沼周市1, 大塚誠二1, 小山田光孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

	Questionary survey about opioid prescription support tool [OpiTool] using 27-P4PM-187 electronic chart terminal and revision based on the findings 笹尾武史, 森真澄, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

	Examination - of the case that the introduction with opioid introduction - fentanyl patch for the patients with impaired the 27-P4PM-188 passage was conducted 三好孝法1,2, 山内浩子3, 三角紳博1, 甲斐祭生2, 吉田絵衣子2, 西野隆1, 蓮尾泰之2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

1 case that a tight military ration using the oxycodone hydrochloride hydrate parenteral injection by the 27-P4PM-189 palliative care team was successful, and was able to leave the hospital
関裕佳里1, 青木純子2, 長岡佑子1, 濱田健太3, 杉山哲大1, 川上恭弘4, 野中泰幸5, 近藤祥代1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

	The case that an objective evaluation of the 27-P4PM-190 sharp pain strength was difficult, and led to opioid overdose 新崎孝夫, 弥山秀芳, 岡田玲子, 米田篤司, 富田浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2014.

	Pharmaceutical intervention to side effect measures in the 27-P4PM-191 tramadol hydrochloride capsule remedy patients 松下尚弘1, 羽田野明子1, 古賀清弘1, 池綾子1, 石丸隆之1, 野口玉枝2, 福島由紀2, 鵤聡子2, 野中敏治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

The expression situation of the drug-related akathisia symptom in our 27-P4PM-192 House and the measures
斉藤匡昭1, 田口舞子1, 江刺家朋美1, 高橋朋子1, 佐々木智子1, 加賀谷明日美1, 相場悠樹1, 鎌田靖子1, 竹原美都子1, 国安美和1, 小松田徹1, 太田寿孝1, 小松英樹2, 大河弘子2, 新田リエ2, 秋山博実2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

	Inspection of retching, the vomiting factor in the 27-P4PM-193 pancreatic cancer Gemcitabine combination proton radiotherapy 團優子1, 柴田博子1, 寺嶋千貴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

	Trial (the first report) of the basis change for the convenience improvement of the 27-P4PM-194 Mohs paste 茂庭美希1, 佐藤淳也1,2, 藤澤晨1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

	Trial (the second report) of the basis change for the convenience improvement of the 27-P4PM-195 Mohs paste 藤澤晨1, 佐藤淳也1,2, 茂庭美希1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

	One case that clindamycin (CLDM) mouth wash was effective for a bad smell with the 27-P4PM-196 mouth floor cancer 北森靖隆1,5, 市村行典1,5, 守田夏希1,5, 岡山浩子2,5, 福島珠美2,5, 平嶋和代2,5, 橋本正博3,5, 玉置秀成1, 石田英明1, 伊藤清隆4,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2014.

	Usefulness evaluation of the diclofenac gargle (hospital preparation) for the sharp pain in the 27-P4PM-197 oral cavity 野村浩英, 宮麻紀子, 六車裕一, 松元麻美, 牧秀美, 平田貴宏, 吉岡亮, 乾有希子, 池田久雄, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

	Evaluation about the effect of the diclofenac sodium gargle on 27-P4PM-198 radiation-related oral mucositis 檜垣宏美, 渡邉真一, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

Comparison and examination ... of the stress reduction effect by the long-term use of the examination - plural species aroma oil of the relaxation effect that assumed 27-P4PM-199 stress marker an index
坂口佐穂子1, 大塚沙穂里1, 岡部友紀代1, 金子明日美1, 下枝貞彦1, 中川沙織2, 大和進2, 太田伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

Examination of stress inhibitory effect and the immunity enhancement effect with the gamma-aminobutyric acid which assumed the IgA out of 27-P4PM-200 saliva an index
大塚沙穂里1, 坂口佐穂子1, 金子明日美1, 岡部友紀代1, 下枝貞彦1, 中川沙織2, 大和進2, 太田伸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

	27-P4PM-201 Analgesic effect part density of opioid immediate release simulation for patients with cancerous sharp pain - About oral oxycodone immediate release - 横井沙緒里, 壁谷めぐみ, 日比聡, 斉藤明子, 久保直子, 神谷絵梨奈, 湯浅周 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

27-P4PM-202 Analgesic effect part level of opioid real time-releasing preparation simulation for patients with cancerous sharp pain 〜About immediately fentanyl-releasing preparation〜
神谷絵梨奈, 壁谷めぐみ, 日比聡, 齋藤明子, 久保直子, 横井沙緒里, 湯浅周
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2014.

	Search of the risk factor to have an influence on the sharp pain control of the 27-P4PM-203 fentanyl patch use patients 平舩寛彦1,2, 高橋宏彰2, 千葉健史1, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

	Effect on bowel movement - preliminary investigation report ... by the changes from 27-P4PM-204 oxycodone controlled-release tablet to a fentanyl patch 衛藤智章, 林稔展, 古海和博, 小早川高徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

	Examination of the conversion ratio and the analgesic effect of the oxycodone injection preparation in the 27-P4PM-205 opioid rotation 山本明紀, 藤井千賀, 石坂敏彦, 八野芳已 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

Change of the change to the opioid injection drug with the 27-P4PM-206 oxycodone (R) note
秦毅司1,10, 渡辺貴志2,10, 中村敏史3,10, 野村翔3,10, 後藤健志4,10, 櫻井まりこ4,10, 伴竜典4,10, 中原典絵4,10, 白木小百合4,10, 寺西二三代5,10, 遠山幸男6,10, 山本倫久7,10, 板倉由縁8,10, 勝見章男9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

	Example that switched from 27-P4PM-207 oxycodone to acetaminophen, and followed the good course 大津貴寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

	The effectiveness in the fentanyl patch introduction for 27-P4PM-208 generic medicine 3rd and safe examination 塚本泰彦1, 梶山徹2, 倉橋基尚1, 眞継賢一1, 岡本朋子1, 古場建1, 市原しのぶ3, 垣見亮4, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2014.

	The effect that the attaching person of the 27-P4PM-209 fentanyl patch gives to a fentanyl survival rate 川口恵1, 沼田千賀子1, 寺岡麗子1, 湯谷玲子1, 岡本禎晃2, 平野剛3, 冨田猛3, 平井みどり3, 北河修治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

Examination about the difference of consciousness, the maneuver of the fentanyl survival rate of the use of 27-P4PM-210 finished fentanyl patch and the attaching person
奥田麻有1, 沼田千賀子1, 寺岡麗子1, 湯谷玲子1, 岡本禎晃2, 平野剛3, 冨田猛3, 平井みどり3, 北河修冶1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

Examination of the usefulness of the introduction sheet in the 27-P4PM-211 fentanyl oral mucosa absorption preparation
立松三千子1,2, 美濃屋亜矢子3, 尾崎千鶴3, 栗木玲子2,4, 秦毅司2,5, 松崎雅英1, 平島佳代1, 橋本直弥1, 前田美恵子1, 長谷川彩子1, 新田都子3, 下山理史6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

	Comparison (the second report) using 27-P4PM-212 fentanyl sublingual tablet and the preparation example in the buccal tablet 遠山幸男, 中村千加弘, 石川亜未, 高岡龍蔵, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

	Action for the proper use of the 27-P4PM-213 fentanyl quick-release preparation 彦坂麻美, 島田泉, 渡邉幸雄, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

	27-P4PM-214 Difficulty and the usefulness that we experienced by use of the fentanyl immediate release 和久井卓1,2, 小野あゆみ1,2, 水沼周市1, 大塚誠二1, 小山田光孝1, 高橋紀子2, 高橋通規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2014.

	Effect to give to PT-INR by the combination of 27-P4PM-215 tramadol hydrochloride capsule and warfarin potassium 皆元文恵, 梅田勇一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

	Action second report of the storage pharmaceutical products use for a 27-P4PM-216 size scale disaster 川口亮1, 水口雅貴1, 菅尾高裕1, 小池道明1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

Questionary survey about the association of 27-P4PM-217 Japanese private medical college chief pharmacist meeting sponsorship 2013 pharmacist practitioner workshop participant disaster medical care
白瀧肇1, 鈴木優司1, 添田真司2, 渡邊昌之2, 横山直3, 平綿洋子3, 丸谷善紀3, 市川訓3, 宮坂宗男3, 川口さち子4, 工藤賢三4, 野村守弘5, 山添譲5, 片山志郎6, 二神幸次郎6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

	About participation in disaster support of the 27-P4PM-218 pharmacy school first grader, rescue operation awareness 中村武夫1, 伊藤栄次1, 田村隆教2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

	Evaluation of the pharmaceutics of the micellar particle diameter and particle count in the 27-P4PM-219 lipid microsphere 長谷川豊1, 依藤健之介1, 波多江崇2, 倉本敬二3, 濱口常男2, 平野泰健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

	Diachronic change of effect and sTNF, sTNF-R1, -R2 of Capsaicin in the 27-P4PM-220 LPS administration mouse 小林由佳, 加藤隆児, 井尻好雄, 林哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2014.

	Action of the open conference enforcement to a local pharmacist in our 28-P1AM-001 House psychiatric care center 冨ヶ原由季1, 坂本修1, 小杉三弥子1, 宮崎三恵子1, 川島千明2, 小田原俊成3, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

	Action to medicine medicine cooperation with 28-P1AM-002 Gunma center Hospital and the Maebashi-shi pharmacist society 新木美枝1, 伊藤典子1, 草間敏子2, 永井和己3, 木村薫3, 濱田えり子3, 井上拓民3, 大島由喜夫3, 内藤浩2, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

	About information cooperation activity between the pharmacy with the hospitalization and release in the 28-P1AM-003 corporation 嶋田聖子1, 濱邊秋芳1, 納富貴子1, 武田典子1, 溝口晶子2, 曽根本恵美2, 小林恵子2, 岩村直也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

	Example of the excellent action about the cooperation of a medical institution working for the safe use of 28-P1AM-004 pharmaceutical products and the drugstore 中常恵美1, 平松彩佳1, 飯村康夫1, 渡邊伸一1, 山本弘史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

	Examine the illness in the outside Parliament prescription of foreign cancer chemotherapy patients in the 28-P1AM-005 eight Municipal Hospital; examination about the usefulness of the medicine cooperation system 小川充恵1,2, 植田真理1, 山崎肇1, 小枝伸行2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

Evaluation of the usefulness of the medicine medicine cooperation introduction in the treatment with oral anticancer agent of the 28-P1AM-006 outpatient
吉田徹也1, 中尾將彦1, 山崎直樹1, 中川朋美1, 木村仁美1, 岡本優美1, 勝島詩恵2, 津谷あす香2, 徳永伸也2, 駄賀晴子2, 武田晃司2, 松井優子3, 吉川眞知子3, 竹内昌司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2014.

	Medicine medicine cooperation in the oral anticancer agent using the 28-P1AM-007 outside Parliament prescription 阿部雅雄1, 成定宏之2, 岩崎由香1, 中園武宣1, 芳野美和1, 森康弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

	Practice support and medicine medicine cooperation by the intervention to 28-P1AM-008 outpatient department internal use cancer chemotherapy 相良克海, 森山愛子, 吉川聡美, 小田慎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

	Usefulness of the medicine medicine cooperation using the Internet and FAX in the treatment with 28-P1AM-009 oral anticancer agent 間俊男, 川崎玄博, 竹葉美香, 藤近拓弥, 示野健介, 谷幸美, 西村さやか, 宮村憲明, 水野李絵, 三浦雅典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

	Patients support with the information communication book between institutions including the telephone support for foreign chemotherapy patients in the 28-P1AM-010 drugstore 角佳亮1, 水野宏昭2, 樋口敦1, 西上潤2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

	About making and the use of the patients reporting tool in the 28-P1AM-011 cancer chemotherapy 日沖雅人, 山川智一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

Questionary survey about the instruction to patient of the cancer chemotherapy to a pharmacist working in 28-P1AM-012 Sakai-shi
渡邊裕之1, 藤井千賀2, 安井友佳子2, 北村瑞穂3, 金田典子3, 藤原季美子4, 古川順章5, 三盃範晃6, 桐子雄志7, 東田美奈8, 金田仁孝9, 高山宏10
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2014.

	The present conditions of the medicine medicine cooperation with the visit pharmacist in the Yachiyo medical center attached to 28-P1AM-013 Tokyo Women's Medical College 高柳論也1, 須貝壮衆1, 渡邉基之1, 金谷法好2, 小川智弘3, 濃沼政美4, 小坂好男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

	It is ... for held - medicine medicine cooperation of the "palliative care" workshop for the 28-P1AM-014 local health insurance ethical pharmacy 梶原徹, 中村智, 小川洋司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

Attitude survey of the pharmacist after the workshop attendance for the purpose of the 28-P1AM-015 medicine medicine cooperation
鈴木大吾1,4, 石井秀明1,4, 松原怜1,4, 伊東和真1,4, 浅野嘉之1,4, 鈴木敦詞1,4, 川村まりこ1,4, 栗本夕夏1,4, 奥田ユミ1,4, 牛田誠2,4, 林きよみ2,4, 山田智美2,4, 河村智美2,4, 市原敬大2,4, 小畑秀夫2,4, 服部雄太3,4, 前田剛司1,4, 坂田洋1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

	Usefulness of hospitalization and release drugstore judging from the attitude survey to 28-P1AM-016 pharmacist, the hospital cooperation workshop 松田千恵1, 大津山裕美子2, 須崎宏子3, 新田朋弘4, 小畑友紀雄5, 安原智久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

	Questionary survey about the actual situation of the medicine medicine cooperation for a hospital, the health insurance pharmacy of 28-P1AM-017 Hokkaido 戸根佑馬1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

Examination about effective mention of the 28-P1AM-018 medicine notebook
宮本康敬1,12, 下條浩史2,12, 塩野州平3,12, 富田治4,12, 伊藤譲5,12, 曽布川美登理6,12, 高橋聡7,12, 下山大地8,12, 杉山裕司9,12, 奥村知香10,12, 柴山芳之10,12, 渡邉進士11,12, 塩川満3,12
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2014.

Questionnaire survey ... of the cooperation - Munakata, Fukuoka pharmacist society germfree preparation workshop with the health insurance pharmacy about the 28-P1AM-019 germfree preparation
月野木祥子1, 三嶋一登1, 秦晃二郎1, 中嶋一惠1, 村岡香代子1, 入佐俊弘1, 江頭伸昭1, 安東恵津子2, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

28-P1AM-020 The making of the general inhalational instruction prescription in the Nagoya southern part and the evaluation
中根茂喜1, 宮原兼二1, 山口智江1, 平松久典1, 松尾正樹2, 伊藤稔宏3, 中村敏史3, 後藤康洋4, 山本雅史4, 松下直樹5, 諸澤美佳6, 野崎裕広6, 松波晋平7, 大津稔彦7, 中村純子7
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

We can approach treatment by cooperation with the 28-P1AM-021 hospital pharmacy in the ethical pharmacy! It is ... by medical therapy by ... inhalational instruction more surely
古島彩代1, 飯森早苗1, 濱出晴美1, 金岡砂那恵1, 東香織1, 小松潤奈1, 向紗矢香1, 國富薫1, 朴善美1, 藪下りよ子1, 平尾広子1, 大山伸子1, 土師久幸2, 久岡清子2, 佐々木健志2, 栗原直嗣3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

	Use of medicine medicine cooperation - antipsychotics durability parenteral injection information sharing - in the 28-P1AM-022 psychiatry 佐野知子1, 石田理恵1, 佐々木元子1, 滝澤理貴1, 島森美光2, 黒澤菜穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

	One case of the psychotropic drug excessive quantity medication that a pharmacist cured before 28-P2AM-001 first aid import and suggested 河村聡志1, 佐藤史織1, 山代栄士1, 上野悦子1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

	Survey of the acute intoxication accident patients in the 28-P2AM-002 third emergency hospital 末延道太1, 上野悦子1, 佐藤史織1, 麻生真由美1, 重松明美1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2014.

	About the 4 case of our 28-P2AM-003 House addicted to organic phosphorus 佐藤誠一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	Example that caused hypoglycemia by combination of 28-P2AM-004 SU agent and quinolone antibacterial, and led to hospitalization 大塚充, 大坪達弥, 澤田真嗣, 小西麻美子, 石田曜子, 堀内あす香, 西川靖之, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	28-P2AM-005 Efforts and Effects of Pharmacists Allocation to ICU in Two Hospitals Takanashi Megumi1, Funakoshi Sachiyo2, Ishida Akiko1, Hara Naoki1, Kase Katsuya1, Maeda Yorinobu2, Matsuda Toshiyuki1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	Intervention - injection drug management ... of the pharmacist in the 28-P2AM-006 critical care center ICU 村上仁志1, 鈴木善貴1, 清田綾子2, 夏目文子2, 森山明美2, 三浦敦子2, 鈴木伸行3, 中山雅人3, 石田隆浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	Enforcement situation investigation of the ward drug duties in the 28-P2AM-007 ICU 鈴木太一, 金城梢, 若杉正, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	Role of the pharmacist in the PCPS introduction team by the 28-P2AM-008 many types of job cooperation 坂井孝行1, 北林浩2, 大橋慎一郎2, 伊藤美穂3, 前田美香子3, 小椋信二4, 笹岡真矢5, 伊藤陽一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2014.

	Investigation of prescription, the problems of formulations that became clear by common use medicine for 28-P2AM-009 emergency ward inpatient confirmation 後藤千栄, 小笠原康雄, 藤井静香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

	Analysis of the adverse drug reaction related information offer in 28-P2AM-010 first aid, the intensive care domain 田中聡, 門口直仁, 宮本典文, 山本創一, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

	28-P2AM-011 Construction of the pharmacist duties in the Oita City Medical Association Almeyda Hospital critical care center 佐藤史織1, 山代栄士1, 河村聡志1, 重松明美1, 中島竜太2, 稲垣伸洋2, 森一生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

	Usefulness evaluation of the parenteral injection incompatibility chart in the 28-P2AM-012 intensive care unit 石田茂, 尾川理恵, 武田真樹, 池末裕明, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

	About an effect by the pharmacist placement to 28-P2AM-013 ICU, CCU 出雲正治2, 四方公亮1, 佐藤香織1, 井上由紀1, 加藤潤一郎1, 岩井健一2, 長谷川英雄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

	Pharmacist duties in the 28-P2AM-014 CCU ward 池谷健一1, 平井啓太2, 木苗あゆみ1, 山崎友朗1, 宇津木博明1, 平野桂子1, 坂本達一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2014.

Medical therapy protocol making for a sleep disorder, the delirium in the 28-P2AM-015 SCU ward and action of CDTM
川田敬1, 山崎好恵1, 大崎美幸1, 高平豊1, 宮本典文1, 山本創一1, 服部暁昌1, 岩本尋世2, 福田真紀3, 岡田憲二3, 福井直樹3, 森本雅徳3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	Evaluation of the paramedical rounds in the 28-P2AM-016 intensive care domain 赤崎瞳1, 廣岡晃子1, 浜元善仁1, 翁長真一郎1, 松野寛子2, 安里あきの2, 仲間清美2, 東恩納のぞみ3, 比嘉保1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	Participation of the pharmacist for the stress ulcer prevention in the 28-P2AM-017 ICU 吉廣尚大1, 桜谷正明2, 平田旭2, 河村夏生2, 吉田研一2, 大田博子1, 橋本佳浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	Examination of the insulin adsorption prevention in the 28-P2AM-018 neonates glucose insulin therapy 小西友美, 中村梨余, 小林加奈, 中村卓巨, 市野貴信, 犬飼直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	An action of the pharmacist placement to 28-P2AM-019 NICU and the effect 横山雅子, 高梨愛, 中島明日香, 鈴木晶子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	Usefulness of the allergy to patients check using the yellow card by the 28-P2AM-020 surgery part exclusive duty pharmacist 向原里佳1, 高倉歩美1, 本多立1, 倉田朋彦1, 赤阪未来1, 清水恵1, 岩本卓也1, 宮部雅幸2, 村木優一1, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2014.

	Duties and the evaluation that were improved in a 28-P2AM-021 surgery part by the intervention of the pharmacist 柴田みづほ, 川口真由子, 橋本杏里, 渡辺健太, 石川雅之, 新部陽子, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

	Duties development in the operating room of the 28-P2AM-022 pharmacist 野田貴義1, 水口雅貴1, 杉本智恵子1, 勝又博司1, 菅尾高裕1, 小池道明1,2, 岡崎敦3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

About the action of the recent ward drug duties in our 28-P2AM-023 House and the result
松田真一郎, 寺本晴美, 岡林悠, 山本智香, 神原千佳, 中谷恵子, 伊藤有紀子, 城尾晃太, 宮崎晃, 近谷理恵子, 小林佳奈, 田中慎, 土井彩愛, 弘田真澄, 淵田悠一郎, 安田将樹, 高野優子, 木俣章, 馬瀬久宜
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

The present conditions and problem of ward duties in HCU in the 28-P2AM-024 Asahikawa Red Cross hospital
田村研太郎, 吉田さゆり, 里利恵子, 紙谷章基久, 中岡由貴, 宮崎祐加, 山田淑恵, 多地貴則, 増渕幸二, 鈴木正樹, 簑島弓未子, 西村栄一, 牧瀬英知, 橋本光生, 後藤吉延
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

	About the present conditions and the evaluation of ward drug duties in the 28-P2AM-025 Kitakyusyu General Hospital 中島一, 池田浩和, 大治万喜子, 柏田匡広, 溝口千秋, 大石貴裕, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

	Ward drug duties in the hospital intensive care unit attached to 28-P2AM-026 Kanazawa University 磯田和也, 三坂恒, 中出順也, 高林真貴子, 板井進悟, 原祐輔, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2014.

It is ... for benefit improvement of the outside Parliament inspection work of prescription by action ... hospital pharmacist to the number of doubt inquiry reduction that we applied 28-P2AM-027 QC technique in
奥村雅美, 船戸元子, 吉田宗広, 階戸美和, 井藤俊, 森正昭
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

Drugstore duties improvement by the action (the third report) CDTM introduction for joint medical treatment management (CDTM) in the 28-P2AM-028 community medical care
小川壮寛1,2, 松下明3, 福嶋寛子1, 佐々木萌子1, 中尾直1, 守安洋子1, 川上茂利1, 島田憲一2, 江川孝2, 高見陽一郎2, 高橋正志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

Proper use ... of action ... vancomycin for the protocol making in the affiliated 8 hospital in 28-P2AM-029 Showa University
鈴木絢子1, 須永登美子1,9, 田中絵里子2, 今井佳世3, 櫻井康亮4, 仁尾祐太5,9, 平藤彰6,9, 屋城由樹7,9, 吉川雅之4, 和田紀子5, 齋藤勲8,9, 向後麻里1,9, 村山純一郎5,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

	It is CDTM in the prevention of recurrence from the onset of the 28-P2AM-030 stroke 廣岡駿, 栗林和美, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

Introduction and drug, effect to give to medical material cost reduction of injection drug preparation duties by the 28-P2AM-031 operating room working full time pharmacist
倉田朋彦1, 向原里佳1, 高倉歩美1, 清水恵1, 赤阪未来1, 岩本卓也1, 宮部雅幸2, 村木優一1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

	Enforcement of pharmacist "training that is strong in 28-P2AM-032" first aid and the evaluation 家田正子1, 野村守弘1, 吉田宏二1, 吉長正紘1, 山添譲1, 窪田愛恵2, 田口博一2, 西内辰也2, 平出敦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2014.

	One case of the prevention of doping activity in the 28-P2AM-033 hospital pharmacist (sports fur better strike) 小出賢吾, 野沢正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Role of the pharmacist in the implantation (homograft) of the 28-P2AM-034 cardiovascular surgery domain 五味知之1, 堀内賢一1, 柳沢国道1, 油井信明2, 竹村隆広3, 津田泰利3, 西澤延宏4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Action of the ward pharmacist for the use of drug patients inducing the QT prolonged using the 28-P2AM-035 ambulatory ECG 山岡慶子, 大本暢子, 山本和宏, 西岡達也, 久米学, 槇本博雄, 平野剛, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Practice and effect of the physician burden reduction by the 28-P2AM-036 pharmacist 佐多照正1, 中村有莉恵1, 赤星真広1, 前村由佳1, 上原友美1, 山路智凡1, 池増鮎美1, 神門孝典1, 宮原広典2, 前之原茂穂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Enforcement of the testing order by the ward pharmacist based on 28-P2AM-037 medical therapy protocol 棗則明, 米川英宏, 鈴木美穂, 湯澤幸久, 小池健太, 一本木之人, 臼井沙耶香, 新井友紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Role prospective in a pregnant woman, nursing mother-related drug reporting in the 28-P2AM-038 kidney internal medicine for a pharmacist 内山耕作, 横井里奈, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2014.

	Fact-finding of the renal excretion type drug for the patients less than eGFR30ml/min/1.73m 2 in the 28-P2AM-039 bringing medicine 森田啓嗣, 角南陽子, 洲脇純三, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

	Intervention fact-finding to the on admission bringing medicine adequacy to the 28-P2AM-040 decreased renal function patients 鈴木雄太, 佐藤圭吾, 追木正人, 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

	Effect of the renal function to give side effect expression at the 28-P2AM-041 liraglutide introduction 磯野哲一郎1,2,3, 平大樹1, 佐々木恭子1, 宇津貴2, 前川聡3, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

	Uric acid drop effect of the febuxostat in the 28-P2AM-042 decreased renal function patients 三星知1, 山田仁志1, 長井一彦1, 岡島英雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

Evaluation - of the change situation and the physician of renal function evaluation and prescription suggestion - prescription of the inpatient by the 28-P2AM-043 ward pharmacist
小松めぐみ, 青木佐菜, 市川麻美, 山科あかね, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 田中照夫
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

	Investigation of the usefulness with changes from allopurinol which we looked at according to 28-P2AM-044 renal function to febuxostat 湯淺有香子1, 高木明子2, 辨野知子1, 柳川晴菜1, 橋本昌幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2014.

	Effect of carnitine on anemia in renal disease in 28-P2AM-045 patients on dialysis and line symptom 中村晋也, 向井賢司, 齋藤友季子, 貴志直哉, 龍田京子, 中村能子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

	About usefulness of the new constipation therapeutic drug agate Pross ton to 28-P2AM-046 haemodialysis patients 望月真太郎1,2, 村松望2, 太田侑宏2, 須田智2, 大貫よし子2, 藤澤浩二1, 高田亜希子1, 牧野和也1, 二宮大和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

	Example that opioid preparation was effective for sharp pain with the lower limbs gangrene of 28-P2AM-047 patients on dialysis 坂本愛1, 相地誠2, 高下智子1, 内山ひとみ1, 吉田俊子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

	It is ... led by comparison between agate Pross ton and use situation - patients on dialysis in other aperient in the 28-P2AM-048 City Nagahama Hospital 大岡千寿子, 野洌孝二, 高山直樹, 田中祐輔, 干井香織, 多賀俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

	Action of the pharmacist in the serum P, revision Ca levels management of 28-P2AM-049 maintenance patients on dialysis 富田敏章, 下河邉安妃子, 相部真希, 萩原里実, 町田聖治, 曽我弘道, 前田朱香, 福島将友, 清水誉志, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

	An action of the many types of job cooperation in the 28-P2AM-050 CKD outpatient department and the effect 椿井朋1, 柴田佳菜子1,2, 濱田昌実3, 水谷友4, 安田宜成2, 加藤佐和子5, 後藤資実6, 林睦晴7, 中尾誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2014.

Search of the factor to have an influence on for effect of treatment of the red blood cell hematopoietic stimulating factor preparation in anemia in renal disease treatment of patients with chronic renal failure for 28-P2AM-051 preservation period
松下紋子1,2,3, 林高弘2, 水野智博1,3, 野口彩香1, 加藤里奈1, 西部星来2, 湯澤由紀夫3, 山田成樹2, 永松正1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

	Two cases that we changed to oral cyclophosphamide therapy from cyclophosphamide pulse therapy for 28-P2AM-052 ANCA-related nephritis 稲秀士1, 佐藤光1, 中原千恵1, 宮川佳子1, 児玉美緒2, 井野純2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

	Role ... of the pharmacist in trial - End Of Life Care Team of the palliative care team which added the elderly people disease to a subject 28-P2AM-053 non-cancer 久保川直美1,4, 横江由理子2,3, 西川満則3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

	The effect that 28-P2AM-054 becomes calm, and adjustment food gives to remedy medicine 山口博美, 落合葵, 滝谷広子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

	Preparation of the film derived from 28-P2AM-055 active carbon component nature polysaccharides 湯川美穂1, 上川畑篤1, 東屋敷史織1, 川原光喜1, 池田浩人1, 湯川栄二2, 安藝初美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

Comparison between on admission and number of at discharge the drugs and drug costs in the hospital old age internal medicine attached to the 28-P2AM-056 Nagoya University School of Medicine
渡邉雄貴1, 横山雄一1, 市川和哉1, 梅垣宏行2, 葛谷雅文2, 山田清文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2014.

	Association of the hyperammonemia onset and the genetic polymorphism with 28-P3AM-001 valproic acid 高橋俊樹1, 井上和幸1, 鈴木絵莉1, 山本吉章2, 高橋幸利2, 今井克美2, 宮川紘2, 井上有史2, 辻大樹1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	Analysis of the KRAS/BRAF genetic polymorphism in patients with Stage IV colon cancer given 28-P3AM-002 FOLFOX/XELOX + C-mab combination therapy 小林靖奈1, 梅本岳宏2, 大林真幸1, 神山紀子1, 田中淳一2, 山元俊憲1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	A maintenance dosage, responsiveness of the 28-P3AM-003 antidepressant and association with the ABCB1 genetic polymorphism 長岡翔1, 井上和幸1, 袴田康弘2, 鈴木晶子2, 木村緑3, 辻大樹1, 伊藤邦彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	Change of the pharmacy school freshman education effect in the 28-P3AM-004 early on-site training 池田賢二, 小西廣己, 浦嶋庸子, 長井克仁, 川西園代, 初田泰敏, 名徳倫明, 廣谷芳彦, 西井諭司, 小川雅史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	Construction ... of the atrial fibrillation model based on simulation education (2) - true clinical practice in the 28-P3AM-005 pharmacy school 高上美詞1, 竹市朱里1, 山本英治2, 大角幸男3, 安田公夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	Using learning effect - marker scenario of the simulation education using 28-P3AM-006 e-PDE - 山下裕己, 大津史子, 後藤伸之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2014.

	Extraction of problems of the physical assessment training by 28-P3AM-007 CS analysis, the factor analysis 大鳥徹, 松野純男, 金裕生, 松山賢治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

Examination ... of problems and the remedy that - student feels with the role of the pharmacist participating in 28-P3AM-008 "business true taking lessons previous learning" (the third report)
村田明子1, 中尾幸代1,2, 松田裕子1, 南恵理子1,3, 山中智香1,4, 波多江崇1, 沼田千賀子1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

The present situation of the medical therapy workshop by 28-P3AM-009 University of Shizuoka, hospital, the community pharmacy cooperation
内野智信1,2, 宮嵜靖則1,2, 秋山欣三2, 浅倉侯子2, 伊藤邦彦2, 井上達秀2, 坂本達一郎2, 柴山芳之2, 菅谷純子2, 鈴木崇代2, 中野眞汎2, 並木徳之2, 北村修2, 松山耐至2, 森本達也2, 山田静雄2, 山田浩2, 賀川義之1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

Association with learning will after satisfaction and the attendance of the 28-P3AM-010 "medicine-based internship volunteer experience-based training" and the after graduation course
栗尾和佐子, 小西元美, 奥野智史, 中尾晃幸, 木村朋紀, 辻琢己, 山室晶子, 山本祐実, 西川智絵, 串畑太郎, 柳田一夫, 安原智久, 河野武幸, 曽根知道
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

	Study introduction effect to pharmacy school life by the 28-P3AM-011 graduate student-led "statistics seminar" enforcement 庄司雅紀, 恩田光子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

Change of the recognition for the team approach in medical care of the pharmacy student which participated in 28-P3AM-012 many types of job cooperation education
佐藤琢哉1, 半谷眞七子1, 野田幸裕1, 毛利彰宏1, 阿部恵子2, 安井浩樹2, 末松三奈2, 亀井浩行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2014.

	A study on communication third report between the 28-P3AM-013 pharmacist - patients: Communication analysis using RIAS 仲山千佳1,3, 木全栞1, 大嶋耐之1, 加藤文子1,2, 新田淳美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

	Attitude survey (the third report) of the Chinese medicine for the pharmacy student just after the 28-P3AM-014 entrance to school - Comparison - between the subjects in the Yokohama college of pharmacy pharmacy school 田子美佐子, 金成俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

It is research ... of pharmacist education system and the national examination system of each ... country and the medical administration system about a pharmacy education, the pharmacist image which is desirable for the Japanese medical care from 28-P3AM-015 this
小林俊博, 池田祐子, 沼尻幸彦, 井上裕, 新津勝, 金本郁男, 杉林堅次
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

	Difference in pharmacist image by the quantity of the opportunity to understand 28-P3AM-016 pharmacist professional ability image 伊原千晶1, 三保紀裕2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

	Construction of the medical English library of medicine, the pharmacy domain by the 28-P3AM-017 text mining 中村光浩1, 梅津亮冴1, 鈴木俊之1, 加藤大和1, 上田夏実1, 中山蓉子1, 羽根由基1, 松井利亘1, 阿部純子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

	Recognition of the nurses' aide about 28-P3AM-018 pharmacist duties 井手若奈1,2, 高橋眞生1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2014.

	28-P3AM-019 pharmacy school pharmacology, the present conditions and comparison of the education about the field of international health medical care in the School of Medicine medicine department 加藤茉悠子1, 野呂瀬崇彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

	Examination about the document making available for a summary of the basic pharmaceutical knowledge before the 28-P3AM-020 drugstore business training 寺下真人1, 角本幹夫2, 岡野友信2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

Development of the physical assessment learning teaching materials for the pharmacist that the confirmation of an evaluation, the side effect of the efficacy in the 28-P3AM-021 ward can train
今田美里, 徳永仁, 小笹彩花, 小森佳奈子, 小野知佐, 西村秋恵, 緒方賢次, 瀬戸口奈央, 佐藤圭創, 松岡俊和, 高村徳人
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

	Investigation of the doubt inquiry in approximately the 28-P4AM-001 chemotherapy regimen order system introduction 宮崎晃臣, 阿部昌宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

Trial to the quality of life improvement of team approach in medical care by the improvement of 28-P4AM-002 cancer chemotherapy regimen and the patients
河野茉里子1,2, 久保田祐1, 高橋真理1, 小倉崇裕1, 高橋哲三1, 小池綾子2,3, 竹之内信2,4, 中島敦夫2,5, 渋谷文則6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

Action for standardization of 28-P4AM-003 cancer chemotherapy regimen, the supportive care and the database management
桝茂典1, 岡田悠美1, 廣瀬俊昭1, 中川隼一1, 高橋真一1, 杉野由依1, 伊藤あゆみ1, 齋藤加奈1, 室伏孔樹1, 上村苑子1, 柴原麻未1, 赤石和久2, 村上敏明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2014.

	The electronic chart of the regimen confirmation matter for the purpose of the 28-P4AM-004 information sharing about becoming it 北野陽子, 細谷嘉行, 田中崇, 長田麻未, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

	The evaluation of the 28-P4AM-005 cancer chemotherapy regimen system of administration and safety management by the pharmacist 上野陽介1, 岡田悠加1, 藤原和彦1, 国東ゆかり1, 辻本勉1, 松岡英仁2, 楠知美3, 居上和代3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

	Introduction of the anticancer agent cumulative dose system of administration in the 28-P4AM-006 electronic chart 青野真弓1, 中田千博1, 實川東洋1, 三上麻衣子2, 高市直子2, 丸山美穂子2, 福田恵子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

	Role of the present conditions and the pharmacist of the cancer chemotherapy regimen examination registration in the hospital attached to 28-P4AM-007 Kawasaki Medical School 槇枝大貴1,4, 二宮洋子1, 笹本奈美2,4, 岡脇誠3, 山口佳之3,4, 玉井恭子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

The rebuilding of the 28-P4AM-008 chemotherapy regimen deliberation system and reevaluation of the registration regimen
大竹明美1, 千葉博暁1, 伊藤千鶴1, 貴田岡徳子1, 湊敬子1, 氏家美帆1, 武田昇1, 加藤裕也1, 舘田要樹1, 伊藤薫2, 石岡千加史3, 中村浩規1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

	Improvement of the care by development, the introduction of the 28-P4AM-009 cancer chemotherapy support system 築田晃直, 谷口潤, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2014.

	Relation of systems construction and the pharmacist of the 28-P4AM-010 malignant glioma therapeutic drug 平田亜希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

	28-P4AM-011 Operation of Stivarga introduction path toward becomes severe avoidance of side effects 林美和子1, 面高みどり1, 古畑文1, 米澤亮1, 網野一真1, 濱至寛1, 跡部治1, 五味邦之2, 島田宏2, 三原基弘2, 梶川昌二2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

	Evaluation of the effect that weight loss of the water load at the 28-P4AM-012 cisplatin administration gives for renal function 辻井大輔, 松本陽子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

	Examination about the effect of dilution concentrations in the Infusion reaction expression at the 28-P4AM-013 rituximab administration 金素安1, 立沢正臣1, 有高奈々絵2, 下嶋和代1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

	Effect of the team approach in medical care in the 28-P4AM-014 outpatient department cancer chemotherapy 松崎雅英1, 佐内俊志1, 長谷川彩子1, 前田美恵子1, 橋本直弥1, 水谷旭良1, 高畑知帆子2, 小原真紀子2, 室圭3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

	Action for the construction of the cooperation with the 28-P4AM-015 outpatient department chemotherapy room 沼崎香, 鯨明美, 岩瀬裕治, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2014.

Utilization ... of introduction - dosage previous assessment seat of the team approach in medical care in the 28-P4AM-016 outpatient department cancer chemotherapy
原竜太郎1, 戸鹿野美織1, 橘淳1, 山本晋平1, 上野麻衣子2, 青山樹理2, 田嶋政之3, 濱浦睦雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

	Evaluation of the nurse about the cancer medical therapy study session in the 28-P4AM-017 blood medical service 安田昌宏1, 梅田道1, 舘知也2, 大澤友裕1, 長屋雄大1, 市橋厚司1, 伏屋洋子3, 廣瀬五十子3, 寺町ひとみ2, 後藤千寿1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

	The activity of the pharmacist in the pancreatic cancer classroom to make with 28-P4AM-018 medical care team and the evaluation 松田紘子1,2, 世古口典子1, 村木優一1, 岸和田昌之2, 杉本浩子1, 岩本卓也1, 伊佐地秀司2, 奥田真弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

28-P4AM-019 physician, pharmacist, examination about the usefulness of "the joint screening by the nurse before cancer chemotherapy enforcement"
吉岡祐貴1, 伴晶子1, 岡戸洋1, 小林義和1, 小島義博1, 小林和子2, 若狭幸子2, 白石久美子2, 織田元3, 生田宏次4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

It is ... for 28-P4AM-020 nurse, construction - continuation-like patients with pharmacist joint ownership support of the foreign chemotherapy "treatment record control system"
六波羅孝1, 北原正之1, 野上こまき1, 上原亜紀子2, 渡辺まゆ美2, 戸田智恵美2, 矢野いずみ2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

	Evaluation of the intervention effect of the pharmacist in the 28-P4AM-021 palliative care team 阿部健太郎1, 赤木徹2, 元永伸也1, 的場元弘3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2014.

	Introduction of CDTM for the supportive care of the 28-P4AM-022 cancer chemotherapy 村上通康, 橋本浩季, 山口恭平, 塩坂育子, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

	Action to standardization and the information communalization of 28-P4AM-023 anticancer agent preparation duties 三谷和恵, 窪田真弓, 波多晶子, 中尾大介, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

Action to the side effect information sharing using the chemotherapy interview sheet by the foreign cancer chemotherapy in the 28-P4AM-024 Itabashi Chuo General Hospital
目黒聡子1, 高山裕子2, 酒井由希子1, 駒井信一郎1, 岡山和広1, 竹内由美2, 山内泰一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

	Action in dermatopathy measures to patients who received 28-P4AM-025 chemotherapy 上原友美1, 中村有莉恵1, 赤星真広1, 前村由佳1, 山路智凡1, 石神誠子1, 池増鮎美1, 神門孝典1, 佐多照正1, 坂口育美2, 中島三郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

	Introduction and evaluation of the anticancer agent check list based on the 28-P4AM-026 questionnaire 日下部鮎子1, 藤原陽子1, 堀金妙子1, 岸元麻紀1, 佐藤佳華1, 菊池一樹1, 大江利治4, 明田克之3, 江副英理2, 八十島孝博2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

About intervention results of the pharmacist outpatient department in the oral 28-P4AM-027 molecules target medicine and a future action
坂本莉紗1, 四十物由香1, 平川寛之1, 根本昌彦1, 佐藤渉1, 齋藤祥子1, 青山芳文1, 城向富由子2, 丸山常彦3, 鴨志田敏郎4, 堤雅一5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2014.

	Inspection of the effect by the interview before medical examination of the pharmacist in the 28-P4AM-028 outpatient department chemotherapy 勝又一雄, 内田直人, 川口洋実, 小林義典, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

Problems and construction of the future medicine medicine cooperation to have of the health insurance pharmacy in 28-P4AM-029 Tegafur gimeracil oteracil potassium combination anticancer agent (TS-1) formulations
古野龍也1, 持永早希子1, 江本晶子1, 柏田知美2, 荒金尚子1,2, 木村晋也2, 藤戸博1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

Evaluation of the antiemesis therapy of 28-P4AM-030 myelodysplastic syndrome therapeutic drug azacitidine
中村勝之1, 野田師正1, 沖田憲司2, 高田弘一3, 井山諭3, 佐藤勉3, 瀧本理修3, 小船雅義3, 加藤淳二3, 池田博4, 林敏昭4, 石田禎夫4, 篠村恭久4, 中田浩雅1, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

The thing which we saw from the fact-finding of patients who received 28-P4AM-031 cancer chemotherapy
小林誠一1, 内田佳菜子1, 新井三紗子1, 銭場愛彦1, 丸岡浩太1, 梅澤仁美1, 伊代田萌子1, 原幸子1, 岩佐桂子1, 長嶋一泰1, 足立孝1, 坂口修治1, 山下敦1, 富沢裕之1, 西尾益治3, 菅野和彦1, 加賀野井純一2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

	Fact-finding of our House in the 28-P4AM-032 moderate emetic risk regimen 倉橋基尚1, 上田綾佳1, 中尾祐子1, 眞継賢一1, 上田浩貴1, 黒岩勇人1, 林万紀子1, 塚本泰彦1, 松本里佳2, 柳原一広3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

	Look at the rear in the present conditions of our examination ... House about the need of aprepitant in the 28-P4AM-033 breast cancer AC therapy; discussion ... from a mark investigation 後藤敏也, 高屋敷奈々, 廣瀬和昭, 鈴木直哉, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2014.

	Examination about the protective efficacy of the hot compress for vascular disorder of the 28-P4AM-034 Fosaprepitant 今津邦智, 中田恭子, 中野愛子, 岩見裕信, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

	About a risk factor of retching, the vomiting expression in patients who received 28-P4AM-035 (R-)CHOP therapy first time 小松弘幸, 加藤梢, 石尾有司, 藤原沙緒里, 八幡弘子, 桂川みき, 小林龍, 小原秀治, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

	Presence or absence of fact-finding - retching vomiting expression of antiemetic about the proper use at the 28-P4AM-036 cancer chemotherapy enforcement and factor analysis - 佐藤麻美子1, 杉浦宗敏1, 中島由紀1, 大谷道輝2, 山村喜一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

Examination of the factor to contribute to the effectiveness of the antiemetic drug to 28-P4AM-037 moderate degree emetogenicity risk TC therapy
栗原竜也1, 向後麻里2, 安田礼美1, 持田早織1, 東野真弓1, 山下祥子3, 佐々木瞳1, 奥山裕美4, 石井正和1, 米山啓一郎5, 中村清吾4, 木内祐二3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

Examination of the factor to contribute to the effectiveness of the antiemetic drug to 28-P4AM-038 altitude emetogenicity risk FEC therapy
栗原竜也1, 東野真弓1, 持田早織1, 安田礼美1, 佐々木瞳1, 山下祥子2, 向後麻里3, 奥山裕美4, 石井正和1, 米山啓一郎5, 中村清吾4, 木内祐二2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

	Backward investigation about CINV in the hematopoietic stem cell transplantation previous treatment that we included 28-P4AM-039 elderly people in 宮本俊一1, 宮本鋼2, 小島理絵3, 吉岡まみ1, 佐藤衛1, 森淑子1, 宮腰重三郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2014.

Evaluation of the expression situation and the quality of life of the adverse event at the 28-P4AM-040 hepatic artery chemistry embolus therapy (TACE) enforcement
原田桂作1,3, 末吉宏成1,3, 米倉紀子1, 坂本佳子1, 野口純也2,3, 木戸川秀生2,3, 岡本好司2,3, 村本眞由美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

	Examination about the effectiveness of olanzapine to use in 28-P4AM-041 antiemesis purpose 田中喜倫1, 久保田康生2, 熊井正貴2, 齋藤佳敬2, 河合祐輔1, 笠師久美子2, 山田武宏2, 上野英文1, 田巻知宏3, 井関健2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

Examination about the effect of the antiemesis therapy for the moderate emetic risk chemotherapy in patients with 28-P4AM-042 progress, recurrent colon cancer
小山佐知子1,7, 荒川裕貴2,7, 佐藤由美子3,7, 牛膓沙織4,7, 江尻将之5,7, 築山郁人5,7, 久田達也2,7, 板倉由縁6,7, 森一博1, 勝見章男8
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

	Examination about the effectiveness of the antiemetic drug in 28-P4AM-043 bone, the soft part tumor chemotherapy 堀勇太1, 坂本昭夫2, 安藤翔治3, 後藤隆1, 山下愛登1, 上村宅司1, 下村真代4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

	Comparison of the antiemesis effect of palonosetron and granisetron with the diet intake situation in the 28-P4AM-044 cancer of the esophagus FP therapy as end-point 佐藤佑一朗1, 早坂州生1, 竹内公美1, 高橋宏明3, 細川正夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

	Antiemesis effect investigation of granisetron and palonosetron in the 28-P4AM-045 colon cancer chemotherapy (moderate emetic risk) 足立茂樹1, 谷沢克弥2, 遠藤秀治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2014.

	Effect on carboplatin combination therapy comparison of granisetron and palonosetron in patients with 28-P4AM-046 lung cancer 橋本早苗, 松浦佳代, 廣畑秀記, 酒井克紀, 浦川龍太, 福田英克, 南波勝栄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

	The use actual situation of high-dose granisetron for retching, vomiting at the cancer chemotherapy in patients with 28-P4AM-047 infantile acute lymphocytic leukemia 中尾將彦, 吉田徹也, 山崎直樹, 大谷司, 竹内昌司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

	1 case that caused an anaphylactic symptom by 28-P4AM-048 5HT3 receptor blocker administration 加藤秀明, 辻愛美, 白崎由貴, 西出洋志, 坂井伸成, 中村尚未, 宇野美津江, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

	Injection site disorder measures second report of the Fosaprepitant in patients with solid cancer given 28-P4AM-049 chemotherapy 辺見光利1,2,3, 和久井章男1, 近藤達郎1, 遠藤美貴子2, 浅野幸代2, 戸倉英之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

Examination of the effect of aprepitant on chemotherapy-induced retching, vomiting in patients with 28-P4AM-050 AC therapy enforcement breast cancer
幕田龍1, 辻大樹1, 金容壱2, 山本圭祐3, 池田翠1, 羽鳥正浩1, 横井茉里1, 大嶽亜季1, 井上和幸1, 平井啓太1, 中道秀徳3, 塩川満3, 伊藤邦彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

Examination about the choice of the NK1 receptor blocker for the purpose of the vascular disorder reduction at 28-P4AM-051 epirubicin component regimen enforcement
平出耕石1, 竹内賢2, 坂下文夫2, 小林洋子3,4, 鈴木文子3,4, 篠崎里水3,4, 今関孝子1, 櫻井賢治郎1, 加藤武司1, 尾関豊2,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2014.

	Examination of the usefulness of aprepitant in the 28-P4AM-052 cervical cancer CCRT therapy 守屋千秋1, 芝崎由美子1, 中山季昭1, 横田治重2, 中村益美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

It is the effect of the change to the palonosetron hydrochloride for the 28-P4AM-053 moderate degree emetogenicity risk anticancer agent
柿本智広, 野間口寛, 桐野玲子, 中島誠, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 福元裕介, 池ノ上知世, 坂元優太, 平田りか, 寺師守彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

	Examination of dexamethasone optimum doses after the chemotherapy next day with the anticancer agent with 28-P4AM-054 moderate degree and the extensive emetic risk 高林真貴子, 樋口真衣子, 志村裕介, 橋本千明, 大井佳子, 平原佑季子, 原祐輔, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

	Effect to give to blood glucose level of dexamethasone to use together by the cancer chemotherapy in patients with 28-P4AM-055 diabetes merger cancer 福田耕太郎, 嘉屋則子, 東修司, 槙田芳, 岩堀真弓, 金子樹利亜, 小原郁司, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

	Action for the onset prevention of the HBV reactivation in the 28-P4AM-056 Hiroshima west medical center 形部文寛1, 山根有美子2, 平崎奈美枝2, 新美寛正2, 下村荘司2, 八本聖秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

	Action to preventive measures against hepatitis B reactivation with immunodepression, the chemotherapy in 28-P4AM-057 Rousaibyoin, Yamaguchi 小川丈彦1,5, 渡壁美香2,5, 黒川典枝3,5, 河野和明4,5, 竹田克明1,5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2014.

	Examination about the PCP onset prevention by the ST medical mixture remedy at 28-P4AM-058 R-CHOP therapy enforcement 宮部芳之1, 土本暁斗1, 山口雄士1, 佐藤和也1, 佐野彩女1, 兼松友紀1, 長谷部千夏1, 柏毅彦1, 岩井雅則2, 花村明利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

	The pre-Abo id example that hepatitis B reactivation measures to occur by immunodepression, the chemotherapy in our 28-P4AM-059 House and a ward pharmacist were involved in 阿部真也1, 齋藤雅俊1, 斎藤太寿1, 小林彦登1, 岩田耕一郎1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

	Review and many types of job cooperation ... of action ... supportive care for the dermatopathy reduction of the 28-P4AM-060 cetuximab panitumumab 高取裕司1,2, 牛膓沙織1,2, 新井孝文1,2, 岸田清子1,3, 桂川健司4, 安藤与里子5, 池上信昭2, 米山文彦1,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

Effect of the pharmacist intervention on dermatopathy of the use of antiEGFR medicine patients in 28-P4AM-061 colon cancer
小柴聖史1,2, 磯知輝1,2, 堀井一輝1, 菊地麻里2, 今田春子2, 原美里2, 高橋啓子2, 根上真理2, 菅尾高裕1, 飯島克順2, 小池道明1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

	Approach to the dermatopathy with the 28-P4AM-062 EGFR inhibitor 水上康弘, 田村健悦, 石倉一樹, 平賀元 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

	Action to standardization of dermatopathy treatment with the 28-P4AM-063 epidermal growth factor receptor tyrosine kinase repressor 竹内小百合1, 畑田万紀子2, 小園亜希1, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2014.

	Inspection of the prophylactic effect of the moisturizer application for the purpose of the reduction of the dermatopathy with 28-P4AM-064 erlotinib 宗村盛1, 鈴木豊史2, 藤井瑞恵1, 井上真由美1, 長島修3, 深水啓朗2, 伴野和夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

	Making and evaluation of the 28-P4AM-065 "cutaneous symptom check sheet" (Iressa Erlotinib) 佐藤知香1, 横田学2, 田中麻衣子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

Example that a change to capecitabine cisplatin trastuzumab combination therapy was effective in the 28-P4AM-066 eruption onset after S-1 cancellation
緑川武志1, 山本健1, 川田史朗1, 林すみれ1, 本多義弘1, 中村彰子1, 町田亜美1, 上野恵美子1, 前田拓哉1, 木村祐2, 西沢春彦3, 三上二郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

	28-P4AM-067 cetuximab, the expression situation of the hypomagnesemia by the panitumumab and future problem 七條ゆかり, 組橋由記, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

	1 case that continued cetuximab while repeating a low Mg blood symptom of 28-P4AM-068 Grade3 小林馨, 格谷美奈子, 高木昭佳, 高橋則正, 屋木裕太, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

	The expression situation of the hypomagnesemia by the 28-P4AM-069 panitumumab and examination about the treatment success period 小中健, 森剛志, 柴田高洋, 西迫寛隆, 中村敏己, 寺岡和彦, 川添和義, 水口和生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2014.

	Examination about the expression situation and measures of the hypocalcemia in 28-P4AM-070 denosumab treated patients 櫻下弘志, 増田有紀, 真志田絵美子, 佐伯康之, 木村康浩, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

	Examination of the important factor affecting the onset of hypocalcemia in 28-P4AM-071 denosumab treated patients 横山峻太, 岡村和彦, 佐々木雄啓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

	Examination of the risk factor of the onset of hypocalcemia in 28-P4AM-072 denosumab treated patients 工藤香澄, 中居肇, 猪股英幸, 高橋明, 中村一成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

	1 case with suspected cardiotoxicity with 28-P4AM-073 5-FU 牧智恵子1, 後藤愛実1, 細見誠1, 花房加奈恵1, 西原雅美1, 勝間田敬弘1, 寺沢哲志2, 後藤昌弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

	Examination of the cardiotoxic expression situation with the 28-P4AM-074 epirubicin administration and the need of the cardiac activity evaluation 藤田さやか1, 松原美紗1, 稲益里映2, 藤丸博紹1, 馬場美樹3, 田中喜久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

	Usefulness of the cardiac activity monitoring system at the 28-P4AM-075 trastuzumab administration 稲益里映1, 松原美紗2, 原田さやか3, 藤田さやか2, 埋金朋子6, 高尾壽美恵4, 堤えり子5, 田中喜久7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2014.

Fact-finding of the TPF therapy as the induction chemotherapy for the 28-P4AM-076 advanced head and neck cancer and report of the side effect expression situation
芦崎雅之1, 早坂州生1, 北山秀則1, 柴田由美1, 田中怜奈1, 千葉里織1, 出町拓也1, 竹内公美1, 渡邉昭仁2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	Toxic examination at the 28-P4AM-077 pemetrexed chronic administration 佐々木由香1, 杉枝里香1, 安森奈緒子2, 坂本由希子1, 林稔展1, 瀬戸貴司3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	Side effect investigation according to the bevacizumab dose for patients with 28-P4AM-078 colon cancer 松谷和子1,2, 松尾多恵1, 廣瀬幸一2, 山下剛史郎2, 北村瑞穂2, 池永雅一3, 木村真策1, 南橋かおる2, 長谷川順一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	Investigation about the side effect expression situation of the FOLFIRINOX therapy in the 28-P4AM-079 Sapporo public welfare hospital 須藤大雄1, 小原秀治1, 小林龍1, 下山光一1, 高橋栄2, 阿部雅一3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	Examination about the non-blood toxicity of the preoperation / introduction Docetaxel + Cisplatin + 5-Fluorouracil (DCF) therapy for the 28-P4AM-080 squamous cell carcinoma of esophagus 坂本かおり1, 菅原充広1, 堅田親利2, 厚田幸一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	Analysis of the dose setting rule factor in the 28-P4AM-081 FEC therapy 杉本佳澄1, 宮地紗央1, 下枝貞彦1, 里村藍子2, 永村陽一郎2, 若林雅人3, 滝沢康志4, 堀治2, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2014.

	28-P4AM-082 The onset of acute phase side effect situation in our hospital outpatient department cancer chemotherapy 天野佑, 渡瀬美登里, 柏田匡広, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

	Investigation about the symptom after the millimeters plastic Japanese spaniel administration for the 28-P4AM-083 hepatocellular carcinoma 安藤舞, 宮澤憲治, 後藤拓也, 井上裕貴, 竹内正紀, 吉田知由, 松本修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

	Examination about the side effect expression of vincristine situation which the combination with the 28-P4AM-084 azole system antifungal agent gives it to 渡邊詩由子1, 金子るみ2, 下枝貞彦1, 里村藍子3, 永村陽一郎3, 堀治3, 太田伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

	About hiccups expression with the 28-P4AM-085 cancer chemotherapy and the correspondence 西和哉, 阿部浩幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

	Example that pregabalin was effective for intractable hiccups with the 28-P4AM-086 cancer chemotherapy 田中麻理子1, 明石直子1, 平岡暖子1, 吉野宗宏1, 田中三晶1, 鏡亮吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

	Example that showed hiccups at the 28-P4AM-087 DCF therapy enforcement, but followed the good course by suggestion of the appropriate supportive care 吉田裕生, 津曲恭一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2014.

Investigation about the risk factor of the hiccups induced at CHOP in patients with 28-P4AM-088 malignant lymphoma and the CHOP homeotherapy enforcement
兼松哲史1, 森章哉2, 向山直樹3, 加藤知次4, 羽田勝彦5, 冨田敦和5, 惠谷里奈5, 宮澤憲治6, 中村あゆみ6, 田中佑佳7, 池田義明8, 福井愛子9, 横山聡10, 中村英明1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

	Analysis of the taste alteration with the 28-P4AM-089 breast cancer chemotherapy 田頭尚士1, 岡崎ちか2, 松本梨早2, 河内啓子2, 原文堅3, 石川徹4, 二五田基文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

	Relation of the pharmacist to the mouth care of patients who received 28-P4AM-090 cancer chemotherapy 畠山浩明1,2, 倉澤弘樹1, 大井徹1, 奥山秀樹2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

	28-P4AM-091 Usage and side effects expression status of Regorafenib Hydrate in our hospital 上森美和子1, 杉浦孝司2, 朴美和3, 加藤文3, 坂井大介4, 佐藤太郎4, 林太郎3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

	1 case that is given Dasatinib / Nilotinib alternating therapy for side effect reduction for 28-P4AM-092 Imatinib-resistant CML-CP 馬場祐一郎1, 西ひかり1, 古賀友香里1, 藤田和彦1, 松野文彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

	The case that was hard to take medicine, and became able to take medicine by the blood level monitoring by the pharmacist for patients with GIST by the 28-P4AM-093 imatinib side effect 西迫多重1, 服部晋司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2014.

Trial investigation ... in intervention ... many institutions of the pharmacist using the treatment support tool for the 28-P4AM-094 hand-and-foot syndrome
藤堂真紀1, 梅村由香利2, 鈴木善貴3, 山本倫久4, 伴竜典5, 筒井裕子6, 田中麻衣子7, 鈴木さやか8, 横田学9, 寺西二三代10, 遠山幸男11, 松浦克彦1, 勝見章男12
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

	Use fact-finding of the rasburicase in the 28-P4AM-095 our hospital 宮脇未来1, 藤井千賀1, 安井友佳子1, 松浦愛2, 石坂敏彦1, 八野芳巳1, 柴野賢2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

Investigation about drug costs used as measures medicine for mucositis, dermatitis to be caused at the CDDP + RT therapy enforcement of the 28-P4AM-096 head and neck cancer domain
藤原大一朗1,2, 眞下惠次1,2, 木村佳世1, 野田明宏1, 武田朋也2, 椿正寛2, 西田升三2, 阪口勝彦1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

	Participation of the pharmacist in treatment with cetuximab for 28-P4AM-097 head and neck cancer 森善洋1, 吉岡大樹1, 藤田有紀子1, 木下真理子1, 佐道紳一1, 岩永哲2, 吉村敏朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

	Usefulness of telephone support (Xtra) to the 28-P4AM-098 capecitabine internal use patients 熊澤崇, 佐々木紀彰, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

Relation to a side effect investigation and drug control before and after the bevacizumab combination to carboplatin / pemetrexed therapy in patients with 28-P4AM-099 non-small cell lung cancer
高田寛奈1, 梅原健吾1, 池本舞2, 若本あずさ1, 初山多恵1, 佐藤秀紀2, 早川達2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2014.

	Relation of the supportive care to 28-P4AM-100 XELOX therapy patients 堀敦雄1, 祖父江伸匡1, 佐野亜紀2, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

	Risk factor analysis of the serious neutropenia with 28-P4AM-101 carboplatin and the pemetrexed combination therapy 平野めぐみ1, 渡邊裕之1, 池末裕明1, 池田宗彦1,2, 近森綾子1, 山田剛3, 江頭伸昭1, 増田智先1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

	Grasp of the blood toxicity and the intensity of treatment in the initial FEC100 therapy in our 28-P4AM-102 House 住谷達也, 阿部多一, 落合里枝, 柳内亮祐, 井口恵美子, 猪俣克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

	Effect on myelosuppression by the simultaneous combination of 28-P4AM-103 chemoradiotherapy and tubercle bacillus heated water extract (answer note) 細井一広1, 中川潤一1, 太田真帆1, 阿保成慶1, 川村広明1, 照井一史1, 板垣史郎1,2, 早狩誠1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

	Examination about the case that anticancer agent administration affected PT-INR in patients with gynecologic malignancy with the 28-P4AM-104 venous thromboembolism 吉田理, 草野淳一, 佐伯佳奈, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

Fact-finding of the prophylaxis situation of the antithrombotic drug in the 28-P4AM-105 lenalidomide administration and the test value monitor situation of solidification, the fibrinolytic system
高橋誠, 別府竜弥, 堤一貴, 松本浩一, 中垣春美, 三輪涼子, 有馬千代子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2014.

	The effect that 28-P4AM-106 serum albumin gives to the clinical response of antibiotics 松木祥彦, 大貫敏明, 安田麻美, 浅井浩子, 高橋優香, 岩佐典子, 杉浦健一, 中村友美, 畦元智子, 藤岡敬子, 小関崇文, 小林健太郎, 西關由梨子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	Examination about the effectiveness of 28-P4AM-107 levofloxacin and the safety 冬頭美加1, 松尾和廣1, 平山忍2, 木村伊都紀2, 横尾卓也2, 花井雄貴2, 佐々木英久1, 渡辺朋子1, 篠原悦子1, 小杉隆祥2, 西澤健司2, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	Examination about the substrate specific expansion type beta lactamase production bacteria and antimicrobial choice in our 28-P4AM-108 House 小川直紀1, 佐藤渚1, 谷古宇修平1, 新井直子2, 香取哲哉1, 出雲貴文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	Investigation of the incidence of 28-P4AM-109 injection antimicrobial and Clostridium difficile-related loose bowels 松本芳信1,2,3, 佐野雅昭1, 平田勝美2, 松島由美3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	Fact-finding of Clostridium difficile infection treatment in our 28-P4AM-110 House 岡村祐嗣1, 高橋志織1, 津山博匡1, 木村正彦2, 板垣史郎1, 萱場広之2, 早狩誠1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	Action for the proper use for the 28-P4AM-111 C.difficile symptom (CDAD) treatment 安井友佳子, 大谷典子, 山本圭城, 塚本あゆみ, 石坂敏彦, 八野芳巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2014.

	It is ... for the making of use situation - inside the hospital dosage guideline of the Clostridium difficile association loose bowels therapeutic drug in our 28-P4AM-112 House 後藤啓之, 吉井智, 長谷川翠, 工藤琢也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	About the outbreak of the Clostridium difficile infection that we experienced with a change of the infection prophylaxis antimicrobial after 28-P4AM-113 technique 柳橋秀行, 都築はる奈, 林昭子, 宮内智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	Examination of the infection risk factor in patients with 28-P4AM-114 rheumatoid arthritis 若松健太郎, 内匠紘子, 福竜太朗, 内村仁美, 岩下健一, 永瀬ゆり子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	Examination of aciclovir note appropriateness doses for the 28-P4AM-115 elderly patients herpes zoster 鶴島克将, 安井友佳子, 石坂敏彦, 八野芳巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	Use of antimicrobial situation investigation in the 28-P4AM-116 perioperative period 吉田奈央1, 野口周作1,2, 宮田広樹2, 此松晶子1, 東さやか1, 宮内秀典1, 竹内崇浩1, 望月徹1, 笠原英城1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	Evaluation of the surgical-site infections protective efficacy by weight differences and 28-P4AM-117 cefazolin treated patients 中村友香1, 東修司1, 田中悠季2, 吉田直哉1, 河合武尊1, 岩堀真弓1, 小原郁司1, 小寺隆二1, 妻木良二1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2014.

	Investigation, examination about the use of pediatric DAP case in our 28-P4AM-118 House 小山智代1, 岡村央1,2, 小池博文1, 西川能治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	Pharmaceutical intervention example to patients with purulent spondylitis in the 28-P4AM-119 orthopedics ward 高田正弘, 井上登美子, 鈴木光明, 高梨真希子, 木下優子, 加藤有希, 森下和美, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	One case that they presented with 28-P4AM-120 epidural abscess, and suffered from treatment 川口奈緒美1, 佐々木暢琢1, 武田真輔2, 福島達樹2, 木村匡男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	One patient who controlled TEIC with a high trough value for purulent spondylitis by the MRSA with suspected the 28-P4AM-121 DAP insusceptibility, and cured 工藤正治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	The use situation of the linezolid in the 28-P4AM-122 cranial nerve center 落合愛子, 細見亜里沙, 平井満子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	1 case that linezolid was effective for MRSA osteomyelitis after 28-P4AM-123 bone fusion 栗崎貴啓1, 和田吉晴1, 久米慎一郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2014.

	One case that supported a super old fulminant form skin soft tissue infection in cooperation with the 28-P4AM-124 other types of job early 藤原信二1, 綺田尚久1, 三田村由枝2, 中村忠之3, 増田鋼冶4, 原田吉将5, 西嶋長1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

	Examination of the ethanol lock therapy for the catheter-associated bloodstream infection related to Candida sp. which developed in the indwelling patients for 28-P4AM-125 central venous catheter long term 福田詩織1,2, 小澤美紀2, 小杉依子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

	One case that produced tongue discolouration, dysgeusia by linezolid administration for the 28-P4AM-126 suppuration-related discitis 中村翔吾1, 瀬戸崇光1, 中村有理1, 寺沢匡史1, 仁田史人2, 内山ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

1 case that was given a Mu col symptom during induction therapy for 28-P4AM-127 ALL for a high-dose long term of suspicion L-AMB
大橋養賢1, 木村有揮1, 廣瀬祥子1, 森達也1, 小川千晶1, 宮野早苗1, 高橋郷1, 工藤浩史1, 矢田部恵1, 佐藤信恵1, 五十嵐彩香1,2, 佐藤美佳子1, 朴載源2, 上野博則2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

	Evaluation of the antimicrobial proper use promotion activity by the ICT round that linked 28-P4AM-128 antimicrobial registration system 三浦遼子1, 並木弥生2, 上田竜大3, 川原千香4, 永井香織4, 佐藤哲夫3, 中村裕義1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

	It is built the antimicrobial regime in connection with ICT led by 28-P4AM-129 ward charge pharmacist 山村伸枝, 中野克哉, 筒井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2014.

	Inhibition measures of the carbapenem system antimicrobial consumption by the cooperation reinforcement of the 28-P4AM-130 drug department, infection department and the effect 塩田智子1,3, 谷長美菜子1, 高橋一栄1,3, 堀田剛2, 高倉俊二2,3, 足立幸人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

	Role of the ICT pharmacist for the treatment of the purulent spondylitis in the 28-P4AM-131 cerebral blood vessel medical center 永井徹, 原弘士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

	It is evaluated the effectiveness with the early administration method and prophylaxis method of the antiviral drug for the prevention of the cytomegalovirus infection after 28-P4AM-132 kidney transplantation 山下浩平, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

Factor search to give to a clinical response of antithrombin preparation for the 28-P4AM-133 sepsis-related DIC and the recombinant thrombomodulin combination therapy
森川祥彦1, 榎屋友幸1, 村木優一1, 岩下義明2, 畑田剛2, 今井寛2, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

	The use situation of the antiinfluenza medicine in the 28-P4AM-134 pediatric initial emergency institution 木村誠1, 石橋和人2, 石田明人2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

	Examination of the antimicrobial proper use in the active intervention by the 28-P4AM-135 infection prevention team 平田備子1,7, 山本真子1,7, 中尾英樹2,7, 西野雅美3,7, 木南佐織4,7, 大西尚5,7, 戸部智6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2014.

	Intervention effect of the pharmacist to 28-P4AM-136 ICT antimicrobial conference 菅野雄太1,2, 中谷紀之1,2, 塚本英範1, 小林俊之1, 三宮乙恵1, 土師美和1, 米澤和彦1, 高橋文彦3, 本川聡2, 森本淳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

The action of the infection measures team about preventive measures against 28-P4AM-137 infection duties and role of the pharmacist
後藤義之, 増林千尋, 西上真, 深見聖也, 若林奈織子, 鈴木里佳子, 本田太朗, 永森理美, 石崎真由美, 岡田久美, 角紀一郎, 森戸敏志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

	Making and evaluation of the round sheet for the 28-P4AM-138 patients-centered infection measures 土屋亜由美1, 峯村純子2, 内藤結花2, 大戸祐治5,7, 吉川雅之1, 前田真之3, 宇賀神和久4, 詫間隆博6, 石野敬子3, 二木芳人6, 村山純一郎2,7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

	The proper use round enforcement of the injectable antimicrobial administration case by the 28-P4AM-139 pharmacist and the effect 北村好申1,2, 篠崎陽一1, 北村正樹1, 河野真二2, 中澤靖2, 川久保孝1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

	The need of the intervention of extraction and the ICT of problems for ESBL detected in our 28-P4AM-140 House 城尾晃太1, 寺本晴美1, 近谷理恵子1, 田中慎1, 菊田真穂2, 北垣瞬2, 石原由貴2, 砂町美沙2, 馬瀬久宜1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

1 case that complicated L4/5 purulent spondylitis following MRSA sepsis that 28-P4AM-141 ICT intervened in continuously
村松英彰1,9, 小林美絵1,9, 田村純2, 西田達也3, 神田明浩4,9, 鈴木裕子4,9, 鈴木こなみ5,9, 牧田道明1, 小林政英6, 佐藤雅樹7,9, 柴田幸信8,9
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2014.

	Proper use of the 28-P4AM-142 perioperative infection prophylaxis antimicrobial 違口晴子, 谷川まり子, 大西加奈子, 高見一徳, 寺元真那, 吉田善子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	Appropriate effect of prophylactic antimicrobial administration and SSI treatment on 28-P4AM-143 spinal operations SSI 松永智子1, 吉田豊1, 福井良枝2, 今村昌美3, 志水貴1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	Effect on in-hospital guideline compliance and sensitivity rate by the support function addition to 28-P4AM-144 injection instructions input screen 新山哲央, 森山史就, 安食健一, 園山智宏, 福田恵美子, 横手克樹, 平野榮作, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	Approach for the antimicrobial proper use using 28-P4AM-145 infection management support system (BACT Web (R)) 大橋健吾, 松岡知子, 森卓之, 吉田真也, 大塚崇史, 篠田康孝, 高田裕子, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	About a held effect of the antibacterial chemotherapy learning society for 28-P4AM-146 new face pharmacists 鳥取部和弘1, 寺町文宏1, 三浦尚子1, 楠田絵梨1, 齋藤友亮1, 有島勉1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	Activity of the link staff in our 28-P4AM-147 House 饗庭孝一1, 菊池裕子2, 北村卓麿1, 斎藤彩1, 長谷川和正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2014.

	28-P4AM-148 "preventive measures against infection in the psychopathic ward" 小口正義1,2, 池上由美子2, 藤森愛子1,2, 小口はるみ2, 依田祐介2, 藤森洋子2, 跡部治1, 立花直樹2, 蜂谷勤2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

	Examination of the satisfaction of addition category and the staff for preventive measures against 28-P4AM-149 infection 三浦布紗子1, 木村修徳1, 永野真久1, 安森奈緒子1, 井上大奨1, 平木洋一1, 辻泰弘2, 神村英利4, 加留部善晴3, 河野文夫5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

	Relations with the consumption of the same POT type detection ward and finger disinfectant of 28-P4AM-150 Pseudomonas aeruginosa 森下拓哉1, 後藤拓也1, 早川恭江2, 松本修一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

	Investigation of the number of the MRSA detection and the number in our 28-P4AM-151 center of hand hygiene enforcement 枦秀樹, 菅野彩那, 鈴木俊一郎, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

	For vaccination rate improvement for the staff less than the personal titration and normal value of measles, rubella, chickenpox, the mumps in our 28-P4AM-152 hospital personnel 尾形和哉1, 橋本隆信1,2, 竹内亜紀2, 岸由希枝2, 西谷百里子2, 中園雅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

Operational improvement by the antiHIV medicine offer system and community medical care cooperation after a needle pad cut wound, the skin mucous membrane exposure that collaborated with 28-P4AM-153 local government
田上直美1,2, 市川康子1, 嘉村基樹1, 下村光一1, 中村嘉久太1, 松井法子1, 木村亜由美2, 中田浩智2, 宮川寿一2, 松下修三3, 友枝沙紀4, 財津和宏4, 満屋裕明2, 齋藤秀之2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2014.

	Fact-finding in the oseltamivir prophylaxis to the 28-P4AM-154 staff 立川奈保美, 岩崎瑛子, 伊藤千恵, 大津由美子, 藤田敬子, 坂上嘉浩, 室井政子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	Action to hepatitis B vaccination for the 28-P4AM-155 hospital personnel 森田淳介1,2, 井川紗希子2, 安野朝子2, 伊藤典子1, 山賀章一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	It is a change by the pharmacist intervention about the pneumococcal vaccine inoculation of the patients after the splenectomy in our 28-P4AM-156 outside Parliament course 山崎洋平1, 鐵野麻美1, 新沼芳文1, 本郷文教1, 中村文隆2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	Evaluation - from the present situation and the physician questionnaire of our role - House of the pharmacist in the 28-P4AM-157 foreign tour vaccination 渡辺暁子, 兒玉美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	Contribution of the pharmacist to the 28-P4AM-158 de novo hepatitis B measures guidelines observance 筒井健一, 後藤志典, 林幹也, 山崎博子, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	1 case of HIV infection with the 28-P4AM-159 dissociative disorder 大道淳二1, 石橋真実1, 横田幸子1, 佐久川亮2, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2014.

	Examination about the change over time of the 28-P4AM-160 antiHIV medicine tenofovir and renal tubules phosphorus reabsorption rate 日笠真一1, 安田恵1, 秀田恭子1, 日笠聡2, 澤田暁宏2, 徳川多津子2, 木村健1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

	Report of the use of studio (R) combination lock case to rebuild in our 28-P4AM-161 House 藤井健司1, 藤田啓子1, 畝井浩子1, 山崎尚也2, 斉藤誠司2, 藤井輝久2, 木村康浩1, 木平健治1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

Fact-finding about the effect that pharmacist intervention in the 28-P4AM-162 HIV infection practice results in to the medical person side
國本雄介1, 吉野宗宏2, 大石裕樹3, 原田幸子4, 井上正朝5, 内山真理子6, 齋藤直美7, 丸山一郎8, 下川千賀子9, 畝井浩子10, 松本俊治11, 千田昌之12, 増田純一13, 佐藤麻希13, 和泉啓司郎13, 宮本篤1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

	Concomitant drug investigation of the 28-P4AM-163 antiretroviral therapy (ART) patients 下川千賀子, 安田明子, 林志穂, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

	Fact-finding of the medical therapy for HIV infection in our 28-P4AM-164 House 二宮洋子1,2,3, 黒川温子1, 玉井恭子1, 渡邉三恵子2, 西村瑞穂2, 徳永博俊3, 和田秀穂3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

	Stability evaluation of mullah biRoch to apply the 28-P4AM-165 simple suspension method 和田美紀, 矢倉裕輝, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2014.

The role to be assumed by the pharmacist for patients on dialysis using 28-P4AM-166 nutrient for intestinal administration and the practice
岡田孝之1,3, 法橋純子1, 世良有雅1, 加茂美智子1, 青山恵未2, 高木好夫1, 原田慎一3, 中本賀寿夫3, 阿瀬井宏一1, 徳山尚吾3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

	An intervention effect and pharmacist intervention example of NST for the 28-P4AM-167 decreased renal function patients 早川兼司, 村越南, 鈴木美千代, 小島圭太, 多田哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

	1 case that caused hyperglycemic hyperosmolar coma during 28-P4AM-168 enteral feeding management 宮田治奈, 平岩歳久, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

	Fundamental researches about the gastric emptying of 28-P4AM-169 half solidification enteral feeding materials and the blood sugar change 豊田行康1, 加藤顕子1, 笹原詩織1, 二村由里子2, 戸田州俊3, 加藤隆文4, 伊藤由紀4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

Evaluation of the enteral feeding tube occlude prevention using the 1% sodium bicarbonate solution in the 28-P4AM-170 digestive organ surgery ward
村地康1, 若林亜耶1,2, 森本啓太1,2, 勝浦正人1,2, 中土居智子3, 門脇裕子1, 竹上学1, 大石雅子2,4, 和佐勝史2, 三輪芳弘1,4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

	28-P4AM-171 Experiment about the evasion of the tube obstruction in the simple suspension method About Aspara potassium 長尾彰太, 新康憲, 森田聡子, 辻隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2014.

	About the effect that rate of application of the 28-P4AM-172 lipid microsphere gives to a liver enzyme, C-reactive protein and lymphocyte counts 大塚淳一, 平間明子, 蔭山博之, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	One case that vitamin K included in the 28-P4AM-173 lipid microsphere was thought to affect the anticoagulant action of warfarin 鈴木美央, 湯川玲奈, 柳原良次, 奈良克彦, 高田龍平, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	Action avoiding 28-P4AM-174 warfarin and interaction of the natto 高橋望月, 岩佐千尋, 小林つば紗, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	The effect that 28-P4AM-175 preoperative alimentation of immunity gives to the immune system of patients with gastrointestinal carcinoma 鈴木彰人1, 白尾一定2, 本吉佳世3, 武田朋子3, 花牟禮富美雄4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	Examination about the dose of vitamin B1 at long-term central venous hyperalimentation enforcement in 28-P4AM-176 elderly people 阿部孝行1, 倉林誠1, 高木淳子1, 池井良貴1, 山田英俊1, 小村博昭2, 櫻谷憲彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	Use situation investigation of the cyanocobalamin parenteral injection to the total gastrectomy patients in our 28-P4AM-177 House 石原祥史1, 久松大介1, 松本智史1, 大澤啓子1, 林昌俊2, 林晴美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2014.

	The need of NST in the 28-P4AM-178 abdominal aortic aneurysm stent graft treatment 加藤恭平, 香取哲哉, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

	Effect ... of the intervention to the aggressive pressure sore measures team of activity - pharmacist of the pressure sore measures team in the 28-P4AM-179 Tsurumakionsen Hospital 高橋麻衣, 新枦義之, 仲里梨紗, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

	Examination about the cost-effectiveness of the iodoform gauze in 28-P4AM-180 pressure sore treatment 有泉牧人1, 西村富啓1, 熊井佳代2, 三谷あずさ2, 牧野麻希子2, 佐橋幸子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

	Examination of the physical property of the skin protection powder for the 28-P4AM-181 perianal region sore 廣瀬香織1,5, 土田学2, 村山由美子2, 関徹也3, 笹津備尚5, 関根祐介4, 磯貝博之1, 大西啓5, 奥山清1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

	Use experience of the Japanese hawfinch pre-building triple-drug therapy in 28-P4AM-182 chronic hepatitis C 小池彩子1,2, 花房伸幸1, 歳森淳一2, 小橋春彦2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

Safety, the effectiveness of the triple-drug therapy including the Japanese hawfinch pre-building for the 28-P4AM-183 chronic hepatitis
鎌田宏和1, 橋本佑香1, 富士芳美1, 田中陽子1, 木村貴1, 高木麻里1, 藤田敬子1, 坂上嘉浩1, 室井政子1, 井上敦雄2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2014.

	The effectiveness and side effect evaluation of the PEG-IFN / RBV / TMC combination therapy for 28-P4AM-184 chronic hepatitis C 於本崇志1, 塩山亜紀1, 山口英美1, 朝賀純一1, 岩渕修1, 佐藤文彦1, 宮坂昭生2, 滝川康裕2, 川口さち子1, 工藤賢三1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

	Problems ... of the DPI inhalational instruction in comparison between discus (R) (DPI) and aerosol - infantile asthma judging from 28-P4AM-185 long-term peak expiratory flow record 青野珠可1, 山本崇晴2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

Examination of the dissolution at simple suspension in the 28-P4AM-186 theophylline controlled release dry syrup
秋山滋男1, 毎田千恵子2, 中田いちこ3, 宮東利恵3, 武藤浩司4, 岡村正夫5, 興村桂子2, 久保田洋子2, 西尾浩次3, 礒野淳一1, 宮本悦子2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

	Clinical efficacy analysis based on β 3 receptor binding occupation of the 28-P4AM-187 new hyperactivity bladder therapeutic drug Mirabegron 渡井健, 高柳理早, 木村耕二, 横山晴子, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

	Evaluation of the therapy with 28-P4AM-188 prostatic hyperplasia and selective alpha-1 adrenergic receptor blocker and anticholinergic agent for the patients complicated with a hyperactivity bladder 岩野友香, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

	Search of the factor associated with the effectiveness of the tolvaptan for the 28-P4AM-189 hepatic induced oedema 加藤麻理乃1,2,3, 犬塚涼子2, 築山郁人2, 松浦克彦2, 斎藤寛子3, 大津史子1, 後藤伸之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2014.

	Administration starting dose examination of the tolvaptan in our 28-P4AM-190 House heart blood vessel center and the evaluation 網野一真1, 神戸千紘1, 宮崎雄紀1, 跡部治1, 筒井洋2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	1 case that tolvaptan had a complete response to for 28-P4AM-191 end stage renal failure furosemide-resistant heart failure 空田洋祐, 山崎博史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	Is the change of volume of urine by the 28-P4AM-192 tolvaptan, serum Na and the serum K affected by the renal function? 中西遼, 今泉有希, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	Effective and safe examination of the febuxostat in 28-P4AM-193 children 高本光次郎1, 日笠真一2, 田中邦佳2, 室親明2, 高木信明3, 木村健2, 西本哲男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	The effectiveness of the febuxostat to be able to put according to 28-P4AM-194 CKD stage and safe examination 鈴木一志, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	Examination about the effectiveness of the tocilizumab subcutaneous injection preparation for the 28-P4AM-195 rheumatoid arthritis 曽根本恵美1, 紙谷友里子1, 溝口晶子1, 辻泰弘2, 藤秀人2, 植木幸孝3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2014.

	28-P4AM-196 Questionnaire survey of rheumatoid arthritis patients who have the device change to the etanercept subcutaneously pen-type 西山博隆1, 大島幹弘3, 坪井声示2, 塩浦朋根2, 松山耐至1, 荒木博陽3, 田中亮裕3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	Examination of the effectiveness and the onset risk factor of the venous thromboembolism preventive preparation in the 28-P4AM-197 lower limbs orthopedics surgery 松本千聡, 宮城宣明, 長島章, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	The effectiveness of the drain clamp method using tranexamic acid in the 28-P4AM-198 total knee replacement 森崎崇文1, 星野輝彦2, 塩津和則1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	The use trend of the 28-P4AM-199 rheumatoid arthritis therapeutic drug and action of our House 植田裕也1,2, 宮武敦子1, 三好奈美瑛1, 近藤洸1, 渡邉秀之2, 古川貴弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	Fact-finding of the case using multiple biological drugs in 28-P4AM-200 rheumatoid arthritis treatment 大原雄希, 國本雄介, 佐々木直美, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	The effectiveness, safe examination of the PTH preparation for the 28-P4AM-201 steroid-related osteoporosis 佐々木柚香1, 佐々木英久1, 松尾和廣1, 篠原悦子1, 渡辺朋子1, 真坂亙2, 松澤康雄3, 龍野一郎4, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2014.

	It is result ... after ... ward drug duties start about correspondence to 28-P4AM-202 "antithrombotic therapy in the perioperative period" 山部美千子1, 浦本邦弘1, 小園亜希1, 柴田義浩2, 中川義浩1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

	Relative examination ... (the second report) with TTR estimate method - INR number of measurement and the TTR prediction precision using %INR in the 28-P4AM-203 warfarin potassium internal use case 木村和美1, 細田宏美1, 坂下可奈子1, 山下英治2, 大島茂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

	Relation of the pharmacist for the warfarin potassium proper use that 28-P4AM-204 is easy to fluctuate 川上尚美1, 久岡清子1, 土師久幸1, 吉村隆喜2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

	One case of PBPM which enabled a discharge by the 28-P4AM-205 at-home PT-INR self measurement in the early stage of PT-INR control delinquent patients with the combination of warfarin and miconazole 岡島亜衣1, 矢野亨治1, 紙谷博子2, 葛谷雅文2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

	One case that a pharmacist was associated with in 28-P4AM-206 warfarin overdosage 杉本佳世1, 小林真菜1, 小西恵里香1, 笹谷佳菜子1, 木村訓世1, 大谷綾1, 中尾啓子1, 笹瀬典子1, 金啓二1, 金守良2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

Research about clot embolus incidence and the side effect under the dabigatran chronic administration in patients with 28-P4AM-207 non-valvular atrial fibrillation
西堀優香1, 篠原悦子1, 千葉達夫2, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 横井妙子2, 加藤裕芳2, 吉尾隆1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2014.

	One case that was given dry person blood clotting ninth factor complex preparation for an intracranial hemorrhage-related lesion during 28-P4AM-208 anticoagulation in preoperation 松原ミキ, 内山良子, 鏑木めぐみ, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	The present conditions of association and the epilepsy medical therapy of the factors of the 28-P4AM-209 seriously disabled child (person) 森本真仁1,2, 橋本俊顕2, 浜田茂明2, 京谷庄二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	Evaluation of the effectiveness of the therapeutic drug for the 28-P4AM-210 restless legs syndrome 細田拓矢, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	One case of Parkinson's disease that hydrochloric acid apomorphine subcutaneous injection was effective for off symptom at the 28-P4AM-211 getting up 辻倫子1, 石田翔1, 浜田真二1, 上利大2, 開浩一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	Example that we were able to reintroduce into by driving home to patients with Parkinson's disease that canceled the use of the Rotigotine patch by 28-P4AM-212 application site response skin care instruction 奥野幸子1,3, 木村隆2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	28-P4AM-213 New onychomycosis treatment : Development of Efinaconazole liquids for external use 奥村智広1, 落合明子1, 巽良之2, 薗田良一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2014.

	Manufacture of the in vitro model that paid its attention to a chronic exacerbation factor of 28-P4AM-214 atopic dermatitis 中山洋輔, 毎熊隆誉, 三谷祐生, 岡崎敏幸, 青井功恭, 手嶋大輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	Improvement of the usability of the 28-P4AM-215 petrolatum album and the evaluation 高谷甲波, 大谷道輝, 野澤茜, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	Effect on moisturizing effect that a basis and concentrations in the 28-P4AM-216 urea preparation give 高尾斎昭1, 大谷道輝1, 眞部遥香1, 野澤茜1, 山村喜一1, 江藤隆史2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	Problems in the do-it-yourself importing of the product that Helicobacter pylori infection testing medicine and a therapeutic drug through the 28-P4AM-217 Internet were set 大塚邦子1,2, 内田直樹2, 安原一3, 小林真一2, 細野哲司1, 鈴木啓太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	1 case ... which we were associated with as relation ... ward charge pharmacist of the pharmacist to treatment with pirfenidone in patients with 28-P4AM-218 idiopathic pulmonary fibrosis 花房伸幸1, 佐久川亮2, 別所昭宏2, 森英樹1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	One patient who was treated effectively with tolvaptan for syndrome of inapp ADH secretion due to 28-P4AM-219 chronic necrosis-related pulmonary aspergillosis 中島文, 高武嘉道, 溝田愛子, 坂本やよい, 竹添達也, 山道研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2014.

	One case of the phaeochromocytoma that the good course was obtained by 28-P4AM-221 dexmedetomidine 井上大奨1, 迫田和樹1, 橋本章子2, 橋本聡3, 平木洋一1, 真鍋健一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

	1 case that used Dimethyl sulfoxide (DMSO) for 28-P4AM-222 bladder amyloidosis percutaneously, and was effective 上田浩貴1, 丹生亜希子1, 木村博子2, 橋村孝幸3, 濱口良彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

	It is evaluated protective efficacy of retching vomiting by the Droperidol note addition in IV-PCA and the safety after 28-P4AM-223 technique 石塚寛和1, 川名真理子1, 永井淳子1, 廣井麻代2, 完戸香3, 吉沼裕美4, 関根龍一5, 佐々木忠徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

Drug composition of PCEA after the 28-P4AM-224 pneumoscope lower lungs malignant tumor surgery and examination of the analgesic effect and the side effect
長谷川哲也1, 落合亮一2, 寺田享志2, 大岩彩乃2, 滝口一彦3, 花井雄貴1, 酒井正博4, 小杉隆祥1, 西澤健司1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

The effect that intravenous autoregulation pain relief after the 28-P4AM-225 peritoneoscope lower enucleatic myomectomy or epidural autoregulation pain relief gives to postoperative pain and nausea post-operative, vomiting
伊藤千裕1,2, 上田絢子1, 井上岳1,2, 柏木政憲3, 松原肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2014.

	Analysis about the effect to rocuronium in consideration of the mechanism of action of 28-P4AM-226 sugammadex sodium and vecuronium 木村耕二, 北見茉利英, 横山晴子, 高柳理早, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

Usefulness of the Everolimus introduction in 28-P4AM-227 heart-transplant recipients
松田紗知1, 和田恭一1, 越智純子1, 岩澤真紀子1, 中村慶1, 桑原健1, 堀由美子2, 坪井志穂2, 中島誠子2, 角南春樹2, 佐藤琢真2, 瀬口理2, 簗瀬正伸2, 中谷武嗣2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

	Literature documentation of RCT which evaluated the intervention of the 28-P4AM-228 pharmacist 鈴木拓真, 牧原玲子, 牧野好倫, 岩瀬治雄, 林憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

The enforcement situation of a being on the register roll institution and the duties of the specialized pharmacist in each 28-P4AM-229 domain and the authorized pharmacist
大森尚美, 長島昌嗣, 加藤将朗, 星隆弘, 菅田和也, 安岡俊明, 佐藤博, 柴川雅彦, 土屋文人, 北田光一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

	About usefulness of the 28-P4AM-230 placenta therapy (human placenta cilia split-product injection) 山岡和幸, 高橋美香, 高井大輔, 大山麻由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

	The treatment example that we practiced by the collaboration with the 28-P4AM-231 physician 重成大介1, 速水章一1, 岡野翔1, 坂本和央1, 伊藤桂子1, 森山真実1, 北島彩郁1, 清水勇基1, 川上麻衣子1, 太田明秀1, 佐賀美裕樹1, 大江利治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2014.

	Efficiency of trial secretariat duties in the 28-P4AM-232 iPad introduction 鈴田浩孝1, 福山雄卯介2, 藤田強記2, 後藤史子3, 植村ちひろ1, 大久保嘉則1, 中尾瑞穂1, 三砂義敬1, 床島英雄1, 草葉一友1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	Action of the clinical experimental medicine management of the ICH-GCP conformity in the hospital attached to the 28-P4AM-233 Mie University School of Medicine 太田康之1,2, 小寺真由美1,2, 村木優一1, 田丸智巳2, 西川政勝2, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	The introduction of the temperature uniform management system in the 28-P4AM-234 clinical experimental medicine temperature management and the effect 神田紘介, 室高広, 城正士, 一瀬菜摘, 高比良理愛, 中村忠博, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	Action for clinical studies, the investigational activation and promotion in the hospital attached to the 28-P4AM-235 Mie University School of Medicine 小寺真由美1,2, 太田康之1,2, 村木優一1, 田丸智巳2, 西川政勝2, 奥田真弘1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	A shift to 28-P4AM-236 Performance Based Payment and subsequent problem 山下克也, 林淳一郎, 高本由紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	Is in charge of a trial and IRB from problem - 1996 when the trial to think about from 28-P4AM-237 benefit reciprocity has it; and - 小野敦央, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2014.

	Safety of medicine evaluation - antitumor agents (blood cancer (third report)) judging from 28-P4AM-238 clinical dose, exposure level and avirulent quantity, exposure level - 窪田幸恵1, 斉藤和幸2, 小野俊介3, 児玉庸夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

Clinical trial about the use of the 28-P4AM-239 antiscabietic Stromectol lock [1] - Effect - that administration gives to the effectiveness and safety after a meal
吉増孝嗣1, 英太一1, 木暮聖2, 杉岡晃仁2, 野口航2, 福沢正男3, 廣田孝司1,2, 小茂田昌代1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

	Clinical trial about the use of the 28-P4AM-240 antiscabietic Stromectol lock [2] 英太一1, 吉増孝嗣1, 木暮聖2, 杉岡晃仁2, 野口航2, 福沢正男3, 小茂田昌代1,2, 廣田孝司1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

	We effectively utilize it with the introduction of storage systems of administration such as the poison which linked 28-P1PM-001 order 森光恵, 北出紘規, 北国憲剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

	Action to the inventory control improvement using the 28-P1PM-002 medicine inventory control system 鈴木由奈, 鎌滝真永, 泉雄介, 伊東美歩, 平原一也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

	Preventive measures against medicine expiration in our 28-P1PM-003 corporation 酒井欣嗣1,2, 伴竜典2, 鈴木さやか1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2014.

	Construction and use of the 28-P1PM-004 pharmaceutical products system of administration 梶田貴司1, 西川実希子1, 上床知佐奈1, 西川豊1, 黒松誠1, 林口剛泰1, 雪矢良輔1, 久保美和1, 福田祐子1, 大鳥徹2, 上田睦明1, 中塚英太郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

	Examination of the duties efficiency of the drug administrative work by changes from Microsoft Excel in our 28-P1PM-005 House to Microsoft Access 谷村紀代子, 臼井麻郁子, 菊井利伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

The construction of the appropriate management method of the gemeprost component vagina bougie using 28-P1PM-006 electronic chart and the evaluation
水谷栄梨1, 濱口直美1,2, 村木優一1, 森實かおり3, 小林恵美子3, 神元有紀4, 池田智明4, 岩本卓也1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

	Construction and use situation investigation of the regime of the fentanyl percutaneous absorption type preparation for "chronic pain" by the 28-P1PM-007 electronic chart introduction 小宮孝俊, 野口朱美, 岩越有美, 中垣春美, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

Construction of the automatic request by the pharmaceutical products system of administration using 28-P1PM-008 prescription order data and the effect
山本晃平, 川口真由子, 宮本仁, 増田和司, 横山威一郎, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

	Cooperation ... of construction - measures order of use, the management of fixed number placement pharmaceutical products by the 28-P1PM-009 SAVEpH introduction 谷口公章, 甲斐章裕, 石川広大, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2014.

	Construction of the muscle relaxant use system based on the prescription in the 28-P1PM-010 operating room 佐々木宏徳1, 影本渉1, 鵜飼泰夫1, 金正煥1, 河井和子1, 伊藤和幸1, 磯谷聡1, 森川千恵美2, 金日成3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

	Real-time medicine system of administration introduction in the 28-P1PM-011 surgery center 武知和子, 森谷康志, 奥田敏勝, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

Examination (the first report) to the introduction of the drug, locking management medicine automatic withdrawal device (Inteligent-Cabinet SYSTEM(R)) in the 28-P1PM-012 surgery part
只見智恵子, 宮崎雅子, 金田純子, 野村亜紀, 山口芳幸, 林勇輔, 沼尾恵里, 長屋美香子, 高橋賢成, 木村利美
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

	It is an action of becoming it the antibiotic fixed number placement in the 28-P1PM-013 operating room 高瀬美希, 米井太志, 加藤梓沙, 齊藤暢子, 加藤雅美, 三木久子, 鈴木竜太, 林高弘, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

Uniform management of the pharmaceutical products by the set & tray combination method in the 28-P1PM-014 operating room
中村美樹, 多胡和樹, 勝部智子, 西田彩織, 廣本真里, 常村弥生, 谷車彩夏, 仲西未佳, 平田貴大, 岸敬子, 松山芽衣, 宮崎彩花, 黄前尚樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

	Efficiency of the drug regime by the interlocking movement with the 28-P1PM-015 surgery support system (Orsi's) 西園寺真二1,2,3, 中村護1, 福原伸治1, 畝知己1, 松本篤1, 前田頼伸1, 前迫一洋2, 日高昌三3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2014.

	Action for the appropriate management of the medicine targeted for the regulation in the 28-P1PM-016 operating room 中村俊貴1, 小林彦登1, 庄野浩子1, 八木澤啓司1, 宮下博幸1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

Drug control duties - PCA (Patient Controlled Analgesia) pump in the 28-P1PM-017 operating room, intervention ... of the epidural anaesthesia preparation
長谷川恭子1,2,3,4, 松橋裕子1, 神谷真衣1, 工藤真弓1, 池田早織1, 大塚一興1, 坂上逸孝1, 横山美恵子1, 村弘子2, 坂本三樹3, 舘田武志3, 大坪毅人4, 増原慶壮1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

	Uniform management of the albumin preparation of our 28-P1PM-018 House 篠原章能1, 小林幸子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

	Action of the pharmacist in the pharmaceutical products management of the practice in front of 28-P1PM-019 Hospital 大谷美奈子, 結城沙英子, 垣尾尚美, 岸本静佳, 松本敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

Relation of the outpatient dispensary pharmacist for the cancellation medicine before surgery, testing in the 28-P1PM-020 orthopedics domain
赤嶺聡彦1, 宇野真理子1, 竹下さおり1, 小林由佳1, 細井祥生2, 山村昌紀1, 平塚公己1, 太田智博1, 横山浩子1, 川野千尋1,3, 飛田夕紀1,3, 本間雅士1, 小原美江1, 高平尚伸4, 黒山政一1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

	Study on factor of the principal ingredient segregation to result from the heating fusion in the 28-P1PM-021 acetaminophen bougie 山本佳久1, 足立真希1, 大貫義則2, 深水啓朗3, 小出達夫4, 香取典子4, 鈴木豊史3, 伴野和夫3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2014.

	Simple identification technique of oral solid pharmaceutical products using the far-red spectrometry for 28-P1PM-022 forged pharmaceutical products distinction 大塚誠1, 瀬古友里恵1, 服部祐介1, Peerapattana Jomjai2, 大塚邦子3, 江口欣也4, 坂本知昭5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	Importance of the free form drug level altered in patients with 28-P2PM-001 liver damage 松岡紗代1, 大野能之1, 樋坂章博2, 山口諒1, 鈴木洋史1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	Contribution to poisoning treatment of the pharmacist by the establishment of the 28-P2PM-002 acetaminophen system of measurement 三谷健人1, 曽田翠1, 伊藤昭夫2, 吉田省造3, 小倉真治3, 伊藤善規2, 北市清幸1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	Backward investigation about the effect that a dose per body-surface area of the 28-P2PM-003 Gefitinib gives for a clinical response and side effect expression 入江慶1, 片上信之2, 岡田裕1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	Examination about the blood propofol levels assay at the 28-P2PM-004 TCI administration 平田和希1, 栗原二葉2, 小田真也2, 冨山直樹1, 河原幸恵1, 角本幹夫1, 川前金幸2, 岡野友信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	PK/PD analysis of the K+ channel inhibitory action by 28-P2PM-005 SSRI and SNRI 伴野拓巳1, 橋場弘武2,3, 矢野健太郎4, 井戸田陽子4, 荒川大4, 林正弘1,2, 荻原琢男1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2014.

	Qualitative analysis of the G-CSF bio follower product by 28-P2PM-006 LC/TOF-MS 松村健吾1,2, 大谷祐基1, 大村友博1, 米澤淳1, 津田真弘1, 吉貴達寛2, 松原和夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

	Carbohydrate chain analysis of antibody pharmaceutical products using 28-P2PM-007 LC/TOF-MS 大谷祐基, 松村健吾, 米澤淳, 大村友博, 津田真弘, 中川貴之, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

	Report of use of 28-P2PM-008 identification antimicrobial system introduction is use of carbapenem system medicine and effect to give to the bacteria rate of detection 倉内寿孝, 久米田一喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

	Proper use of the antimicrobial by the management method review of the 28-P2PM-009 report antimicrobial and improvement effect of the sensitivity rate 佐々木康弘1, 山田透2, 宮本智恵子3, 矢野雅隆4, 八木原栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

About association with use index (AHI) of the Pseudomonas aeruginosa in the 28-P2PM-010 blood tumor department ward-sensitive rate and antimicrobial and use density (AUD)
藤澤宗央1,2,3,4,5, 佐伯康弘1, 堀田尚子2, 遠藤康伸2, 中村明世3, 小川綾子3, 青墳信之4, 野口博史5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

The effect that a change of the 28-P2PM-011 antimicrobial consumption gives to the antimicrobial sensitivity of gram-negative bacilli
小関崇文, 松木祥彦, 大貫敏明, 安田麻美, 浅井浩子, 高橋優香, 岩佐典子, 杉浦健一, 畦元智子, 中村友美, 藤岡敬子, 小林健太郎, 西關由梨子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2014.

	Examination about consumption and the chemosensitivity of the antimicrobial in the 28-P2PM-012 Morioka friendship hospital 阿部慎太郎, 登坂理恵, 中島稔也, 大森英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

	Action to antimicrobial proper use by the 28-P2PM-013 antimicrobial round introduction 佐々木暢琢1,2, 藤井愛理1,2, 木村匡男1,2, 岡宏次2, 横田和美2, 鈴木由香2, 宮崎伸子2, 田中公2, 加藤公2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

	About the use situation of the injectable antimicrobial in our 28-P2PM-014 House 久米田一喜, 倉内寿孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

	The use situation of the antimicrobial judging from effect of the preventive measures against 28-P2PM-015 infection addition 中村伸也, 塚元夏苗, 井上公博, 谷山康子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

Local joint surveillance about use of antimicrobial density and the resistant bacteria separation rate with the 28-P2PM-016 Hiroshima throughout the prefecture 29 institution
池本雅章, 伊藤孝史, 小笠原康雄, 川上恵子, 木村友美, 栗原晋太郎, 先森満子, 正畠和美, 菅原隆文, 滝雪歩, 華山博子, 日浦昌洋, 武郷徹, 藤井秀一, 船越幸代, 細川宜嗣, 堀田修次, 増田博久, 光廣貴紀, 宮田篤, 安原昌子, 山口伸二, 余越芳子, 米津亜希子, 木平健治
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

The separation situation and the acquisition of resistance situation of Acinetobacter spp. in 28-P2PM-017 this country
木村修徳1, 松井真理2, 鈴木里和2, 鈴木仁人2, 柴山恵吾2, 三浦布紗子1, 永野真久1, 安森奈緒子1, 井上大奨1, 平木洋一1, 真鍋健一1, 河野文夫3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2014.

	Enlightenment activity of the 28-P2PM-018 blood culture sampling and the evaluation 上條泰弘1,3, 鎌倉明美2,3, 篠原章能1, 保科滋明1,3, 忠地花代2,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

About the observance situation of effect of the antimicrobial consumption to give the number of the methicillin-resistant staphylococcus aureus bacteria carriers in the 28-P2PM-019 Tokai Municipal Hospital and the standard precaution
小林義和1,6, 吉岡祐貴1,6, 山田昌矢2,6, 佐野菊絵3,6, 浅井雅彦3,6, 織田元4,6, 下川高賢3,6, 生田宏次5,6
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

	Discussion about a risk of developing factor of the impaired renal function with 28-P2PM-020 vancomycin and the reversibility 小嶋希望, 坪田晃司, 宮本康史, 新崎祐馬, 横山朝子, 河合祐輔, 吉田憲史, 倉島弘道, 田中喜倫, 高野陽平, 上野英文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

	Identification and property analysis of the isolated MRSA clinical in 28-P2PM-021 Tsuyama center Hospital 内田多恵子1, 和田朋子2,3, 塩津あかり1, 福島大貴1, 三好暁1, 見尾光庸1,2, 藤岡充史4, 黒田照夫5, 塩田澄子1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

	Improvement of the TDM rate of use of the antiMRSA medicine which utilized 28-P2PM-022 system 山口佳津騎, 田井達也, 樋口和子, 田中裕章, 乗松真大, 山本高成, 水川奈己, 高橋功一, 朝倉正登, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

	Property examination of the daptomycin-resistant MRSA isolated in our 28-P2PM-023 House 和田朋子1,2, 三好暁3, 内田多恵子3, 山田陽一4, 工藤季之5, 塩田澄子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2014.

	28-P2PM-024 Efforts to influenza infection by ICT 多田緑1,2, 大坊佳子1,2, 佐藤久美1, 岡本満希1, 原田典明1, 小山恭正1, 續敬之1, 結城秀樹1, 高畠啓輔2, 三田村敬子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

	About the development situation of Clostridium difficile-related loose bowels in the 28-P2PM-025 Kumamoto Red Cross hospital and the factor 四郎園巧, 浦田由紀乃, 下石和樹, 合澤啓二, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

	Action for an investigation and the standardization of the prescription intervention of the infection in the 28-P2PM-026 neurosurgery ward 倉田武徳, 石井淳一, 山本隼也, 佐村優, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

A study on fluoroquinolone tolerance of 28-P2PM-027 Pseudomonas aeruginosa isolates and application to hospital infection measures
磯崎未帆1,4, 福田達也4, 小林秀樹2,4, 寺井幸子3, 内野卯津樹3, 増田雅行3, 長島誠3, 真坂亙1, 安齊洋次郎4, 加藤文男4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

	Questionary survey about the levofloxacin medication method in the 28-P2PM-028 area 大久保嘉則, 中尾瑞穂, 三砂義敬, 床島英雄, 植村ちひろ, 鈴田浩孝, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

	Measures after the 28-P2PM-029 S.maltophilia inside the hospital development and examination of the risk factor 田中基稔1, 津曲恭一1, 大津貴寛1, 吉田裕生1, 西村尚芳1, 成田千穂2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2014.

	Clinical examination according to the age hierarchy for the patients that MRSA was detected in our 28-P2PM-030 House outpatient department 坂元佑哉1, 宮崎元康1, 永田忍彦2, 松尾宏一1, 神村英利1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

Investigation about the development situation of bloodstream infections with the Bacillus genus in our 28-P2PM-031 House and the use situation of the low-concentrated sugar addition amino acid infusion preparation
瀬名波宏昌1, 名徳倫明3, 小角麻衣1, 菅野紫2, 河田夫美代2, 橋本重樹2, 川口進一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

	Examination of the clinical background and prognostic factor of patients with iliopsoas muscle abscess in our 28-P2PM-032 House 櫻川さほり, 塚本仁, 高橋翠, 新谷智則, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

	Activity evaluation of the infection control pharmacist in the cottage-hospital out of 28-P2PM-033 守内匡1, 浅野聡美1, 田中治1, 松井ひろみ1, 松田芳美1, 白井亜紀2, 高田加壽代3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

Action to antimicrobial proper use by the 28-P2PM-034 ICT
潮平英郎1,2, 仲松正司1,3, 武加竹咲子1, 富島美幸1, 上地幸平1,4, 芦塚陵子1, 柴田馨日2, 福島裕貴2, 山内祐子1,2, 比嘉太1,3, 大湾知子1,5, 健山正夫1,3, 外間惟夫2, 植田真一郎6, 藤田次郎1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

	Example that Thyradin suppository succeeded to the patients after the total thyroidectomy which came to have difficulty with 28-P2PM-035 internal use 齋藤暢人1, 篠原義剛1, 蒲池英博1, 實松絵美子1, 日高博1, 浅原稔生1, 井上譲2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2014.

	Examination of the usefulness of the rotation, the revolution-type mixer in the 28-P2PM-036 vagina bougie preparation 山本有佳里, 加賀谷隆彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

	Evaluation of the combination ratio and the bioavailability of the greasy base to use for 28-P2PM-037 pregabalin bougie 秋本純矢, 村田勇, 井上裕, 木村昌行, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

	Efficiency of the ointment preparation with a lot of 28-P2PM-038 preparation apparatus 宮下博幸1, 八木澤啓司1, 柴田壮一1, 松原肇1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

	Examination of the Mohs ointment preparation method using 28-P2PM-039 "what like that kneading on fire Taro" 長岡匠, 臼井悟, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

Examination at the rotation, the mixed time when the revolution-type mixer is appropriate in the ointment mixture preparation using the 28-P2PM-040 hydrozincite ointment
蝦名勇樹, 棚谷貢, 佐藤裕資, 廣瀬哲也, 越田晋太郎, 管大地, 鈴木千波, 田畑裕和, 柴波明男
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

Examination about the preservation method of the polaprezinc candy agent used for stomatitis treatment treatment after the 28-P2PM-041 chemotherapy and the intraoral zinc level
宮澤映里花1,2,3, 中島孝則1, 齋藤博1, 大河内真弓2, 日比徹2, 岩田政則3, 森本一洋1, 松田佳和1, 木村正幸1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2014.

About usefulness of the ST medical mixture encapsulation using examination - simple type capsule filler about the ad here Lance improvement for children during 28-P2PM-042 chemotherapy -
田中裕章, 朝倉正登, 元木貴大, 渡邊政博, 山口佳津騎, 立道貴清, 辻繁子, 磯部芳江, 木村若菜, 野崎孝徒, 小坂信二, 芳地一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	The taste bitter masking of the intraoral film for stomatitis treatment using 28-P2PM-043 loperamide and the preparation 齋藤裕香1, 笹津備尚1, 河野弥生2,3, 花輪剛久2,3, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	Stability at masking reagent addition of 28-P2PM-044 antiHIV medicine TDV 田所諒子1, 笹津備尚1, 関根祐介2, 明石貴雄2, 大西啓1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	Examination about the making of the 10% w/v APAP suspension in the 28-P2PM-045 cancer pain relaxation 梅下翔, 瀧本紫乃芙, 藺上圭子, 宇夛裕基, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	Effect of the storage temperature to be rheological property of the 28-P2PM-046 xyloglucan solution and drug-releasing, and to give it to 下山哲哉, 前川英輝, 宮城由莉子, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	Examination of the dissolution of the enteric capsule to prepare 28-P2PM-047 inside the hospital 奈良克彦, 河合正矩, 柳原良次, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2014.

	Examination about adsorption and the preparation method to the filter of the protein ingredient included in 28-P2PM-048 autoserum eye drops 徳田篤志, 柳原良次, 中島克佳, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

	Examination about the sterilitas of the hospital preparation made under clean environment by the use of 28-P2PM-049 clean zonal generation device KOACH 村瀬哲也, 泉谷悟, 垰越崇範, 岡本知子, 須川涼, 西垣内亮, 森下麻里, 木平健治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

A search and reactions of drugs evaluation of the optimal prescription in the 28-P2PM-050 psychotropic drug component percutaneous absorption type preparation development
赤木千夏, 小幡誉子, 大貫義則, 山本章午, 池上めぐみ, 池田弘子, 亀井淳三, 高山幸三
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

	Development of the 28-P2PM-051 hospital preparation management support system 舟橋智美1, 木下功1, 川澄紀代1, 高橋直希2, 津村直樹2, 鳥井拓也3, 松浦克彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

	The collapse time for 28-P4PM-001 orally disintegrating tablet and examination about the hardness 岡山未来, 山本千鶴子, 辻和敏, 末安正典, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

	Examination of the pharmaceutics of the 28-P4PM-002 tamsulosin hydrochloride orally disintegrating tablet 白石久, 平田歩, 船戸裕樹, 阿部譲朗, 常風興平, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2014.

	Dosage form design of the opal mon lock for the purpose of the stability improvement under the 28-P4PM-003 high humidity 井上靖雄1, 関屋昇1, 片山和格1, 鳴瀧壮二1, 山本政信1, 武田和久2, 須藤眞生3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

	Study on change of the elution rate of the indomethacin capsule in the 28-P4PM-004 room temperature preservation 栗林和美, 板井裕樹, 遠藤友梨, 齋藤里砂, 吉村沙織, 阿部麻衣, 関場美香, 吉田継親, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

	Factor to have an influence on the elution rate of the 28-P4PM-005 indomethacin capsule 庄司聖, 湯谷玲子, 寺岡麗子, 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

	Preparation stability evaluation of the cream using 28-P4PM-006 MRI 大貫義則, 長谷川直毅, 黄田千尋, 鮒谷千明, 小幡誉子, 高山幸三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

	Discussion of the possibility of ward drug duties by the 28-P4PM-007 prescription intervention example analysis 高坂聡, 川辺千苗美, 畑中絵里子, 石塚久仁子, 吉元公一, 奥山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

	Examination about the way of the ward drug duties in the ward specialized in patients with 28-P4PM-008 cancer 日比野英幸1,2, 牧野好倫2, 岩瀬治雄2, 秋好健志1, 今岡鮎子1, 大谷壽一1, 林憲一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2014.

Content analysis of the pharmaceutical intervention after the ward drug duties enforcement addition calculation in the 28-P4PM-009 Gifu Municipal Hospital
大橋洵1, 水井貴詞1, 説田英利子1, 大野祐城1, 大澤友裕1, 土田陽子1, 福田聖啓1, 田中和秀1, 田中佑佳1, 市橋厚司1, 舘知也2, 安田昌宏1, 小林健司1, 佐橋誠1, 後藤千寿1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

	Action to the qualitative improvement of 28-P4PM-010 ward drug duties 田子尚史, 小材直人, 大熊範和, 田子加代子, 森田淳介, 村田文, 橋本碧, 新木美枝, 伊藤典子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

	About the good use of prescription suggestion seat as the outcome of 28-P4PM-011 ward drug duties 辻本朗, 佐山祐香, 廣末毅, 茂山真悠子, 原知斉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

	Outcome investigation after the 28-P4PM-012 ward drug duties start 羽村康一, 平綿洋子, 矢野忠, 市川訓, 宮坂宗男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

	Examination about the need of the pharmacist placement in the 28-P4PM-013 convalescent rehabilitation ward 瀧祐介, 日下豊史, 揚張真利子, 栗原梢, 山崎愛子, 後藤貴裕, 安藤奈津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

	Significance of the patient monitoring for use of safe injection drug which assumed IPSG in the 28-P4PM-014 JCI certification an index 松本早矢香, 鈴木正論, 桝田浩司, 永井淳子, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2014.

Contribution to medical security of the pharmacist ward permanent residence to see in 28-P4PM-015 pre-Abo id report
川島千夏, 益子里美, 佐山千春, 植田生織, 内藤梨奈, 松本麻美, 川迫睦美, 秋本円香, 陳内博之, 若林千草, 豊田真志, 太田和歌, 清宮麻未, 和貝直亮, 藤本菜奈, 川崎寛一, 岡部佳郎, 松本啓一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

The change to the 28-P4PM-016 ward pharmacist placement 1 ward 1.5 two weeks change system and the effect
吉田有貴子, 成川祥子, 高橋恭子, 勝田良子, 新穂祐子, 渡辺孔明, 吉澤雅恵, 風岡真実, 小野妙子, 川崎智子, 佐藤綾子, 島盛一郎, 倉橋祥子, 山内たきよ, 上村彩子, 中嶋一恵, 小林貴志, 桜井美杏, 湯浅智恵, 長澤宏之
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

Development of the ward drug duties that utilized 28-P4PM-017 balun strike scorecard
高瀬尚武1, 中田日早枝1, 三木育子1, 千崎昭輝1, 樋本繭子1, 木村有子1, 新免徹1, 合田俊一1, 相楽友香1, 尾上由華1, 塩江真代1, 松岡詩子1, 米澤圭祐1, 遠藤幹子1, 川上辰三1, 田中智也1, 赤瀬朋秀2, 室井延之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

	Ward job evaluation after the ward exclusive duty system start by the analysis of the pharmaceutical intervention contents in the 28-P4PM-018 surgery system ward 冨田昌志, 渡邊清人, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

	An action to the ward drug duties introduction in the scale hospital out of 28-P4PM-019 and the outcome evaluation 宗村雅男, 濱宏仁, 公門法子, 赤瀬博文, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

	About the prescription suggestion in 28-P4PM-020 ward drug duties 宍倉啓介, 野地良子, 安嶋優, 松本侑季, 小竹慶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2014.

	Action of the efficiency of drug control instruction duties using 28-P4PM-021 drug control instruction support system 細野由佳1, 徳武静香1, 菅原順子1, 安田礼子1, 三代貴康2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

	The effect that the development of the drug duties by the 28-P4PM-022 ward full-time union official gives to prescription intervention 山田真帆, 小田都紀子, 村木優一, 中本亜樹, 杉本浩子, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

Change of 28-P4PM-023 Japanese Society of Hospital Pharmacists medicine political situation long notice duties to see from "the present conditions investigation of the hospital pharmacy gate"
加藤将朗, 長島昌嗣, 大森尚美, 星隆弘, 菅田和也, 安岡俊明, 佐藤博, 柴川雅彦, 土屋文人, 北田光一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

	Relation of the discharge medication counseling in our 28-P4PM-024 House 鈴木さやか1, 竹尾恵理子2, 後藤健志2, 酒井欣嗣1, 石川真平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

	Evaluation (from a nurse) from other types of job before the 28-P4PM-025 "ward drug duties enforcement addition" introduction 清水けいこ, 大西祥代, 細川朋弘, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

	About an evaluation after the present conditions and the enforcement of the ward drug duties in our 28-P4PM-026 House 古俵孝明, 新谷智則, 矢野良一, 五十嵐敏明, 渡辺享平, 上谷幸男, 今野彩, 佐々木逸美, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2014.

	Effect of the ward drug duties introduction in 28-P4PM-027 pharmaceutical products proper use and the risk aversion 新谷智則, 古俵孝明, 田嶋恭典, 福岡奈央, 今野彩, 中村敏明, 政田幹夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

	Grasp of the enforcement situation of the ward drug duties that use and application performed of 28-P4PM-028 electronic chart system and future problem 町谷安紀, 甲田和恵, 池宮安葵子, 黒田絵里香, 山下恵, 浦瀬友絵, 薗村雅代, 中埜晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

	Relation of the pharmacist for the 28-P4PM-029 nursing necessary degree 池田絢, 井上尚彦, 百武宏志, 小林明信, 高木章次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

	We prevent contraindicated medication in 28-P4PM-030 pre-instructions check list 中尾耕治, 西本辰也, 杉山かおり, 田邊聖委子, 松本哲哉, 森春樹, 丹羽寿, 岩瀬崇, 西尾益治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

	One case that showed ALP high level by 28-P4PM-031 alendronic acid Na tablets and teriparatide subcutaneous administration 櫻井晴奈, 濱宏仁, 石本学司, 田中詳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

Analysis about the onset report of Stevens-Johnson syndrome using the 28-P4PM-032 adverse event spontaneous report database and the toxic epidermal necrolysis
又木香那子1,2, 梅津亮冴1, 鈴木俊之1, 阿部純子1,3, 上田夏実1, 中山蓉子1, 加藤大和1, 原英彰2, 紀ノ定保臣4, 中村光浩1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2014.

	Examination and application of the 28-P4PM-033 quickness allergy diagnostic method 安高勇気1,2, 芝口浩智2,3, 今給黎修1,2, 二神幸次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	Examination of the allergic expression of patients with amoxicillin (LMT positive) drug eruption mechanism by the cytokine mRNA analysis using 28-P4PM-034 RT-PCR 本田真知子1, 田淵紀彦1, 古川智康2, 継田雅美2, 大石智洋3, 福長将仁1, 宇野勝次1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	The actual situation of the hyperuricaemia with pyrazinamide in our 28-P4PM-035 House 右川浩, 田中三枝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	Comparison between Japan and judging from 28-P4PM-036 adverse event spontaneous report database (FAERS) side effect onset risk of isoniazid in the United States 河合加奈, 小川喜寛, 西川良平, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	About the present conditions and safety measures of the thrombosis with the oral 28-P4PM-037 female sex hormone preparation 兼松美和, 井澤唯史, 阿部和佳子, 米谷美穂, 飯村康夫, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	An example of the hyperammonemia derived from valproic acid restored by 28-P4PM-038 levocarnitine preparation 近藤勝弘1, 奥苑朱加2, 江崎哲夫1, 森義徳3, 木村和哲1,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2014.

	One case that the tremor relieved by 28-P4PM-039 famotidine cancellation 廣岡賢輔, 前田祥花, 清水浩幸, 國森公明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

	About blood sugar abnormality with 28-P4PM-040 levofloxacin 上田伊吹1, 志野訓之2, 野村泰生2, 河野修治1, 津島美幸1, 橋詰勉1, 高山明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

	Factor analysis of the husky voice expression that is a side effect of 28-P4PM-041 inhalation steroid medicine 岡田章1, 松本結希1, 山越達也2, 西川誠2, 福島恵造1, 杉岡信幸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

	Onset of low Ca blood symptom situation investigation by the 28-P4PM-042 denosumab (orchid mark note) 金子綾乃, 平井成和, 土井啓員, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

	Risk factor of the hypermagnesemia in the 28-P4PM-043 magnesium oxide preparation 畑中由香子, 足立恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

	Background investigation of the hyperkalemic inpatient in the 28-P4PM-044 Kasugai Municipal Hospital 田中伸明, 沢田俊朗, 伊東和真, 服部芳明, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2014.

Relative examination of fixed-quantity of coumalin in Chinese medicine containing the 28-P4PM-045 cinnamon bark and coumalin total intake and the liver damage
内田愛子1, 貝沼茂三郎2, 岩田直大1, 大園沙保子1, 菅原尚子1, 小林大介1, 窪田敏夫1, 島添隆雄1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

It is investigated the interruption reason of the use of PCA patients after the operation in our 28-P4PM-046 House
北森翔子, 吉岡大樹, 藤本智大, 石田あい, 上田華世, 喜多川緑, 田中比奈子, 松尾多恵, 久保智士, 山崎瑞貴, 鶴崎亮, 青木美沙, 松谷和子, 中川巌, 三嶋仁美, 木村真策
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

	Effect of the cancer chemotherapy on central nervous system side effect expression of 28-P4PM-047 opioid 土江晴江, 土井教雄, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

	About the association of 28-P4PM-048 cramps in the calves and the drug 竹下秀司1, 北川禎子1, 村松宗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

	Examination about the evaluation method of the renal function estimate in the 28-P4PM-049 dabigatran remedy patients 森田真裕子, 大久保純, 池崎友明, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

	About the effect that age and sex differences give for the effectiveness and adverse event expression of 28-P4PM-050 febuxostat 彦坂紗世1, 水野智博1,2, 林高弘3, 島袋優花1, 村瀬真穂1, 高橋和男2, 林宏樹2, 湯澤由紀夫2, 山田成樹3, 永松正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2014.

	28-P4PM-051 Drug treatment support in Janus kinase (JAK) inhibitor XELJANZ tablet taking patients 八木下敏彰1, 長谷川佳孝2, 太田孝一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

Uniform management of the information on adverse drug reactions using 28-P4PM-052 adverse drug reaction development report and content analysis
門村将太, 林祐希, 西倉奈央, 川本康太郎, 山田尚枝, 関根有貴, 藤井達郎, 鈴木智子, 野田聖奈子, 竹内美奈, 福田由布子, 井藤達也
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

	Analysis of the safe related information of the infusion put to the DI center in 28-P4PM-053 2013 津田朋枝1, 堀越由里1, 竹林佑花1, 佐々木美由紀1, 吉岡小都子1, 星泉1, 福田まゆみ1, 河野裕則1, 岩原良晴1, 松野太郎2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

	Than the serious side effect case - citizen medicine ream side effect monitor activity that occurred in 28-P4PM-054 grade 3 case and the decreased renal function patients - 田中亜紀1, 神浦茉奈実2, 山内美子3, 森吉男4, 廣田憲威5, 松本ミユキ6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

	About a side effect of 28-P4PM-055 unregulated drug and cosmetics report 井澤唯史, 兼松美和, 阿部和佳子, 米谷美穂, 飯村康夫, 高松昭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

	The effectiveness of the Teiko plastic Nin administration plan based on 28-P4PM-056 antimicrobial TDM guidelines 杉田裕貴, 田中絵美, 細見健悟, 小牧佐知子, 稲田智子, 高子優子, 増本憲生, 大槻裕朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2014.

	Examination of the optimal initial administration of Teiko plastic Nin judging from blood level of the 28-P4PM-057 simulation 青木有希1, 塩田有史2,3, 中村敦2, 木村和哲1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Examination of the Teiko plastic Nin aim trough value in the 28-P4PM-058 Enterococcus faecium blood infection treatment 岡冨大輔1,2, 宅江良隼1, 山西紀子1, 谷口雅敏1, 岡谷健史2, 板垣充弘2, 麻奥英毅2, 許泰一2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Presence or absence of 28-P4PM-059 Cancer bearing and relations of the Teiko plastic Nin blood level 佐々木紀彰, 熊澤崇, 古元俊徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Development and application ... of the PK-PD analysis - MRSA treatment support tool aiming at 28-P4PM-060 daptomycin administration optimization 石原慎之1,2, 西村信弘1, 猪川和朗2, 右川博明2, 岡崎美香1, 玉木宏樹1, 森川則文2, 直良浩司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Examination of the optimal medication method of the daptomycin by 28-P4PM-061 statistics software R 長井日生1, 並木孝哉1, 金子真隆2, 松尾和廣3, 佐古兼一4, 大林雅彦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Clinical pharmacokinetic examination for the proper use of the 28-P4PM-062 amikacin 森脇世奈1, 橋本直人1, 佐古兼一1, 松木祥彦2, 大貫敏明2, 矢嶋美樹2, 河村剛至1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2014.

	Examination of the effect on TDM of the arbekacin by the 28-P4PM-063β- lactam drugs combination 茂木武, 小林貴志, 高橋成博, 横山裕貴, 山口友里, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

	Improvement of the linezolid HPLC assay by the 28-P4PM-064 acetonitrile processing 三浦剛, 山崎伸吾, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

	Search - second report - of the blood lamotrigine levels change factor of patients with 28-P4PM-065 bipolar disorder 寺澤美穂1, 山折大1, 勝山善彦1, 北山美乃里2, 市川かおり2, 二村緑2, 田中章2, 荻原朋美2, 杉山暢宏2, 鷲塚伸介2, 大森栄1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

Clinical pharmacokinetic examination for the use of 28-P4PM-066 valproic acid fitness
谷田理奈1,2,3,4, 吉野のぞみ1, 佐古兼一1, 嶋野仁1, 柘植昂太1, 臼井沙織1, 松木祥彦2, 大貫敏明2, 町田充3, 上田恵子3, 新井亘4, 小林理栄4, 矢嶋美樹5, 河村剛至1, 松田佳和1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

	Clinical pharmacokinetic examination for the 28-P4PM-067 zonisamide proper use 柘植昂太1, 佐古兼一1, 町田充2, 上田恵子2, 小林理栄3, 新井亘3, 増田裕一3, 嶋野仁1, 谷田理奈1, 臼井沙織1, 橋本直人1, 矢嶋美樹4, 河村剛至1, 松田佳和1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

Analysis of the blood level change factor at tacrolimus route of administration change in the 28-P4PM-068 hematopoietic stem cell transplantation
末次王卓1, 内田まやこ1, 槇原洋子2, 池未裕明1, 渡邊裕之1, 矢野貴久1, 大畠俊一1, 宮本敏浩3, 江頭伸昭1, 増田智先1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2014.

	Blood tacrolimus levels analysis in patients with 28-P4PM-069 rheumatoid arthritis 吉村美里1, 須古杏子1, 高岡宏和2, 中村正2, 森岡淳子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	It is ... about a correction of the clearance during enforcement - administration of the TDM in the immunosuppressive drug administration after the 28-P4PM-070 hematopoietic stem cell transplantation 椙山聡一郎1, 上手真梨子1, 藤澤信2, 橋本真也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	1 case of the pemphigus vulgaris that needed pharmaceutical invention for CyA administration in enzyme induction of 28-P4PM-071 RFP 久保嘉靖1, 奥野昌宏1, 堀川達弥2, 中田学1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	Construction of the blood level assay of mycophenolic acid using 28-P4PM-072 column switching LC/ESI-MS/MS 相馬真志1, 菊地正史1, 前川正充1, 鈴木裕之1, 久道周彦1, 山口浩明1, 島田美樹1,2, 眞野成康1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	Blood level monitoring after the busulfan once a day administration in the transplant pre-treatment of the 28-P4PM-073 acute leukemia in childhood 石渡泰芳1, 永田将司1, 高橋弘充1, 富澤大輔2, 青木由貴2, 宮脇零士2, 森尾友宏2, 安原眞人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	Study on blood level and effectiveness of imatinib in patients with 28-P4PM-074 chronic myelogenous leukemia and safety 瀬戸良教1, 小松敏彰1, 石田有香2, 国分秀也1, 近藤留美子1, 厚田幸一郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2014.

	Examination of the administration plan by the 28-P4PM-075 dabigatran blood level measurement 松田翔平1,2, 今津智子1,2, 濱崎浩一1, 村中美香1, 中村護1, 松本篤1, 村上照夫2, 前田頼伸1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	Action of the anticancer agent preparation support system IMRS-TCA development using the 28-P4PM-076 weight inspection method 手嶋由加1, 與田賢作1, 柳原佳奈1, 日高美緒1, 野村浩子2, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	Inspection for the introduction of the anticancer agent preparation support system in the hospital attached to the 28-P4PM-077 Mie University School of Medicine 須藤宏文, 森川琢也, 村木優一, 山本弥里, 河原佑樹, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	Introduction and evaluation of the inspection system using the network camera in 28-P4PM-078 injection anticancer agent germfree preparation duties 北出紘規, 北国憲剛, 森光恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	Usefulness of the anticancer agent preparation inspection using the 28-P4PM-079 digital camera and examination of the effect to preparation time 元木孝, 足立浩, 渡邊清人, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	About automation and the inflection of the 28-P4PM-080 cancer chemotherapy preparation plan 玉井宏一, 渡部早苗, 西畑友尋, 石田佳裕, 奥津武志, 大野純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2014.

	Exposure investigation with the IMRS-TCA introduction in 28-P4PM-081 anticancer agent preparation duties 與田賢作1, 手嶋由加1, 柳原佳奈1, 日高美緒1, 野村浩子2, 平川雅章1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

	Pollution degree investigation for the clinical introduction of the 28-P4PM-082 anticancer agent mixture preparation robot 丹田雅明1, 水田直美1, 槇本博雄1, 山口徹郎1, 家田啓史2, 西岡達也1, 久米学1, 平野剛1, 平井みどり1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

Improvement for the purpose of the compatibility improvement of 28-P4PM-083 anticancer injection drug automatic preparation device APOTECA and the evaluation
森川琢也1, 杉本紗梨1, 岩本卓也1, 宮田知明2, 稲葉友之2, 江上篤2, 樋口耕平2, 守隆宏3, 村木優一1, 奥田真弘1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

	Formula in our House of 100 mg for the 28-P4PM-084 oil xanthan gum (R) infusion 黒田健吾, 寺山和利, 佐藤亜衣, 佐藤大輔, 加藤菊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

	Fact-finding about the administration time after the anticancer medicine preparation that is unstable after 28-P4PM-085 dissolution 宇佐美英績, 木村美智男, 守屋昭宏, 竹中翔也, 岡田和智, 吉村知哲, 森博美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

	Comparison between the product about the speed of the 28-P4PM-086 portable constant infusion pump 宮本仁1, 山崎伸吾1, 鈴木達也1, 仲佐啓詳2, 中村貴子1, 鈴木貴明1, 有吉範高1, 石井伊都子1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2014.

	One case using the suspension method simple in 28-P4PM-087 Valixa (R) lock remedy 高橋愛未1, 寺岡知香1, 望月千枝2, 井尻夏1, 永井絵里子1, 北川直1, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

	Examination of the formula of the endoxan bulk for oral 28-P4PM-088 市東優美, 高橋良平, 嶋崎幸也, 佐々木孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

Examination for the quantity of exposure to 28-P4PM-089 anticancer medicine in the simple suspension method
朴美姫1, 池本憲彦1, 戸屋成未1, 奥山美結樹1, 畠山和子1, 河崎陽一2, 倉田なおみ3, 清原義史4, 駒田富佐夫4, 大野雅子1, 桂木聡子1, 重松誠1, 森山雅弘1, 天野学1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

	Action to prevention of exposure to oral medicine with teratogenicity, the mutagenesis in 28-P4PM-090 children 井尻夏1, 寺岡知香1, 望月千枝2, 高橋愛未1, 永井絵里子1, 北川直1, 石川照久1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

Examination - of prevention of environmental pollution measures - scattering and the powdered medicine divided powder plane cleaning method with the 28-P4PM-091 powdered medicine anticancer agent
永井浩章, 愛甲佳未, 高本光次郎, 中山淳司, 籾井佳奈, 池田絵里佳, 三輪祐太朗, 廣瀬晃子, 福田朝恵, 赤松規子, 合田泰志, 福井由美子, 西本哲男
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

Decoration pollution with 28-P4PM-092 volatilization-related anticancer agent oral medicine cyclophosphamide and examination of the prevention method
花田貴惠1, 高見陽一郎1, 森山圭1, 大呂真史2, 小川壮寛1,2, 守安洋子2, 井上結夏1, 兼光朝子1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 島田憲一1, 高橋正志2, 江川孝1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2014.

	Investigation of the PTP sheet pollution status of the 28-P4PM-093 5-FU oral medicine 川本英子1, 高見陽一郎1, 森山圭1, 花田貴恵1, 小川壮寛1,2, 井上結夏1, 兼光朝子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 江川孝1, 島田憲一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	Examination - third report ... about the vial surface pollution of the 28-P4PM-094 anticancer medicine 吉田昭昌1, 高見陽一郎2, 森近俊之1, 花田貴恵2, 島田憲一2, 江川孝2, 松久哲章1, 二五田基文3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	Conduct an exposure to anticancer agent investigation by the 28-P4PM-095 sampling sheet method 高梨真希子, 高田正弘, 佐藤雅也, 長山晃, 角田一成, 川上典子, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	Adsorptive evaluation of the work sheet to use at 28-P4PM-096 anticancer agent preparation 佐藤淳也1,2, 菊地聡美2, 工藤賢三1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	Fact-finding of the work environmental pollution with the 28-P4PM-097 anticancer agent and action to prevention of human body exposure using the ozone water 都築大輔, 中川典江, 増田都子, 水野馨子, 小林理枝子, 阿部正博, 木内司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	An environmental pollution investigation with the anticancer medicine in the hospital built 28-P4PM-098 and future measures 三宅知宏, 野口祥紀, 服部公紀, 中西由衣, 前山恵里加, 伊藤美南子, 和田亜希, 谷村学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2014.

	The introduction of the anticancer agent exposure prevention tool of 28-P4PM-099 four and the evaluation 西健太郎1, 佐々扶美1, 山下愛子1, 北岡朋子1, 飯島愛梨1, 東小織3, 中村いずみ4, 境健爾2, 田上治美1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

	Investigation of anticancer agent exposure to 28-P4PM-100 cancer chemotherapy nursing authorization nurse course measures for nurses 宮澤真帆1, 石丸博雅2, 三浦里織3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

Simulation anticancer agent preparation class for 28-P4PM-101 area pharmacists
柿原圭佑1,2,3, 葉田昌生1,2,3, 堤一貴2,3,4, 畑瀬圭佐2,3,5, 岩永陽子2,3,6, 林田栄一2,3,7, 三宅秀敏2,3,8, 黒崎一博2,3,9, 桑野淳2,3,10, 前田健一2,3,11, 松原美紗2,3,12, 有馬千代子2,3,4, 野瀬育宏1,3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

	To prevention of anticancer agent radiation exposure for the floor nurse in our 28-P4PM-102 House wrestle 堀江都1, 堀江達夫1, 水本一生3,4, 杉本奈々絵2, 胡摩田千春2, 橘由香2, 高橋正彦1, 石橋博司1, 野宗義博3,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

Start the use of 28-P4PM-103 "handlings such as the cytotoxic waste, excrement at the anticancer agent administration"; and the attitude survey of the patients, the healthcare worker (hospital, ethical pharmacy)
伊東美歩1, 加藤幸三1, 泉雄介1, 海老原貴之1, 柄澤珠貴1, 宮城彩音1, 大森和美2, 田中紀子2, 山本勝枝2, 平原一也1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

Examination about the method for measurement of the quantity of anticancer agent pollution of the restroom due to the excrement of patients who received 28-P4PM-104 chemotherapy
兼光朝子1, 高見陽一郎1, 林瑶子2, 名和秀起2, 井上結夏1, 川本英子1, 長瀬彩花1, 浜原安奈1, 山本温子1, 花田貴恵1, 北村佳久2, 千堂年昭2, 江川孝1, 島田憲一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2014.

	Examination of the technical evaluation of the anticancer medicine preparation training using the 28-P4PM-105 fluorescein sodium 大森崇行, 石丸博雅, 高山慎司, 川名賢一郎, 後藤一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

Medical economic effect - in setting and the use of the mixed preparation duties - chemotherapy room of the 28-P4PM-106 antitumor agents of division of the antitumor agents
源川良一1,2,5, 伊藤幸1,2, 増田怜平1, 下川淳子1, 酒井慎治1,2, 木村直也1,2, 鎌田成芳2,3, 厚田幸一郎4,5
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

	Action of the aperient proper use in the 28-P4PM-107 psychopathic ward 木村伊都紀1, 五月女祐一2, 齋藤百枝美3, 小杉隆祥1, 西澤健司1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

	Relation of the ward pharmacist for the proper use of the 28-P4PM-108 lithium carbonate 安食健一, 勝部直美, 福田恵美子, 園山智宏, 横手克樹, 平野榮作, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

	Person in charge of a trend and the pharmacist of the 28-P4PM-109 risperidone sustained-release injection (RLAI) injection patients 五味和彦1, 酒井晶子1, 和田美由紀1, 前澤正和1, 羽場昇1, 樋掛忠彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

	Action (1) of the health insurance pharmacy pharmacist for the 28-P4PM-110 benzodiazepine dependent evasion 谷博子, 宮崎直子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2014.

	About drug choice in the psychiatry sleeplessness treatment judging from 28-P4PM-111 fall, a fall accident 中居香織1, 中居肇2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	About an action of the drug department for the polypharmacy of the foreign outside Parliament prescription with the 28-P4PM-112 fee-for-service revision 伊藤直美1, 和田智仁1, 伊藤由香1, 羽佐田祥浩1, 藤田康平2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	Effect of drug deprivation of benzodiazepine drugs by the brochure distribution to 28-P4PM-113 neuropsychiatry outpatient 進健司1, 梅田勇一1, 大谷達郎1, 牛島悠一1, 内田守次1, 天津透彦2, 金澤康範1, 竹本伸輔1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	Usefulness of the blood glucose level monitoring at the drugstore store which cooperated with 28-P4PM-114 psychiatrist 堀場亜佐子1,2, 藤田直希2, 森道成1, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	Role of the pharmacist in the 28-P4PM-115 alcohol detoxification 森京子, 竹中克之, 竹田正美, 山田和子, 琴坂幸広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	It is ... through the questionnaire of the medical therapy attitude survey - drug reporting book of the 28-P4PM-116 psychopathic ward inpatient 栗原梢, 日下豊史, 揚張真利子, 山崎愛子, 後藤貴裕, 安藤奈津子, 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2014.

	Evaluation of the pharmacist-led type conference in the 28-P4PM-117 psychopathic ward 大谷達郎, 進健司, 牛島悠一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	Prescription investigation of the 28-P4PM-118 Alzheimer type dementia therapeutic drug remedy patients 金子幸弘, 最上雄史, 磯部浩之, 亀川綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	28-P4PM-119 hospitalization and comparison of the medical therapy in patients with schizophrenia during ambulant treatment 福山雄卯介1,2,3,4, 後藤史子2, 福山順子3, 福嶋翔3, 鈴田浩孝4, 西野隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	Medical treatment for BPSD of patients with 28-P4PM-120 dementia 保科くるみ, 寺原史貴, 西牧武志, 勝股祐美, 齊藤俊一郎, 佐藤公人, 田村広志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	28-P4PM-121 The use situation of the psychotropic drug in the Fukuoka University Hospital 大塚誠1, 土倉史香1, 上野雅代1, 有元明恵1, 塩塚昭一1, 脇田昌子1, 鷲山厚司1, 今給黎修1,2, 二神幸次郎1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	The prescription situation of the paliperidone palmitate sustained-release suspension injection (PP) in the 28-P4PM-122 Yawata public welfare hospital 柴田木綿, 高橋麻美, 木村愛子, 園田美樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2014.

	It is fact-finding of continuously using it for 28-P4PM-123 risperidone sustained-release parenteral injection 36 months 新宅将史1, 小谷裕子1, 住吉久子1, 長尾正嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

Attitude survey of the patients for the treatment with clozapine of the 28-P4PM-124 treatment-resistant schizophrenia therapeutic drug
伊藤美那子1,2,3, 竹内一平1,2, 大谷早也佳1, 杉浦貴哉1, 半谷眞七子1, 宇野準二2, 天野雄平3, 藤田潔2, 亀井浩行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

	Comparison between psychotropic drug prescription actual situation and psychotropic drug prescription fact-finding in Toyama of our 28-P4PM-125 House 高城正利, 高橋理紗子, 新喜昌子, 平井邦彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

	Fact-finding about a psychotropic drug and the drug costs in the 28-P4PM-126 clozapine introduction case 柏宗伸1,2, 宮川慶子1, 加藤浩充1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

Fact-finding in the proper use of treatment-resistant schizophrenia therapeutic drug clozapine for 28-P4PM-127 physician and pharmacists
大谷早也佳1,2,3, 竹内一平1,2, 伊藤美那子1, 杉浦貴哉1, 半谷眞七子1, 宇野準二2, 天野雄平3, 藤田潔2, 亀井浩行1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

	Use of antipsychotics fact-finding in patients with schizophrenia during 28-P4PM-128 hospitalization 市川暁1, 原恵子1, 鈴木秀則1, 田島芳夫1, 斉藤郁夫2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2014.

	28-P4PM-129 memantine improves amyloid beta-induced cognitive functional disorder 日比陽子, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	Examination of the factor influencing the lamotrigine long-term use in the 28-P4PM-130 psychiatry domain 祖川倫太郎1, 持永早希子1, 門司晃2, 藤戸博1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	Epidemiological investigation of the ivermectin blanket operation to the scabies outbreaks in the 28-P4PM-131 psychiatry closedown ward 永井努1,2, 齋藤勲1,2, 杉沢諭1,2, 池ヶ谷訓章2, 平藤彰1,3, 内倉健1,4, 稲本淳子5,6, 村山純一郎1,4, 加藤進昌2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	It is visual testing about the absorbency at becoming it one 28-P4PM-132 paliperidone lock (in Vega (R) lock) 木藤弘子1, 神村英利2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	Examination about a clinical response and the side effect expression of 28-P4PM-133 GLP-1 receptor agonist 別當知佐, 中西大介, 出口綾子, 柳川泰裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	Examination of a diabetes onset factor at the 28-P4PM-134 adrenal cortical hormone administration and the appropriate diabetes therapeutic drug 赤羽美香1, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 篠原悦子1, 真坂亙2, 龍野一郎3, 古尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2014.

	Examination about the estrangement of HbA1c in patients with 28-P4PM-135 diabetes and glycoalbumin 六車龍介1, 内山幸子1, 佐田竜尚1, 岡本勇二1, 永江隆二1, 土井真弓2, 大塚章人3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

	Effect on type 2 diabetes nephropathy with the 28-P4PM-136 molecularity hydrogen component water administration 李静1, 薬師寺史厚2, 定本清美3, 柳川忠二1, 佐藤芳雄2, 細矢睦子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

	Evaluation - for the need of report - pharmacist participation second about the need that a pharmacist is associated with for 28-P4PM-137 diabetes dialysis prophylactic instruction management 益成宏1, 實近彩子2, 飯塚晶子2, 田畑真弓2, 田中佳江3, 畑尾克裕4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

Meta analysis about the effectiveness and the safety of water-soluble and fat-soluble statin in patients with type 2 diabetes to be complicated with 28-P4PM-138 dyslipidemia
石黒友紀1, 向井潤一1, 須田哲史1, 尾鳥勝也1, 毛利順一1, 春日井(木村)公美1, 石田有香1, 矢島愛理1, 厚田幸一郎1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

	Examination about the factor influencing bleeding, subcutaneous haemorrhage at the self-injection in patients with 28-P4PM-139 diabetes 二神咲子, 由井薗陽一, 槙林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

	It is ... for the drug proper use in patients with ... elderly people diabetes about the combination actual situation of the drug which has an influence on the 28-P4PM-140 hypoglycemic action 千田泰健1, 元木孝1, 黒澤菜穂子2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2014.

	Examination of an action and the instruction effect to 28-P4PM-141 diabetes dialysis prophylactic instruction 藤本綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

	Fact-finding of the medication self interruption in patients with 28-P4PM-142 diabetes 中島啓二1, 宇佐美英績1, 安部絵里1, 森博美1, 傍島裕司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

	We analyze a risk factor of the blood sugar control aggravation after the discharge in patients with 28-P4PM-143 type 2 diabetes 川島優季1, 岡安伸二2, 原田紗希2, 西田承平2, 鈴木昭夫2, 小林亮2, 杉山正1, 伊藤善規2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

Study on patients self-care support program by the drugstore pharmacist for the purpose of the aggravation prevention of patients with 28-P4PM-144 diabetic nephropathy (the first report)
井上岳1, 飯岡緒美2, 森貴幸3, 浅田美子3, 松本千鶴4, 古川綾4, 厚田幸一郎1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

The study on patients self-care support program by the drugstore pharmacist for the purpose of the aggravation prevention of patients with 28-P4PM-145 diabetic nephropathy (the second report): Mainly on patients satisfaction
飯岡緒美1, 井上岳2, 森貴幸3, 浅田美子3, 松本千鶴4, 古川綾4, 厚田幸一郎2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

	Use experience report of the insulin Degludec in our 28-P4PM-146 House 中辻崇子, 村上とよみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2014.

	Examination about diabetes merger dyslipidemia and the small intestine morphological functional change in the 28-P4PM-147 type I diabetes mellitus model rat 小塩浩子1, 高野美菜1, 川瀬寛子1, 木村美保子1, 高橋唯1, 藤田純佳1, 宮崎誠2, 島本史夫1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	Treatment with insulin preparation prognostic comparison for patients with 28-P4PM-148 type I diabetes mellitus 桐谷拓磨1, 佐々木英久1, 松尾和廣1, 渡辺朋子1, 篠原悦子1, 真坂亙2, 龍野一郎3, 吉尾隆1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	Examination of the important factor affecting the treatment result by the 28-P4PM-149 sustained-release insulin analog preparation Degludec 佐々木雄啓, 横田智美, 伊藤瑠美, 玉理千晴, 横山峻太, 谷後友絵, 高橋栄子, 藤本綾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	Questionary survey of the insulin pen type instillator (pre-filled type) in the 28-P4PM-150 working member of society 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	Action of the pharmacist to the diabetes education inpatient in our 28-P4PM-151 House 岡田衣里子1, 中谷成美1, 山崎肇1, 小川義高2, 辻真由美2, 木戸里佳2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	Insulin instruction and intervention result to the other courses inpatient by the 28-P4PM-152 diabetes team pharmacist 小林華南子1, 山口恭平1, 須藤久実1, 佐田賢二1, 松本早苗1, 相良英憲2, 近藤しおり3, 仙波昌三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2014.

	It is examination with the HPLC of the insulin stability at acid sodium sulfite addition to 28-P4PM-153 insulin solution 興村桂子, 山田洵也, 宮本悦子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Examination about the effect of sediment development and the preservative at blood mixture on 28-P4PM-154 insulin preparation 関野健史1, 田中幸子1, 住谷賢治2, 吉田直弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Effect of building Doug re-Putin in 28-P4PM-155 patients on dialysis and the teneligliptin 西正浩, 松井法子, 畑加奈子, 向井光一朗, 櫻間啓基, 上田晶, 坂本一貴, 羽田野桂史, 石炭兼征, 亀丸明莉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Examination about the effect of the linagliptin in the 28-P4PM-156 decreased renal function patients 辻香里1, 彦坂麻美1, 島田泉1, 渡邉幸雄1, 阿部康治1, 百々修司2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Examination of the effect on blood pressure of the 28-P4PM-157 DPP-4 inhibitor 難波静奈, 中野史也, 晴山知拓, 石田陽美, 佐藤弘康, 稲垣育宏, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Comparison of HbA1c between the 28-P4PM-158 DPP-4 inhibitor 4 preparation and the dyslipidemia improvement effect 高橋希望1, 早川伸樹1,2, 桑原宏貴3, 津川透2,3, 林高弘1,3, 福井愛子1, 亀井浩行1, 鈴木敦詞2, 伊藤光泰2, 山田成樹3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2014.

	Examination of the second invalidity in the 28-P4PM-159 DPP-4 repressor 松野下絢子, 田村未香, 大倉幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

	Elucidation of the vascular disorder inhibition mechanism through the NADPH oxidase activity inhibition of the 28-P4PM-160 DPP-4 inhibitor anagliptin 野田雅人1, 菊池千草2, 永味千枝1, 堀英生2, 松永民秀2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

	Study on kidney protection of the DPP-4 inhibitor (linagliptin) for patients with 28-P4PM-161 diabetes 田渕寿美1, 横山晋一郎2, 竹松茂樹2, 辻琢己1, 河野武幸1, 玉田太志2, 河合実2, 上野裕之4, 坂根直樹3, 北村良雄2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

Investigation of the prescription situation and the effect by the renal function distinction of sitagliptin and building Doug re-Putin in our 28-P4PM-162 House
武重彩子1, 池滝晶子1, 石川紗耶香1, 加藤小織1, 林慶人1, 西村富啓1, 佐橋幸子1, 松下啓2, 宇治原誠3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

	Investigation of a dose and the clinical response depending on renal function of the 28-P4PM-163 sitagliptin 中山英明, 小林庸子, 篠原高雄, 永井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

	The use situation of building Doug re-Putin in our 28-P4PM-164 House 駒井勇太, 小松祐輔, 人見百合子, 喜多洋嗣, 則武隆佑, 松田絵理菜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2014.

	Examination of the proper use judging from a use of DPP-4 inhibitor situation investigation in our 28-P4PM-165 House 中埜梓1, 木村麻紀1, 林千麗1, 桝田出2, 吉村尋典1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	Discussion - from questionnaire results in understanding degree - diabetes education hospitalization about the medicine of the 28-P4PM-166 diabetes education inpatient 内山幸子1, 六車龍介1, 本多優江2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	About an association between dementia evaluation scale and medication compliance in patients with 28-P4PM-167 type 2 diabetes 岡田志保1, 林洋平1, 下川福子1, 清水裕行1, 谷口一成1, 池上英文1, 山本恒彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	Summary of a role and the action of the pharmacist in the medical care team in the prevention of 28-P4PM-168 diabetes-related medical accident 守谷顕人1, 原山拓也2, 山口美裕紀3, 村上由美4, 山西妙子5, 平田敦宏1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	Action for the at-home self-injection introduction addition acquisition by the 28-P4PM-169 pharmacist 石田詞子1,2, 小野達也1,2, 西田英之1, 徳山尚吾2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	Inflection - of action - diabetes conversation map R to the class for diabetics as the 28-P4PM-170 diabetes team pharmacist 宮永幸実1,2,3, 平岩知子1, 北里博仁2, 市川敬太3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2014.

	About an association between number of the prescription drugs and glycemic control of the hypoglycemic agent in patients with 28-P4PM-171 outpatient department type 2 diabetes 石川麻利絵1, 齊藤達郎1, 蛭田剛俊1, 川口良人2, 森田雅之1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	Relation of the present situation and the pharmacist of the 28-P4PM-172 diabetes round 白石彩乃1,2, 戸倉由美子1, 志賀千恵子1, 草野仁美1, 山本舞1, 平岩あずさ1, 塚本由美子1, 小杉明日香1, 田中映美1, 吉田厚志1, 加藤大也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	Appropriate choice of the simple self-blood sugar measuring instrument in patients with 28-P4PM-173 anemia 島祐子1, 辻晶子1, 林美由紀2, 山本優子2, 太田正之3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	Usefulness of the HbA1c screening using the simple measuring instrument to perform at 28-P4PM-174 drugstore 榊原明美1,2, 石黒雅江1, 三浦進也1, 鈴木匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	1 case of the medical treatment ward which came to have good glycemic control by the intervention of the 28-P4PM-175 ward pharmacist 中川貴史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	Example that we gave Everolimus for 28-P4PM-176 insulin production pancreas neuroendocrine tumor, and hypoglycemia improved 原敬一1, 山口崇2, 渡辺怜奈2, 龍野一郎2, 真坂亙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2014.

	Elucidation of hyperoxide-producing increase by AGEs in the 28-P4PM-177 type 2 diabetes model rat femoral artery and the inhibitory effect mechanism with pravastatin 堀英生1,2, 永味千枝3, 菊池千草1,3, 竹内正義4, 松永民秀1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

	An effect of the aspirin which gives it to the platelet agglutinating capacity of the 28-P4PM-178 diabetes rat and effect with the insulin sustained administration 早勢伸正1, 松井愛子1, 鹿野宏大1, 野坂貴文1, 寺本愛子3, 駒澤愛4, 加納誠一朗2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

	28-P4PM-179 prevents a side effect in the physical assessment enforcement in being at home 岡本龍徳1,2,3, 武内幾夫2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

Physical assessment for patients with COPD wannabees excavation by the 28-P4PM-180 pharmacist
西尾廣昭1, 土谷大樹1, 小嶋英二朗1, 田中哲郎1, 数野博2, 孫尚孝3, 尾上洋3, 谷田恭洋3, 森広亜紀4, 山田真弘5, 岡田昌浩6, 横田武治7, 徳毛孝至8, 横田いつ子9, 荒川隆之10, 上敷領淳1, 杉原成美1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

	Action of the pharmacist for the Operation asthmatic death zero in 28-P4PM-181 Okayama 森英樹1,2,5, 監物英男2,5,6, 山根隆志2,3, 立野朋志5,7, 小笠原加代5,8, 小山敏章5,9, 赤澤昌樹5,10, 木村五郎11,12, 谷本安11,12, 宗田良11,12, 千堂年昭2,4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

	Action of the compliance improvement for patients with dementia by the 28-P4PM-182 visit drug control instruction 篠崎希望, 鐵尚美, 田口美菜子, 大和田有, 土居美幸, 濱武久美子, 蛭田千昭, 田村明広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2014.

	Support to a healthcare worker, the patients who utilized 28-P4PM-183 "Shiga diabetes net" 佐々木恭子1, 磯野哲一郎1, 松田雅史1, 森田真也1, 森本明子2, 宮松直美2, 寺田智祐1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

	Usefulness of the blood pressure management at the drugstore with the 28-P4PM-184 home blood pressure remote management system (medical link) 松本千鶴1,2, 水野智博1, 鍋谷伸子2, 安田宜成3, 永松正1, 梅村紀匡2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

Action (the third report) to home medical care support in 28-P4PM-185 treatment at home promotion Committee - Evaluation - of maintenance and the systems construction of the community medical care system information
青木悠1,2, 岩下誠2,3, 渕澤宏明2,3, 倉本泰志2,3, 大森健2,3, 林和枝2,3, 田中美和2,4, 小松良2,3, 竹内裕子5, 花岡幹郎3, 小松裕和6, 由井俊文1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

It is (1) about the introduction of a 28-P4PM-186 cloud type electronic chart and the single dose prescription order ring - Present conditions and problems - of the home care patient visit drug control instruction in our House
福森和俊1, 越智麻友1, 猪田幸邦1, 小澤一夫1, 光根緑2, 築田恵2, 宮本美千代2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

	Difference of the action situation to the treatment at home by the scale of the 28-P4PM-187 drugstore 秋山真里奈1, 前川史門1, 柏木宏仁1,2, 浅井秀星2, 加藤光史2, 知花聖尚2, 竹内正幸2, 合田和志1, 山下修司1, 林秀樹1, 杉山正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

	Recognition investigation of the drugstore function for 28-P4PM-188 separation of pharmacy and clinic 池田未来1, 村杉紀明2, 冨山直樹1, 角本幹夫1, 岡野友信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2014.

An investigation and examination of the thing prospective by the at-home visit instruction of the 28-P4PM-189 pharmacist
森厚司1,3, 森智彩貴2, 浅見麻莉子1, 太田淳子1, 成瀧知佳1, 松本直美1, 丹羽良子1, 吉田和美1, 伊藤由美3, 山田隆博3, 澤田敏成3, 三枝勇夫1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

Investigation about prescription contents and the medication support of the house call patients whom 28-P4PM-190 Muscat drugstore performs meeting a demand of
福嶋寛子1, 小川壮寛1,2, 川上茂利1, 守安洋子1, 高見陽一郎2, 島田憲一2, 江川孝2, 高橋正志1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

It is ... based on the Residual medicine investigation in the basic hospital in mountains out of examination ... of the factor which has an influence on 28-P4PM-191 medication ad here Lance and a questionnaire
山本直子1, 神庭隆1, 木戸脇久美1, 山口浩一2, 櫃田豊3, 大谷眞二4
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

	About the pharmaceutical products offer system medical for ergonomy, evolution - acute phase of the 28-P4PM-192 treatment at home - 串田一樹1,2,3, 白石丈也2, 前田桂吾3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

	Usefulness of the PCA pump in the 28-P4PM-193 at-home palliative care 大久保純1, 池崎友明1, 森田真裕子1, 竹内都子1, 田辺公一2,3, 北澤英徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

	The need of the common recognition of the patients and the caretaker for appropriate medical care to be provided in 28-P4PM-194 treatment at home 柏木宏仁, 浅井秀星, 今里啓二, 脇元一彰, 遠藤文人, 竹内正幸, 宮本洋行, 知花聖尚 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2014.

	Construction and practice of the clinical competence upbringing program of the pharmacist taking 28-P4PM-195 treatment at home 長嶺幸子1, 杉浦佳子1, 中村治正2, 百道敏久2, 太田光熙1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

	Development of the medication deglutition adjuvant jelly kit for 28-P4PM-196 oral intake 三上大帆, 野崎雅男, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

	Research 1 about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-197 home care patient 青木友紀1, 恩田光子1, 藤井真吾1, 廣岡真理1, 生田貴広1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

Pay the attention to patients with research 2 - dementia about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-198 home care patient; and ...
廣岡真理1, 恩田光子1, 藤井真吾1, 青木友紀1, 生田貴廣1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

Pay the attention to research 3 - arthritis deformans about the occurrence of adverse event situation judging from the main disease of the 28-P4PM-199 home care patient, patients with rheumatoid arthritis; and ...
生田貴廣1, 恩田光子1, 藤井真吾1, 青木友紀1, 廣岡真理1, 倉橋絢子1, 宮村実沙紀1, 七海陽子2, 荒川行生1, 今井博久3
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

	Relation (the first report) of the hospital pharmacist to the 28-P4PM-200 HPN introduction patients 熱海幸恵, 尾崎昌大, 添田真司, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2014.

	The present conditions and problem of the action of the pharmacist for the 28-P4PM-201 treatment at home 前川史門1, 秋山真里奈1, 柏木宏仁1,2, 浅井秀星2, 加藤光史2, 知花聖尚2, 竹内正幸2, 合田和史1, 山下修司1, 林秀樹1, 杉山正1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

	The effect that participation of the conference before 28-P4PM-202 discharge gives for visit drug control instruction 柴田賢三, 宇野達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

	Than practice - ward pharmacist of the medicine for patients with 28-P4PM-203 dementia medicine cooperation which aimed at the stable home medical treatment ... 添田美季1, 木ノ下智康1, はじ丈一郎2, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

	Than practice ... support pharmacist at home of the medicine for patients with 28-P4PM-204 dementia medicine cooperation which aimed at the stable home medical treatment ... 木ノ下智康1, 添田美季1, はじ丈一郎2, 古田勝経3, 伊藤一弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

	Than practice ... visit pharmacist at home of the medicine for patients with 28-P4PM-205 dementia medicine cooperation which aimed at the stable home medical treatment ... 櫨丈一郎1,2, 木ノ下智康2, 添田美季2, 伊藤一弘2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

Action ... to a hospital, the drug industry internship of the 28-P4PM-206 "campus Asia" core base support project report (the second report) - doctoral course graduate student
龍伸和1,2, 松原利行1, 新山雅夫1, 周徳軍1, 徐承姫1, 酒口弘光3, 高畑英信4, 今中常雄1, 細谷健一1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2014.

	Action to 28-P4PM-207 participation type long-term business training 漆舘希, 若本瑞穂, 伊藤宏彰, 櫻井良平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	Action to the pharmacy business training in our 28-P4PM-208 House 太田哲徳, 枦秀樹, 金森大祐, 宮原由香里, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	Action for the business training enhancement in the hospital attached to the 28-P4PM-209 Mie University School of Medicine 河原佑樹, 池村健治, 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	Result of the kidney disease medical therapy education in the 28-P4PM-210 pharmacy student hospital business training 吉沢純, 原直己, 大月沢雄, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	The construction of the foreign chemotherapy training program in the 28-P4PM-211 business training and the evaluation 舘知也1,2, 大澤友裕2, 田中和秀2, 安田昌宏2, 水井貴詞2, 棚橋純子3, 野口義紘1, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	A trial of the palliative care education in the 28-P4PM-212 trainee and the effect (the second report) 飛鷹範明, 木村博史, 和田昌子, 井門敬子, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2014.

	A learning effect and stress of the business training in the 28-P4PM-213 Fukuoka University Chikushi Hospital 田中麻衣子1,2, 松尾宏一1,2, 後藤美和2, 山廣胤之2, 金子朋博2, 五十嵐保陽2, 神村英利1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

	Change of the consciousness of the business trainee for the 28-P4PM-214 palliative care 藤本伸一郎, 伊藤武志, 藤原季美子, 古川諭, 木寺康裕, 川口明範, 淺野肇, 柳江正嗣, 野村守弘, 山添譲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

	Attitude survey for the pharmacy school fourth grader about the ward training of the 28-P4PM-215 cancer domain 曽賀千智1,2, 江戸清人1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

	Analysis of the factors such as the education or training instruction system before training to give to an acquisition degree of the student of the 28-P4PM-216 business training 橋本久邦, 河村剛至, 有冨桂子, 中島孝則, 松田佳和, 木村正幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

Confirmation of the training result in the preparation, injection room training of the 28-P4PM-217 pharmacy school fifth grader and future problem
柳野紗智子, 小園幸輝, 渡辺和美, 長谷川哲也, 濱田真紀子, 池田貴之, 今川貴仁, 大谷隼斗, 尾栢有美, 馬渕匠, 越川一誠, 小杉隆祥, 西澤健司
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

	Present conditions investigation - SBO about the evaluation of achievement of the 28-P4PM-218 business training and relative - of the number of evaluations 千葉健史1, 松浦誠2, 前田智司3, 佐塚泰之2, 工藤賢三1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2014.

	Inspection ... by the questionary survey from 28-P4PM-219 2011 to summary and problem - student of the long-term business training in the 2013 Tsurumakionsen hospital 新枦義之, 福田詩織, 内海誠司, 樋島学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

	Questionary survey - for examination - staff of the usefulness of the hospital training team in our 28-P4PM-220 House 寺山和利, 若木麻由, 岡田侑子, 佐藤亜衣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

	Study on usefulness of the homepage in the intelligence of the training for the 28-P4PM-221 business training 諏訪祥太郎1, 関根令奈1, 東千里2, 石塚和美2, 櫻井正太郎2, 湯本哲郎1,3, 稲葉健二郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

	Usefulness of the antiMRSA medicine TDM pass in the 28-P4PM-222 drug monitoring training 鈴木仁志1, 上岡泰弘1, 野上佳奈子1, 土屋節夫1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

	Diabetes education curriculum introduction and the effect on 28-P4PM-223 business trainee 長谷川裕矢, 奈良由里絵, 山田義明, 松本利恵, 野田孝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

	Relation (the second report) to the business training in the 28-P4PM-224 mental hospital 笠原真理1,6, 鶴谷勝実1,6, 白井博1,6, 佐藤芳惠2,6, 高橋満里3,6, 石動郁子4,6, 齊藤浩司5,6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2014.

An action and evaluation of the field of emergency intensive care, disaster medical care in the 28-P4PM-225 pharmacy education business training
原直己1, 高梨愛1, 加瀬和也1, 座間味義人2, 金明俊1, 大月沢雄1, 石田明子1, 永嶋一貴1, 内田佳菜子1, 松田俊之1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

	Prior explanation for the 28-P4PM-226 effect-like business training 小林典子, 鈴木小夜, 青森達, 手塚叔人, 中村智徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

	Refinement of the lecture for the business trainee of the 28-P4PM-227 hospital pharmacist 齊藤康介1, 舘知也1, 江崎宏樹1, 臼井一将1, 加藤未紗1, 浅野祥子1, 横井貴文1, 野口義紘1, 後藤千寿2, 寺町ひとみ1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

Investigation about the present conditions in the long-term business training at the hospital attached to the 28-P4PM-228 Kumamoto University School of Medicine and the resident teacher
成田勇樹1,2, 宮本晋治2, 城野博史2, 政賢悟2, 上田泰子2, 木永舞2, 野正孝子2, 片野田朋美2, 内田隆2, 齊藤綾子2, 橋口ゆみ2, 山下諒祐2, 門脇大介1, 齋藤秀之2, 平田純生1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

Trial of the good use of to duties ward drug duties manual which 28-P4PM-229 new face pharmacist made and self-assessment check sheet
植田真理1, 和田佳世子1, 米田勇太1, 南野麻衣1, 田中待希1, 小川充恵1, 森本千穂1, 中谷成美1, 長谷圭悟1, 香川雅一2, 小枝伸行3, 山崎肇1,2
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

	The construction of the duties acquirement degree check list in the hospital pharmacy attached to the 28-P4PM-230 Mie University School of Medicine and the evaluation 村木優一, 岩本卓也, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2014.

	Construction of the education system for the early duties acquisition for the 28-P4PM-231 new face pharmacist 佐藤仁宣1, 押賀充則1, 駒井信子2, 本郷知世1, 平野光枝1, 伊藤博1, 山口正和3, 加藤一郎1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	The new face training in our 28-P4PM-232 House, action third report of the lifetime education 須貝瑶子1, 坪谷綾子1, 加藤利康1, 土師日香里1, 松本浩1, 濱野公俊1, 坂下裕子1, 増原慶壮1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	Examination of the factor to affect ad here Lance by the simulated experience of the pharmacist of the 28-P4PM-233 diabetes medical therapy 藤田直希, 菊池千草, 松永民秀, 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	Practice and attitude survey of the clinical power improvement program of the 28-P4PM-234 pharmacist 金正興1, 川添潤1, 嶋村久美子1, 遠藤美緒2,3, 星茜1,3, 塩田一博1, 北原加奈之1,3, 増島絵里子4, 垂水庸子5, 峯村純子1, 村山純一郎1,3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	About the clinic of the pharmacist in the 28-P4PM-235 Hyogo Prefectural Awaji medical center 国東ゆかり, 岩根奈緒美, 青井直樹, 岡田悠加, 畑祥平, 嶋田友香, 辻本勉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	Experience the 28-P4PM-236 Thomas Jefferson University paramedics training 宮原由香里, 青山幸枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2014.

	Action ... experience type learning 2014 ... of the 28-P4PM-237 Saitama hospital pharmacist society area training sectional meeting west block 渡邉絵美1,6, 安野伸浩1,6, 新井成俊2,6, 鍵山智樹3,6, 黒下龍二4,6, 古高裕子5,6, 井澤正義6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

	Action aiming at 28-P4PM-238 inhalational instruction unification 今岡寛美, 井上博之, 榎本美幸, 飯野倫子, 池原茉理, 石原美加 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

	The effect that a palliative care study session in the 28-P4PM-239 pharmacy gives to the knowledge equalization of the pharmacist 佐藤亮, 岡本明大, 濱口直美, 赤阪未来, 須藤宏文, 水谷栄梨, 宮本明希, 岩本卓也, 村木優一, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

	Action of medicine-based universities, graduate schools for the 28-P4PM-240 cancer professional training of the whole country 青森達1, 望月眞弓2, 中村智徳1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2014.

	27-P5-IN001 The Effect of Patient's Satisfaction with Medication Counseling throughout Administration on Medication Compliance and Reporting Side effects Kim Soyoung, Im Taehwan, Choi In Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

	27-P5-IN002 Evaluation of Antimicrobial Use in Chemotherapy - induced Febrile Neutropenia SeolHee Jeon, HyunJung Choi, SoHyun Lee, YoungMi Kim Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

	27-P5-IN003 Evaluation of Delirium Management and Assessment Team in Surgical Patients Kiminaka Murakawa1,2, Yoshihisa Kitamura1,3, Saori Watanabe3, Shiho Hongo3, Shinitirou Inoue2, Kazuaki Shinomiya3, Toshiaki Sendo1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2014.

	27-P5-IN004 Toxicology of Photoinitiators Found in Intravenous Injection Solution Yoichi Kawasaki1, Chiaki Tuboi2, Noriko Kuhara2, Miwa Morizane2, Mariko Takai2, Kenta Yagi2, Satoru Esumi1, Yoshihisa Kitamura1,2, Toshiaki Sendo1,2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

27-P5-IN005 Assessment of Pharmaceutical Intervention by Ward Pharmacists for Inpatients' Drug Therapy
Ko-ichi Ohtaki1,2, Toshio Awaya1, Tomomi Tanikawa1, Shinya Iida1, Chieko Hara1, Yasunori Yamashita1, Takashi Ono1, Masatomo Inoue1, Norihisa Kimura1, Katsutoshi Tahara1, Tomoka Asashita1, Ko-ichi Yoshida1, Kaori Yamamoto1, Kuniko Yamamoto1, Satoshi Ogawa1, Masahide Fukudo1, Kazuo Matsubara3, Yoshikazu Tasaki1, Kaori Yamamoto1, Kuniko Yamamoto1, Satoshi Ogawa1, Masahide Fukudo1, Kazuo Matsubara3, Yoshikazu Tasaki1
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

	27-P5-IN006 Drug tracebility system using IC tags in hospitals - Construction of a trace model system through effective application of electronic tags - Takao Orii1, Chikayuki Ochiai2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2014.

27-P5-IN007 International Exchange Committee activities report 2013 - 2014 in The Japanese Society of Hospital Pharmacists
Takao Orii, Yasuo Takeda, Hiroko Ota, Hitoshi Sasaki, Naomi Sogabe, Hiromitsu Takahashi, Yoshikazu Tasaki, Makoto Hayakari, Satohiro Masuda, Keishiro Izumi, Kazuo Matsubara, Toshiaki Yasuoka, Mitsukazu Kitada
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

	27-P5-IN008 Tacrolimus medication management for patients with nephrotic syndrome by clinical pharmacists Bing Shao, Gaofeng Liu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

	27-P5-IN009 Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia : a meta-analysis Jun Lu, Hai-Rong He, Mao-Yi Wang, Ya-Lin Dong Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2014.

	27-P5-IN010 Chemical Profile- and Pharmacokinetics - Based Investigation of the Synergistic Property of Platycodonis Radix in Traditional Chinese Medicine Formula Shengxian Decoction Feng Zhang, Qin Zhan, Wan-Sheng Chen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

	27-P5-IN011 Exploration and Experience of Training Pediatric Clinical Pharmacist Liu Ying Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

	27-P5-IN012 A Survey of Off - label Drug Use Prescriptions in Pediatrics Outpatient in Peking University People's Hospital Li Ying, Huang Lin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2014.

	27-P5-IN013 Building a model of Objective Structured Clinical Examination in a Medical Center in Taiwan. Mei-Chu Huang1,2, Jui-Ling Fu1, Yow-Wen Hsieh1, Hui-Yun Chang2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

	27-P5-IN014 Analysis of Off-label Drug Use in Hospitalized Children in Department of Endocrinology in Our Hospital Meng Yao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

	27-P5-IN015 Rapid and Sensitive LC-MS/MS Method for the Analysis of Paclitaxel, Docetaxel, Vinblastine and Vinorelbine in Human Plasma Shouhong Gao, Jingya Zhou, Wansheng Chen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2014.

	27-P5-IN016 Utilization of National Essential Drugs in Community Medical Institutions of Beijing Si Yanbin, Zhao Zhigang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

	27-P5-IN017 A simple and accurate method for voriconazole concentration determination in human plasma with UHPLC-MS/MS Wang Jing-jing, Zhou Qiong, Yao Qin, Huang Hua, Zheng Qiao-ling, Zhang Jun Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

	27-P5-IN018 Inhibition of Atorvastatin on the catalytic activity of human UDP-glucuronosyltransferases Wu Yuan, Dong Rui-hua, Liu Ze-yuan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2014.

	27-P5-IN019 Analysis of 88423 Prescriptions from Outpatient and Emergency Departments in My Hospital Yan Han, LI Chao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2014.

	27-P5-IN020 Determination of Oseltamivir and Oseltamivir Carboxylate in Placental Perfusate by HPLC-MS/MS Yao Qin, Huang Hua, Zheng Qiao-ling, Wang Jing-jing, Zhang Jun Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2014.

	Pharmacoepidemiologic research design and example 赤沢学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2014.

	28-C-SS-1 oral anticancer medicine and ad here Lance 安藤雄一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2014.

	Examination ... of the pharmacist outpatient department usefulness in the treatment with practice ... oral molecules target medicine for team approach in medical care of the collection of 28-C-SS-2 study 四十物由香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2014.

	Example - in multidirectional action - public general hospital by the pharmacist specialized in a cancer in the 28-C-SS-3 cancer medical therapy 木村美智男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2014.

	The medicine medicine cooperation that utilized 28-C-SS-4 area unification type medicine notebook "society Tsu medicine notebook" 木本真司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2014.